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Summary 
In the present study, recombinant proteins representing the transmembrane 
domain of M. haemolytica outer membrane protein A (OmpA) from a bovine 
serotype A1 isolate (rOmpA1) and an ovine serotype A2 isolate (rOmpA2) were 
over-expressed, purified and used to generate anti-rOmpA1 and anti-rOmpA2 
antibodies, respectively. An examination of the binding specificities of these 
antibodies to M. haemolytica isolates representing different OmpA subclasses 
revealed that cross-absorbed anti-rOmpA1 antibodies recognised OmpA1-type 
proteins but not OmpA2-type proteins; conversely, cross-absorbed anti-rOmpA2 
antibodies recognised OmpA2-type proteins but not OmpA1 type proteins. This 
demonstrated that OmpA1 and OmpA2 are surface-exposed and could potentially 
bind to different receptors in cattle and sheep. The outer membrane 
subproteomes of seven M. haemolytica isolates and one M. glucosida isolate 
were also characterised and compared after growth in complex growth medium 
in order to identify OMPs with putative roles in host-specificity and virulence. 
First, a simple bioinformatic workflow (E-Komon et al., 2011b) was used to 
confidently predict 93 unique OMPs encoded among the genomes of a bovine 
serotype A1 M. haemolytica isolate and two serotype A2 isolates (one bovine and 
one ovine). Secondly, a combination of gel-based and gel-free proteomic 
approaches employing MALDI-TOF-TOF and LC-ESI-QqTOF mass spectrometry 
identified 55 unique OMPs among the outer membrane fractions of seven M. 
haemolytica isolates and one M. glucosida isolate (of which 50 were predicted by 
the bioinformatic approach). A role in host-specific adaptation could not be 
established for any of the identified OMPs, however, the study represents the 
most comprehensive analysis of M. haemolytica and M. glucosida outer 
membrane subproteomes to date. In order to identify putative virulence-
associated OMPs, the outer membrane subproteomes of the same representative 
isolates were also characterised after in vitro growth under conditions that were 
designed to mimic the in vivo host respiratory tract microenvironment. These 
conditions included growth in iron-restricted medium, serum-supplemented 
tissue culture media and growth on solid-surface agar (in the absence or 
presence of Congo red). This approach allowed the identification of 13 
additional OMPs that were not identified after growth in complex medium alone. 
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1.  INTRODUCTION 
1.1 The organisms 
1.1.1 History and taxonomy of M. haemolytica and M. glucosida 
The causative agent of a disease which caused pneumonic pasteurellosis in 
calves was originally described as Bacterium bipolare multocidum in 1885 (Kitt, 
1885). It was later renamed Bacillus boviseptica in 1896, and then further 
subdivided into separate groups that cause either bovine fibrinous pneumonia 
(Pasteurella boviseptica) or haemorrhagic septicaemia (now Pasteurella 
multocida) (Jones, 1921). Newsom & Cross studied this group in detail and 
suggested the name Pasteurella haemolytica for the bacterium that causes 
pneumonia in calves (Newsome and Cross, 1932). This species was subdivided 
into biotypes A and T, according to their ability to ferment L-arabinose and 
trehalose, respectively (Smith, 1961, Smith, 1959). Capsular serotyping of P. 
haemolytica has established seventeen different serotypes to date (Biberstein et 
al., 1960, Biberstein and Gills, 1962, Angen et al., 1999a). P. haemolytica was 
later removed from the genus Pasteurella based on DNA-DNA hybridization 
(Mutters et al., 1985). The trehalose fermenters were also later reclassified as a 
separate species, Pasteurella trehalosi (now Bibersteinia trehalosi), based on 
evidence from numerical taxonomic analyses and DNA-DNA hybridization (Sneath 
and Stevens, 1990, Biberstein and Francis, 1968). Twelve of the biotype A 
organisms (serotypes 1, 2, 5-9, 12-14, 16 and 17) have been reclassified as 
Mannheimia haemolytica and the A11 serotype has been renamed as a separate 
species, Mannheimia glucosida (Angen et al., 1999a).  
M. haemolytica is no longer a Pasteurella sensu stricto, but now occupies a 
place in the Mannheimia genus on a branch of a phylogenetic tree within the 
gamma subdivision of the Proteobacteria, whose closest relatives are B. 
trehalosi, Actinobacillus capsulatus, and Haemophilus parainfluenzae 
(Highlander, 2001) (Fig. 1.1). 
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Figure 1.1. Phylogenetic tree of members of the Pasteurellaceae produced 
from 16S rRNA sequences. GenBank Accession numbers for the 
sequences used are shown in parentheses. 
Phylogenetic tree adapted from Highlander et al. (2001). 
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1.1.2 Morphological and biochemical characteristics of M. haemolytica and 
M. glucosida 
1.1.2.1 Cell morphology  
M. haemolytica and M. glucosida are small, non-motile, encapsulated Gram-
negative coccobacillus exhibiting slight pleomorphism and occasional bipolar 
staining (Adlam, 1989). Fimbriae have been described on the surface of serotype 
A1 M. haemolytica isolates grown in culture (Potter et al., 1988, Morck et al., 
1987) and isolated from infected cattle (Morck et al., 1989), but have not been 
identified on other M. haemolytica serotypes or on M. glucosida. 
1.1.2.2 Cultural morphology  
Colonies of M. haemolytica and M. glucosida are smooth and greyish in colour 
and are 1-2 mm in diameter after 24 h growth on blood agar (Angen et al., 
1999a). Most strains of M. haemolytica and all strains of M. glucosida are 
haemolytic on bovine blood agar (Angen et al., 1999a). 
1.1.2.3 Biochemical characteristics 
The biochemical characteristics of M. haemolytica and M. glucosida have been 
previously described (Angen et al., 1999a, Mutters et al., 1989) and are 
summarised in Table 1.1. The two species have common characteristics for 
haemolysis and the fermentation of trehalose, D-sorbitol, D-xylose, maltose, 
dextrin, indole and D-melibiose, but can be differentiated by the NPG test. 
1.2 The diseases 
1.2.1 Pneumonic pasteurellosis in cattle (shipping fever) 
M. haemolytica is the principal etiological agent of bovine pneumonic 
pasteurellosis, a disease which is often referred to as shipping fever (also transit 
fever, bovine respiratory disease, dust pneumonia, bronchial pneumonia, 
fibrinous pleuropneumonia and bovine epizootic pneumonia). Various 
combinations of environmental stresses can contribute to the pathogenesis of 
the disease, including shipment, weaning, overcrowding and inclement weather 
(Singh et al., 2011). Several viruses that are ubiquitous in the cattle population 
are also associated with the disease, including bovine parainfluenzae virus 3, 
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Table 1.1. Biochemical characteristics of M. haemolytica and M. glucosida. 
 
Property M. haemolyticaa  M. glucosidaa 
Haemolysis + + 
Orthinine decarboxylase − +/− 
Trehalose − − 
L-Arabinose − +/− 
D-Sorbitol + + 
D-Xylose + + 
Maltose + + 
Dextrin + + 
Glucosides − +/− 
Gentiobiose − +/− 
NPG (β-glucosidase) − + 
Meso-Inositol +/− + 
ONPF (α-fucosidase) + +/− 
ONPX (β-xylosidase) +/− +/− 
ONPG (β-galactosidase) +/− + 
Indole − − 
D-Melibiose − − 
aSee references Angen et al. (1999a) and Mutters et al., 1989. 
‘+’ = positive; ‘−’ = negative; ‘+/−’ = positive or negative 
 
  
 5
bovine respiratory syncytial virus, bovine herpesvirus 1, bovine viral diarrhoeae 
virus, Mycoplasma species, and other bacteria (Singh et al., 2011). The 
processes by which environmental stresses or viral infections, either alone or in 
combination with each other, predispose cattle to shipping fever are not fully 
understood. In healthy cattle, M. haemolytica are carried in the nasopharynx 
and tonsils in low number and are not readily detected by nasal swab cultures 
(Frank, 1989). Under the context of immune suppression, caused by 
environmental stress or viral infection, specific serotypes of M. haemolytica 
rapidly multiply in the upper respiratory tract. Serotype A1 isolates are most 
commonly associated with cases of bovine disease (although serotype A6 isolates 
are responsible for an increasing proportion of disease cases), whereas serotype 
A2 isolates are frequently recovered from asymptomatic animals. The larger 
bacterial numbers result in aerosolised droplets containing bacteria accessing 
the trachea and lungs and causing pneumonia. Death can occur in as little as 2 to 
3 days, or the infection can proliferate and cause chronic lung damage. The 
early clinical symptoms of the disease are fever, cough, depression, anorexia, 
dyspnoea, and nasal and eye discharge (Frank, 1989). 
1.2.2 Pneumonic pasteurellosis in sheep 
Pasteurellosis is one of the most common infectious bacterial diseases of sheep 
(Gilmour and Gilmour, 1989). M. haemolytica is responsible for causing 
pneumonia in all ages of sheep and septicaemia in young lambs (Gilmour and 
Gilmour, 1989). All M. haemolytica serotypes are recovered from sheep. In ovine 
pneumonic pasteurellosis disease cases, serotype A2 is most frequently 
recovered, followed by serotypes A7 and A9, whereas serotype A1 isolates are 
frequently recovered from asymptomatic animals. Similar to bovine disease 
cases, predisposing factors to ovine pneumonic pasteurellosis include 
environmental stresses and viral infection. M. glucosida is an opportunistic 
pathogen of sheep that is not normally associated with disease conditions and 
probably represents part of the resident microflora in the upper respiratory tract 
(Biberstein and Gills, 1962, Angen et al., 1999a). 
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1.3 The Gram-negative cell envelope 
The cell envelope of Gram-negative bacteria is comprised of two membranes, 
the inner membrane and the outer membrane, separated by the periplasm. The 
inner membrane is at the boundary between the cytoplasm and the periplasm, 
whereas the outer membrane is at the boundary between the periplasm from the 
external environment. Although these two membranes are both lipid bilayers 
which contain proteins, their structure and composition are dramatically 
different as a result of their different functions and the dissimilar environments 
that they contact (Ruiz et al., 2006) (Fig 1.2). 
1.3.1 Inner membrane 
The inner membrane is composed of a symmetrical phospholipid bilayer 
interspersed with proteins. Although inner membrane phospholipid content 
varies between different species of bacteria, in E. coli 70-80% is 
phosphatidylethanolamine, 15-20% is phosphatidylglycerol and 5% or less is 
cardiolipin (Kanemasa et al., 1967, Yamagami et al., 1970). These proteins can 
be of two types, integral proteins and lipoproteins. Integral inner membrane 
proteins span the inner membrane with α-helical transmembrane domains, 
whereas inner membrane lipoproteins are anchored to the periplasmic side of 
the membrane by lipid modifications at the N-terminus of the prolipoprotein. 
Inner membrane proteins are involved in important cellular processes including 
energy production and conservation in the respiratory chain, signal transduction, 
cell division and transport across the membrane. 
1.3.2 Periplasm 
The periplasm is a highly viscous compartment that contains soluble proteins and 
a thin peptidoglycan layer. Proteins in this compartment are involved in 
processes such as protein folding, transport and degradation, outer membrane 
biogenesis, and sensing and responding to environmental stimuli. It is an 
oxidising environment and contains enzymes which catalyse disulphide bond 
formation, a crucial process for the folding and stability of proteins secreted 
through the cell envelope (Nakamoto and Bardwell, 2004). The peptidoglycan 
layer serves as an extracytoplasmic cytoskeleton that contributes to the rigidity 
of the cell envelope, maintains cell shape and prevents cell lysis.  
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Figure 1.2. Schematic diagram of the Gram-negative cell envelope. 
The cell envelope of Gram-negative bacteria is comprised of an 
inner membrane (IM), the periplasm and the outer membrane (OM). 
The inner membrane is a symmetrical phospholipid bilayer 
containing integral membrane proteins that have α-helical 
transmembrane domains. The peptidoglycan separates the inner 
and outer membrane and contains a thin layer of peptidoglycan. 
The outer membrane is an asymmetrical lipid bilayer containing 
phospholipids on the inner leaflet and LPS on the outer leaflet. The 
outer membrane also contains integral proteins that mainly adopt 
β-barrel conformations. Both membranes contain lipoproteins that 
anchored to the periplasmic side. The outer membrane also 
contains lipoproteins which are exposed on the outer leaflet. Figure 
adapted from Ruiz et al. (2006). 
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1.3.3 Outer membrane 
In contrast to the inner membrane, the outer membrane is asymmetric, with the 
inner leaflet composed of phospholipids and the outer leaflet composed mainly 
of LPS. The phospholipid composition is slightly different to that of the inner 
membrane, as the outer membrane is enriched with saturated fatty acids and 
phosphatidylethanolamine (Lugtenberg and Peters, 1976, White et al., 1972). 
The LPS functions as an effective permeability barrier due to its low fluidity and 
strong lateral interactions between molecules (Nikaido, 2003). Like the inner 
membrane, the outer membrane also contains both integral OMPs and 
lipoproteins; however, in contrast to the α-helical integral proteins of the inner 
membrane, integral OMPs span the outer membrane predominantly with 
amphipathic antiparallel β-strands which adopt a β-barrel conformation that 
allows many OMPs to serve as channels (Koebnik et al., 2000, Schulz, 2002). 
Similar β-barrel proteins are also found in the membranes of chloroplasts 
(Schleiff et al., 2003) and mitochondria (Casadio et al., 2002). Outer membrane 
lipoproteins can be anchored to either the periplasmic or extracellular face of 
the outer membrane (Tokuda and Matsuyama, 2004). About 50% of the outer 
membrane mass consists of integral OMPs and lipoproteins (Koebnik et al., 
2000). 
1.3.3.1 Getting things in: OMPs involved in nutrient uptake 
The outer membrane of Gram-negative bacteria is a very effective permeability 
barrier that also poses a challenge with respect to nutrient uptake. For this 
reason, Gram-negative bacteria possess a range of OMPs for either passive or 
active uptake of essential nutrients from the extracellular milieu. 
1.3.3.1.1 General porins 
The general porins form aqueous channels that allow diffusion of small 
hydrophilic molecules (< 600 Da) into the cell and show no particular substrate 
specificity (with the exception of preferences for cations or anions) (Nikaido, 
2003). They are generally between 30 and 50 kDa in size (Nikaido, 2003). The 
first porin crystal structures were of the Rhodobacter capsulatus porin (Weiss et 
al., 1991) and the E. coli general porins PhoE and OmpF (Cowan et al., 1992) 
(Fig. 1.3). These revealed that the porins were present as homotrimers in the  
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Figure 1.3. The crystal structure of the E. coli OmpF porin homotrimer.  
Extracellular loops 2 (L2) and 3 (L3) are indicated for each subunit 
monomer. OmpF structure was adapted from Cowan et al. (1992); 
PDB reference 10PF. 
 
 
  
 10
outer membrane and that each monomer was a β-barrel containing 16 
antiparallel β-strands. The size of the eyelet region of OmpF was measured at 
0.7 by 1.1 nm (Cowan et al., 1992). In porins, the third extracellular loop (L3) 
folds back into the barrel, forming a constriction zone and contributing 
significantly to the permeability properties of the pore (i.e. exclusion limit and 
ion selectivity). The second extreacellular loop (L2) bends over the wall of the 
neighbouring barrel subunit, playing a significant role in trimer stabilisation 
(Nikaido, 2003). Porins are able to transition between open or closed states 
depending on the transmembrane potential across the outer membrane (Koebnik 
et al., 2000). 
1.3.3.1.2 Substrate-specific porins 
Besides the general diffusion porins described above, the outer membrane also 
contains porins that are substrate-specific. The best-studied example is the E. 
coli maltoporin LamB, a specific transporter of maltooligosaccharides of various 
sizes. Like the general porins, LamB is present as a homotrimer in the outer 
membrane and each monomer is a 47 kDa β-barrel containing 18 antiparallel β-
strands (Schirmer et al., 1995). The L1, L3 and L6 loops fold back inside the 
barrel, forming a channel (0.5 to 0.6 nm in diameter) that is more constricted 
than the general porins (Schirmer et al., 1995). The length of the channel 
interior contains a row of aromatic amino acid residues (greasy slide) that are 
lined up by polar residues (polar track), creating a maltooligosaccharide-specific 
translocation pathway that facilitates passage through the channel (Dutzler et 
al., 1996). Similar structural characteristics are also seen in the Salmonella 
typhimurium sucrose-specific porin ScrY (Forst et al., 1998). 
1.3.3.1.3 TonB-dependent receptors 
TonB-dependent receptors bind and actively transport specific substrates across 
the outer membrane which are either poorly permeable through porins (> 600 
Da) or are present at very low concentrations and require energised transport for 
their translocation. These substrates include host iron-binding proteins, 
siderophores, haemophores, vitamin B12, nickel chelates and carbohydrates 
(Schauer et al., 2008). TonB-dependent receptors contain a C-terminal integral 
membrane β-barrel comprised of 22 antiparallel β-strands (Ferguson et al., 
1998, Locher et al., 1998, Buchanan et al., 1999) (Fig. 1.4) that form a pore 
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Figure 1.4. Schematic diagram of TonB-dependent receptor transport.  
A substrate binds to the TonB-dependent receptor with high-affinity 
and is transported across the outer membrane. In the periplasm, 
the substrate binds to a periplasmic-binding protein (PBP) that 
transports it across the periplasm to the inner membrane. The 
substrate is then transported across the inner membrane into the 
cytoplasm by an ATP-binding cassette (ABC) transporter. TonB-
dependent receptor structure was adapted from Ferguson et al. 
(1998); PDB reference 2FCP. 
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which is larger (3.5 by 4.7 nm) than that of the porins. The N-terminus forms a 
plug domain which occludes the pore and prohibits the passage of substrates. 
Substrate binding occurs at sites on the extracellular side of the plug domain and 
on the walls and extracellular loops of the β-barrel. Transport of the bound 
substrate through the β-barrel is an energy-dependent process; however, the 
outer membrane is not capable of producing energy due to the absence of either 
ATP-hydrolysing enzymes or a proton gradient. The required energy is obtained 
from the proton motive force of the inner membrane and transduced to the 
outer membrane via three inner membrane proteins: TonB, ExbB and ExbD. TonB 
is anchored to the inner membrane by the ExbB-ExbD transmembrane complex 
and interacts with an eight amino acid sequence in the receptor plug domain 
called the ‘TonB box’. The exact mechanism of energy transduction is not 
understood. However, it is thought that upon substrate binding and subsequent 
energy transduction conformational changes in TonB result in a conformational 
change in the plug domain that allows transport of the substrate through the 
receptor. Once in the periplasm, the substrate is transported to the inner 
membrane by a periplasmic binding protein. At the inner membrane, the 
substrate is transported into the cytoplasm by an ATP-binding cassette (ABC) 
protein. 
1.3.3.2 Getting things out: OMPs involved in secretion 
Gram-negative bacteria possess a wide array of secretion systems for exporting 
proteins and other substances out through the cell envelope. A range of 
different OMPs are utilised in these systems which act in conjunction with other 
proteins in the inner membrane and periplasm.  
1.3.3.2.1 Type I secretion (TolC export channel) 
Type I secretion systems consist of three proteins: a pore-forming OMP (TolC) 
and two inner membrane proteins, a membrane fusion protein (MFP) and an ABC 
transporter protein (Fig. 1.5). The ABC transporter recognises a specific 
secretion signal motif at the C-terminal end of the protein which is to be 
secreted. Subsequent binding of the MFP protein to TolC allows secretion of the 
protein into the extracellular milieu. Hence, secretion occurs across the inner 
and outer membrane in one continuous step, without the formation of 
periplasmic intermediates. TolC is an outer membrane channel comprised of  
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Figure 1.5. Schematic diagram of the type 1 secretion pathway, including 
the crystal structure of the TolC protein.  
TolC structure adapted from Koronakis et al. (2000); PDB reference 
1EK9. 
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three TolC monomers that each contribute four β-strands to the formation of a 
β-barrel containing 12 antiparallel β-strands (Koronakis et al., 2000). The 
channel also possesses an α-helical barrel that extends from the integral outer 
membrane β-barrel into the periplasm (Koronakis et al., 2000). Efflux of 
antibacterial drugs and other small inhibitory molecules may also occur via an 
interaction between TolC, an MFP, and an inner membrane translocase which 
can be either an ABC protein, or a proton antiporter of either the resistance 
nodulation division or major facilitator superfamily classes (Koronakis et al., 
2004). 
The E. coli alpha-haemolysin (HlyA) was the first RTX toxin described to be 
secreted via a type I secretion system (Gentschev et al., 2002); however, 
another well characterised example is the secretion pathway of M. haemolytica 
LktA (described in 1.4.1.1).  
1.3.3.2.2 Type II and type III secretion (secretin channels) 
Outer membrane proteins of the secretin family are present in type II (Brok et 
al., 1999, Chami et al., 2005) and type III (Marlovits et al., 2004, Burghout et 
al., 2004, Hodgkinson et al., 2009) secretion systems. They are also present in 
type IV pilus biogenesis systems (Martin et al., 1993, Collins et al., 2001) and 
filamentous phage secretion systems (Opalka et al., 2003). Secretins typically 
form highly stable oligomers of 12-14 subunits in the outer membrane.  
In type II secretion, secreted proteins are first translocated across the inner 
membrane by either the Sec (Pugsley et al., 1991) or Tat (Voulhoux et al., 2001) 
translocons. They are subsequently transported out of the cell by a complex of 
12-15 proteins which span the cell envelope (Pugsley, 1993, Sandkvist, 2001). 
The prototypical type II outer membrane secretin is the PulD protein of 
Klebsiella oxytoca which is required for the secretion of pullulanase (Chami et 
al., 2005).  
Type III secretion systems are used by many pathogenic bacteria to directly 
inject effector proteins into eukaryotic cells and are hence often referred to as 
‘injectisomes’. At least 20 different proteins are utilised in this system (Worrall 
et al., 2011) of which several are genetically and structurally related to the 
bacterial flagellum (Blocker et al., 2003). Proteins enter the injectisome directly  
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from the cytoplasm in a process that is Sec- and Tat- independent. The 
prototypical type III outer membrane secretin is the YscC protein of pathogenic 
Yersinia species (Burghout et al., 2004). A putative type III secretion system has 
been identified in the sequenced bovine and ovine serotype A2 M. haemolytica 
genomes, but not the bovine serotype A1 M. haemolytica genome, that shows 
low to moderate homology to type III secretion components of E. coli O157 
(Lawrence et al., 2010b). Unlike typical type III secretion systems, the M. 
haemolytica genes encoding this putative system are not arranged in an operon 
or separate plasmid. The presence of this system may represent a new method 
of bacterial effector protein delivery into host cells for M. haemolytica. 
1.3.3.2.3 Type IV secretion (double membrane spanning channel) 
The type IV secretion system is used by a variety of Gram-negative bacteria (and 
Gram-positive bacteria) to mediate the transfer of effector proteins into host 
cells or for the conjugation of plasmid DNA and transposons into other cells 
(Christie et al., 2005). In Agrobacterium tumefaciens, the core complex of the 
type IV secretion system is composed of three proteins, VirB7, VirB9 and VirB10, 
that are each present in 14 copies and form a 1.1-megadalton two chambered 
structure that spans both the inner and outer membrane (Chandran et al., 2009, 
Fronzes et al., 2009). The outer membrane chamber is the largest secretion 
channel to be found associated with the outer membrane to date (Chandran et 
al., 2009). It also contains a hydrophobic double α-helical transmembrane 
domain that is the only other example, alongside Wza, of α-helical insertions in 
the outer membrane (Chandran et al., 2009). 
1.3.3.2.4 Type V secretion (autotransporter pathway) 
Gram-negative bacteria possess a range of OMPs that contain the apparatus for 
the transport of their secreted domains across the outer membrane and are 
hence names autotransporters. These proteins are members of the type V 
secretion pathway and can be grouped into three distinct groups (Fig. 1.6) which 
reflect similarities in their primary structures and modes of biogenesis: classical 
autotransporters (type Va secretion), two-partner secretion systems (type Vb  
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Figure 1.6. Schematic diagram of the different groups of type V 
(autotransporter) secretion systems. 
Figure was adapted from Henderson et al. (2004). 
 
 
  
 17
secretion), and trimeric autotransporters (type Vc secretion) (Henderson et al., 
2004). 
Classical autotransporters (type Va). The primary structure of classical 
autotransporters contains three distinct domains: the N-terminal signal 
sequence, the passenger domain and the C-terminal translocation unit 
(Henderson et al., 2004). The signal sequence targets the protein to the inner 
membrane for Sec-dependent translocation into the periplasm. The passenger 
domain contains the effector function of the protein. The translocation unit 
consists of a short α-helical linker region and a β-core that forms a β-barrel with 
12 antiparallel β-strands after insertion into the outer membrane (Oomen et al., 
2004, Barnard et al., 2007, van den Berg, 2010, Zhai et al., 2011), which 
facilitates translocation of the passenger domain from the periplasm to the 
bacterial surface. Once exposed on the bacterial surface, the passenger domain 
can either remain intact as a large protein extending into the extracellular 
milieu or it can be proteolytically cleaved. Cleavage results in the passenger 
domain being either released into the extracellular milieu or remaining non-
covalently associated with the β-barrel domain. Proteolytic cleavage can occur 
by either autoproteolysis or by another membrane-bound protease. Examples of 
M. haemolytica proteins with homology to classical autotransporters are Ssa, 
NanH and Iga1-like proteases (described in 1.4.3.4, 1.4.3.5 and 1.4.3.6, 
respectively) 
Two-partner secretion (type Vb). Whereas in the autotransporter pathway the 
secreted protein is translated as a single polypeptide, in the two-partner 
secretion (TPS) pathway the passenger domain and the pore-forming β-barrel of 
the secreted protein are translated as two separate proteins, termed TpsA and 
TpsB proteins, respectively (Henderson et al., 2004). The genes encoding these 
proteins are generally arranged in a tpsA-tpsB operon. The TpsA protein contains 
an N-terminal signal sequence which targets the protein for Sec-dependent 
transport into the periplasm. It also contains an N-proximal TPS domain which 
interacts specifically with the TpsB protein prior to translocation across the 
outer membrane. The crystal structure of one TpsB protein, FhaC of Bordetella 
pertussis, has been solved and contain 16 β-strands (Clantin et al., 2007). They 
may also be involved in the processing of the TpsA protein into its active form.  
 18
The prototypical TPS system is that of the B. pertussis filamentous 
haemagglutinin protein, FhaB, which is secreted through the pore forming β-
barrel FhaC (Locht et al., 1992, Willems et al., 1994). It has been reported that 
another B. pertussis autotransporter, SphB1, is involved in the surface 
maturation of FhaB (Coutte et al., 2001). Genes encoding proteins that are 
orthologous to the FhaB and FhaC proteins of B. pertussis are present in M. 
haemolytica genomes (Gioia et al., 2006, Lawrence et al., 2010a) (described in 
1.4.1.3). 
Trimeric autotransporters (type Vc). Trimeric autotransporters contains six 
distinct domains: (i) an N-terminal signal sequence, (ii) head, (iii) neck, (iv) 
stalk, (v) linker region, and (vi) a C-terminal region consisting of four β-strands 
(Hoiczyk et al., 2000, Henderson et al., 2004). The head, neck and stalk 
comprise the passenger domain and the linker and C-terminal region comprise 
the translocator domain. Trimerisation of C-terminal subunits creates a β-barrel 
with 12 β-strands that confers an overall lollipop-like structure to the protein 
displayed on the cell surface (Hoiczyk et al., 2000). The prototypical trimeric 
autotransporter is the YadA protein of Yersinia pestis (Nummelin et al., 2004). 
Several trimeric autotransporters have been described in M. haemolytica 
(described in 1.4.3.7).  
1.3.3.3 OMPs involved in outer membrane biogenesis and maintenance 
In addition to controlling the passage of substances into and out of the cell, 
several OMPs are also involved in the biogenesis and maintenance of the outer 
membrane. 
1.3.3.3.1 The BAM complex (integral OMP assembly) 
Nascent integral OMPs are synthesised in the cytoplasm and possess an N-
terminal extension, the signal peptide, which is required to deliver the 
preproteins to the Sec translocon located in the inner membrane. Translocation 
of the nascent OMP across the Sec apparatus is dependent on the proton motive 
force (Driessen and Nouwen, 2008). Upon entering the periplasm, the signal 
peptide is removed by a signal peptidase enzyme and the nascent OMP 
associates with one or more periplasmic chaperones (Ruiz et al., 2006). In E. 
coli, the periplasmic chaperones DegP, SurA and Skp mainly facilitate delivery to 
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the outer membrane (Knowles et al., 2009). It has been proposed that SurA is 
primarily responsible for the assembly of most nascent OMPs, whereas Skp And 
DegP rescue those that have missed the normal assembly route (Sklar et al., 
2007). Unlike the actively driven Sec translocon, the outer membrane contains 
the passive β-barrel assembly machinery (BAM) complex (Fig. 1.7). The BAM 
complex is required for the correct folding and insertion into the outer 
membrane of nearly all integral OMPs identified to date. In E. coli, the BAM 
complex is comprised of five proteins: BamA (formerly known as YaeT, or 
Omp85/D15 in N. meningitidis), an integral OMP, and four accessory 
lipoproteins, BamB (YfgL), BamC (NlpB), BamD (YfiO) and BamE (SmpA), which 
are localised to the inner leaflet of the outer membrane. BamA is universally 
present in all Gram-negative bacteria and contains two major domains: a set of 
five POTRA (polypeptide transport-associated) domains which extend into the 
periplasm and an integral β-barrel inserted into the outer membrane (Sanchez-
Pulido et al., 2003). It is thought that the POTRA domains have a role in binding 
unfolded OMPs (Sanchez-Pulido et al., 2003, Robert et al., 2006). The BamA 
protein recognises a specific C-terminal motif in unfolded OMPs that is required 
for efficient assembly into the outer membrane in vivo (Robert et al., 2006, 
Struyve et al., 1991). The exact functions of the accessory outer membrane 
lipoproteins are unknown, but they have been demonstrated to have roles in 
OMP biogenesis as their depletion results in OMP assembly defects (Werner and 
Misra, 2005, Wu et al., 2005, Doerrler and Raetz, 2005, Malinverni et al., 2006). 
1.3.3.3.2 The LolABCDE complex (lipoprotein assembly) 
Prelipoproteins are synthesised in the cytoplasm and possess an N-terminal 
signal peptide containing a consensus lipobox sequence close to the signal 
peptide cleavage site (Hayashi and Wu, 1990, Inouye et al., 1977). The 
prelipoprotein is then translocated to the periplasmic face of the inner 
membrane by the Sec translocon and processed into its mature form. This is 
achieved by the attachment of a diacylglycerol moiety to the sidechain of a 
conserved cysteine residue in the lipobox (Sankaran and Wu, 1994). Mature 
lipoproteins are localised to the periplasmic face of the inner or outer 
membrane by the lipoprotein localisation (Lol) machinery, which consists of an 
inner membrane transmembrane protein complex (LolCDE), a periplasmic 
chaperone (LolA) and an outer membrane lipoprotein receptor (LolB) (Fig 1.8) 
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Figure 1.7. Schematic diagram of integral OMP biogenesis by the BAM 
complex in E. coli. 
Nascent unfolded OMPs are translocated across the inner membrane 
by the Sec translocon and delivered to outer membrane BAM 
complex by either SurA or Skp/DegP chaperones. The BAM complex 
inserts the protein into the outer membrane and folds it into its β-
barrel conformation. Figure was adapted from Knowles et al. 
(2009).  
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Figure 1.8. Schematic diagram of outer membrane lipoprotein biogenesis 
by the Lol machinery in E. coli. 
A lipoprotein destined for the outer membrane binds to LolE and is 
then subsequently transferred to LolC. The lipoprotein is accepted 
by LolA in an ATP-dependent manner. The LolA-lipoprotein complex 
traverses the periplasm and reaches the outer membrane. The 
lipoprotein is transferred from LolA to LolB and is subsequently 
inserted into the outer membrane. Figure adapted from Okuda and 
Tokuda (2009). 
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(Tokuda, 2009, Okuda and Tokuda, 2009). Lipoproteins which are targeted to the 
outer membrane are received by the LolCDE complex and subsequently released 
to LolA. The LolA-lipoprotein complex traverses the periplasm, whereby the 
lipoprotein is accepted by LolB and incorporated into the outer membrane. The 
determining factor which is responsible for a lipoprotein being directed to the 
outer membrane by the Lol apparatus or retained at the inner membrane was 
initially believed to be the identity of the amino acid adjacent to the conserved 
N-terminal cysteine residue, known as the +2 rule (Yamaguchi et al., 1988). An 
aspartate residue at this position acts as a LolCDE avoidance signal, leading to 
retention of the lipoprotein at the inner membrane. Substitution of this 
aspartate residue with a different amino acid results in Lol-mediated 
translocation to the outer membrane. The +2 rule is not universal (Seydel et al., 
1999), and amino acid residues at positions +3 and +4 have been demonstrated 
to be involved in targeting lipoproteins to the outer membrane in other Gram-
negative species (Narita and Tokuda, 2007, Silva-Herzog et al., 2008). 
Lipoproteins are also present on the outer leaflet of the outer membrane in 
several Gram-negative bacteria, although the mechanism by which they are 
translocated through the membrane remains unknown (Kovacs-Simon et al., 
2011). 
1.3.3.3.3 Wza (CPS transport) 
The E. coli, repeat polysaccharide polymer units are assembled in the cytoplasm 
by a reaction initiated by WbaP, and are subsequently flipped across the inner 
membrane by Wzx (Collins and Derrick, 2007). Polymerisation occurs at the 
periplasm and is dependent on the integral membrane protein Wzy, a putative 
polymerase (Collins and Derrick, 2007). Polymerisation by Wzy requires the 
activity of the tetrameric Wzc protein. Wzb is a protein tyrosine phosphate 
enzyme that enables the cycling phosphorylation of Wzc, a process that is 
crucial for export (Collins and Derrick, 2007). Wzc interacts with Wza to form a 
complex that spans the periplasm. Wza is an the outer membrane lipoprotein 
that forms ring-shaped multimeric complexes (Drummelsmith and Whitfield, 
2000). The crystal structure of Wza revealed an octomer containing a unique α-
helical transmembrane barrel structure (Dong et al., 2006) (Fig. 1.9), 
representing a new structural paradigm for OMPs (Collins and Derrick, 2007). 
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Figure 1.9. Synthesis and export of CPS export in E. coli, showing the 
crystal structure of Wza octomer.  
Figure adapted from Dong et al. (2006). See text for  details. Wza 
structure adapted from Dong et al. (2006). PDB ref. 2J58.  
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The capsule biosynthetic locus of serotype A1 M. haemolytica has been 
characterised and comprises twelve genes that are grouped into three regions 
based on their functions: capsule transport, capsule biosynthesis and 
phospholipid substitution (Lo et al., 2001). 
1.3.3.3.4 LptD and LptE (LPS transport) 
Biosynthesis of core-lipid A occurs at the inner leaflet of the inner membrane 
(Osborn et al., 1972) and is flipped across the inner membrane by the ABC 
transporter MsbA (Doerrler et al., 2001, Doerrler and Raetz, 2002). O-antigen 
repeat units are synthesised in the cytoplasm, flipped across to the periplasm, 
and ligated to core-lipid A to form mature LPS. Transport of mature LPS to the 
outer membrane requires the LPS transport (Lpt) machinery, a protein complex 
comprised of seven different proteins which spans the entire cell envelope 
(Sperandeo et al., 2009) (Fig. 1.10). The integral inner membrane proteins LptG 
and LptF, along with the cytoplasmic ABC protein LptB, most likely provide 
energy to the complex through ATP hydrolysis (Sperandeo et al., 2009). The 
integral protein LptD and the outer lipoprotein LptE form a complex in the outer 
membrane (Wu et al., 2006). It has recently been shown in E. coli that LptE is 
required at the outer membrane for the correct insertion of LptD (Chimalakonda 
et al., 2011). LptA, a periplasmic protein with a fibrillar structure (Suits et al., 
2008), is expected to connect the inner membrane to and the LptD/LptE outer 
membrane components, and to chaperone LPS across the periplasm (Sperandeo 
et al., 2009). The function of LptC is currently unknown, although it is thought 
to be a docking site to the inner membrane for LptA (Sperandeo et al., 2009). 
1.4 Virulence factors of M. haemolytica 
1.4.1 Secreted proteins 
1.4.1.1 Leukotoxin (LktA) 
The M. haemolytica LktA protein is a member of the RTX (repeats-in-toxin) pore-
forming cytotoxins (Linhartova et al., 2010) that includes the Escherichia coli 
alpha-haemolysin (Strathdee and Lo, 1987) and toxins of other Pasteurellaceae 
(Kraig et al., 1990, Frey et al., 1993).   
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Figure 1.10 Transport of LPS from the inner membrane to the outer 
membrane via MsbA and the Lpt transport system 
Figure adapted from Sperandeo et al. (2009). See text for details. 
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LktA is produced by all M. haemolytica serotypes and in nearly all isolates 
examined to date (Burrows et al., 1993, Saadati et al., 1997). LktA is species-
specific and has leukotoxic activity only against ruminant lymphocytes (Shewen 
and Wilkie, 1982, Kaehler et al., 1980, Clinkenbeard and Upton, 1991). It also 
has haemolytic activity (Murphy et al., 1995). Cytolysis is dependent on the 
interaction of LktA with the lymphocyte-function associated antigen 1 (LFA-1) 
molecule of target cells (Li et al., 1999, Jeyaseelan et al., 2000). At high 
concentrations, LktA creates pores in the cell membrane of target cells that 
results in swelling and lysis (Clinkenbeard et al., 1989). At sub-lytic 
concentrations, LktA activates neutrophils (Czuprynski et al., 1991), induces 
release of proinflammatory cytokines (Yoo et al., 1995b) and respiratory burst 
products (Maheswaran et al., 1992), and causes cytoskeletal changes resulting in 
apoptosis (Stevens and Czuprynski, 1996, Sun et al., 1999). LktA has also 
recently been demonstrated to target leukocyte mitochondria (Kisiela et al., 
2010). LktA is a significant M. haemolytica virulence factor and is considered to 
be largely responsible for widespread tissue damage caused during infection 
(Highlander, 2001). 
LktA is encoded in the lktCABD operon, where lktA encodes the inactive 
prototoxin, lktC is required for posttranslational activation of the prototoxin 
prior to secretion, lktB encodes an inner membrane ABC transporter, and lktD 
encodes a membrane fusion protein. Like other RTX proteins, LktA is secreted 
via a type I secretion mechanism directly from the cytoplasm into the 
extracellular space through a continuous channel created by LktB, LktD and TolC 
(Linhartova et al., 2010). The lktCABD operon has a highly complex mosaic 
structure resulting from extensive inter- and intra-species horizontal DNA 
transfer and assortative recombination (Davies et al., 2002, Davies et al., 2001). 
1.4.1.2 Glycoprotease (Gcp) 
The glycoprotease protein, Gcp, is a zinc metalloglycoprotease that cleaves O-
sialoglycoproteins from host cells (Abdullah et al., 1992, Sutherland et al., 1992, 
Otulakowski et al., 1983). All serotypes of M. haemolytica possess the gcp gene 
and have glycoprotease activity whereas M. glucosida possesses the gcp gene but 
does not display glycoprotease activity (Abdullah et al., 1990, Lee et al., 1994). 
The protease is thought to enhance adhesion of M. haemolytica to host cells and 
 27
is also capable of inducing platelet activation, adhesion, and aggregation, 
leading to their deposition in the lung alveoli (Nyarko et al., 1998). 
1.4.1.3 Filamentous haemagglutinin (FhaB) 
M. haemolytica encodes a putative filamentous haemagglutinin protein (FhaB) 
which shares significant amino acid similarity to the FhaB protein produced by 
the human respiratory pathogen Bordetella pertussis and other organisms (Gioia 
et al., 2006). The B. pertussis FhaB protein is a 220 kDa protein found both on 
the bacterial cell surface and in the extracellular milieu. It is transported across 
the outer membrane via FhaC, a pore-forming OMP encoded by a gene which lies 
immediately downstream of FhaB (Locht et al., 1992, Willems et al., 1994). An 
fhaC orthologue is also present adjacent to fhaB in M. haemolytica, suggesting 
that M. haemolytica FhaB is secreted via a similar mechanism (Gioia et al., 
2006). In B. pertussis FhaB is a well characterised adhesin (Smith et al., 2001), 
but the function of FhaB in M. haemolytica is currently unknown. In Bordetella 
bronchiseptica, a respiratory pathogen of pigs, FhaB is required for the efficient 
establishment of colonisation in the lower respiratory tract (Cotter et al., 1998) 
and fhaB mutants are unable to cause disease (Nicholson et al., 2009). An FhaB 
homologue in the bovine respiratory pathogen Histophilus somni was also 
suggested to have an important role in biofilm formation (Sandal et al., 2009). In 
Actinobacillus pleuropneumoniae, the gene encoding an FhaB homologue was 
transcribed at much higher numbers in isolates recovered from diseased pig 
lungs compared to an isolate grown in complex growth medium (Deslandes et 
al., 2010). If the M. haemolytica FhaB protein does function as an adhesin then 
it must have a different binding physiology to B. pertussis FhaB, as it lacks an 
integrin-binding RGD motif (Gioia et al., 2006).  It does, however, contain a 
bacterial intein-like (BIL) domain (Amitai et al., 2003) at the carboxyl terminus 
which does not feature in B. pertussis FhaB (Gioia et al., 2006). These domains 
are involved in post-translational autoproteolysis, hence the possibility of 
allowing variability in receptor recognition and receptor release. Since 
autoproteolysis would change the structure of FhaB, it may also interfere with 
host immune recognition and help evade the host immune response. To date, no 
expressed FhaB protein been identified in M. haemolytica. 
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1.4.2 Cell wall carbohydrates and pili 
1.4.2.1 Capsular polysaccharide (CPS) 
To date, twelve different capsular serotypes have been identified in M. 
haemolytica (A1, A2, A5-A9, A12-A14, A16 and A17) and one in M. glucosida 
(A11) (Angen et al., 1999b). The serotype A1 capsule has been implicated in 
diverse functions including adherence to alveolar surfaces (Brogden et al., 
1989), resistance to complement-mediated serum killing (Chae et al., 1990), 
resistance to phagocytosis by bovine neutrophils and alveolar macrophages (Chae 
et al., 1990, Czuprynski et al., 1989), and facilitating microcolony formation in 
the bovine pneumonic lung (Morck et al., 1989, Morck et al., 1988). 
1.4.2.2 Lipopolysaccharide (LPS) 
Lipopolysaccharide (LPS) is the major glycolipid molecule present in the cell 
envelope of Gram-negative bacteria and makes up between 12 and 25% of the 
dried cell weight of M. haemolytica (Keiss et al., 1964). The basic structure of 
LPS is composed of three well-defined regions: (i) lipid A, composed of sugars 
and fatty acids and anchors LPS to the outer membrane, (ii) the oligosaccharide 
core, composed of approximately 10 monosaccharides and connects the lipid A 
and O-antigen regions and, (iii) the O-specific antigen, consisting of repeating 
units containing between one to seven monosaccharides (Hitchcock et al., 1986). 
It is common for Gram-negative bacteria to possess LPS that does not contain O-
antigen side chains. The two different LPS types, with and without O-antigen 
side chains, are commonly described as ‘smooth-type’ and ‘rough-type’ LPS, 
respectively, according to bacterial colony morphology (Hitchcock et al., 1986). 
Enteric bacteria generally possess smooth-type LPS whereas, in contrast, 
bacteria that reside on respiratory and genital mucosa have evolved a unique set 
of surface glycolipids called lipooligosaccharides (LOSs) (Preston et al., 1996). 
The LOS molecules are analogous to LPS but their O-antigen side chains are 
limited to around ten saccharide units. M. haemolytica LPS is unusual in that 
both smooth- and rough-types occur independently in different isolates (Ali et 
al., 1992, Davies and Donachie, 1996, Lacroix et al., 1993, Davies et al., 1991). 
Interestingly, only a single O-antigen type is present in isolates possessing 
smooth-type LPS, suggesting that the gene encoding this part of the LPS 
molecule may have been recently obtained by horizontal transfer (Davies and 
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Donachie, 1996). It is possible that the structure of M. haemolytica LPS is 
actually closer to that of LOS, but this has not yet been demonstrated. 
LPS is an important M. haemolytica virulence factor in serotype A1 isolates, 
causing damage to pulmonary endothelial cells (Paulsen et al., 1989) and 
inducing alveolar macrophages to release proinflammatory cytokines (Yoo et al., 
1995a, Lafleur et al., 1998) and reactive intermediates (Yoo et al., 1996). It also 
forms aggregates with and enhances the effects of the leukotoxin LktA (Lafleur 
et al., 2001, Li and Clinkenbeard, 1999).  
1.4.2.3 Pili 
The genomes of M. haemolytica contain genes that encode the type IV pili locus 
pilABCD (Gioia et al., 2006, Lawrence et al., 2010a). Type IV pili are known to 
be involved in several bacterial processes including adhesion, DNA uptake and 
twitching motility (Proft and Baker, 2009). The amino acid sequence of PilC is 
identical in the bovine serotype A1 and serotype A2 genomes, whereas in the 
ovine serotype A2 isolate there is a 29 amino acid deletion at the amino 
terminus (Lawrence et al., 2010b). In Neisseria gonorrhoeae, PilC is localised to 
pili tips and acts as an adhesin which binds to human epithelial cells (Rudel et 
al., 1995). It has been suggested that the amino-terminal deletion in the ovine 
serotype A2 PilC may serve as a modification for host species-specific binding to 
ovine epithelial cells (Lawrence et al., 2010b). 
1.4.3 Outer membrane proteins (OMPs) 
1.4.3.1 Outer membrane protein A (OmpA) 
The OmpA protein is a highly conserved, integral OMP that is universally present 
in Gram-negative bacteria and has been implicated in a diverse range of 
functions in different species (Smith et al., 2007). It comprises an N-terminal 
transmembrane β-barrel domain embedded in the outer membrane and a C-
terminal globular domain which extends into the periplasm and interacts with 
the underlying peptidoglycan (Demot and Vanderleyden, 1994). The N-terminal 
domain consists of eight membrane-spanning anti-parallel β-sheets and four 
relatively long, mobile, hydrophilic external loops (Pautsch and Schulz, 1998).  
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Molecular mass heterogeneity of OmpA has been observed among bovine and 
ovine M. haemolytica isolates that correlates with the host of origin (Davies and 
Donachie, 1996). Subsequent comparative nucleotide sequence analysis of the 
ompA gene from 31 M. haemolytica isolates revealed the presence of 
hypervariable domains within the four surface-exposed loops (Davies and Lee, 
2004). The amino acid sequences of these domains are very different in bovine 
and ovine isolates but are highly conserved among isolates recovered from the 
same host species. The ompA gene can be categorised into four distinct alleles, I 
to IV. The class I (ompA1) alleles are associated exclusively with bovine M. 
haemolytica isolates, whereas the class II to IV (ompA2 to ompA4) alleles occur 
only in ovine isolates of M. haemolytica (Davies and Lee, 2004). Significantly, 
the ompA1- and ompA2-type alleles are associated with the major pathogenic 
lineages of bovine [electrophoretic type 1 (ET 1)] and ovine (ETs 21 and 22) 
isolates, respectively (Davies et al., 1997). Based on the distribution of the 
OmpA1 and OmpA2 proteins among bovine and ovine isolates, respectively, and 
the localisation of the amino acid variation to the tips of the four loops, it was 
hypothesised that OmpA plays an important role in adherence and is involved in 
host specificity. The exact role of M. haemolytica OmpA is unknown, although 
studies from bovine serotype A1 M. haemolytica isolates have demonstrated 
binding of OmpA to bovine bronchial epithelial cells (Kisiela and Czuprynski, 
2009) and fibronectin (Lo and Sorensen, 2007), indicating a role in host 
adhesion. It has been demonstrated in several other Gram-negative bacteria, 
including H. infuenzae, P. multocida, and E. coli, that OmpA plays an important 
role in adherence and invasion of host cells (Bookwalter et al., 2008, Dabo et 
al., 2003, Hill et al., 2001, Prasadarao et al., 1996, Reddy et al., 1996).  
1.4.3.2 Iron-acquisition OMPs 
An essential prerequisite for successful colonisation of mammalian hosts by 
bacteria is the ability to adapt to a microenvironment containing virtually no 
free iron. In host tissues, nearly all iron is sequestered by high-affinity iron-
binding proteins such as transferrin, lactoferrin, ferritin and haemoglobin. High-
affinity host haem-binding proteins such as haemopexin and haptoglobin also 
contribute to the sequestering of free haem. Bacteria which colonise mucosal 
surfaces have therefore evolved a number of iron acquisition systems including 
the secretion of siderophores (small molecules with high affinity for iron) and 
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outer membrane receptors specific for iron-containing host proteins 
(Wandersman and Delepelaire, 2004, Wooldridge and Williams, 1993). In many 
bacteria, expression of iron acquisition proteins is under the control of a 
transcriptional repressor called the ferric uptake regulator (Fur) (Andrews et al., 
2003). M. haemolytica also possesses a fur gene, although its function may be 
atypical as its transcription is not repressed by iron (Gioia and Highlander, 
2007). 
1.4.3.2.1 Transferrin binding receptor (TbpA and TbpB) 
The M. haemolytica transferrin receptor, comprised of TbpA and TbpB, is 
responsible for acquiring iron that has been sequestered by host transferrin 
(Ogunnariwo et al., 1997). TbpA is a TonB-dependent integral OMP that forms a 
pore through which iron passes after its release from transferrin. TbpB is a 
putatively surface-exposed outer membrane lipoprotein that is thought to 
increase the efficiency of iron uptake from transferrin (Moraes et al., 2009). 
TbpA and TbpB have molecular masses of approximately 107 and 63 kDa, 
respectively, and together form a receptor that is highly specific for ruminant 
transferrin (Ogunnariwo and Schryvers, 1990, Yu et al., 1992). The genes 
encoding the two proteins are arranged in an operon arrangement of tbpB-tbpA. 
In a recent study, comparative nucleotide sequence analysis revealed that the 
tbpBA operon has a complex mosaic structure and a common gene pool exists for 
tbpBA in M. haemolytica and the closely related species M. glucosida and B. 
trehalosi  (Lee and Davies, 2011).  
1.4.3.2.2 Haem/haemoglobin receptors 
Transcription of genes encoding two putative haemoglobin receptors was 
strongly upregulated in a bovine serotype A1 M. haemolytica isolate under iron-
restricted conditions and in infected lung tissue (Roehrig et al., 2007). 
Furthermore, transcription of genes encoding a putative haemin [ferric (Fe3+) 
haem] receptor complex was also upregulated under iron-restriction (Roehrig et 
al., 2007). It has been suggested that LktA could play an important role in the 
liberation of haemin and haemoglobin from host erythrocytes, thereby providing 
substrates for these receptors (Roehrig et al., 2007). 
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1.4.3.2.3 Haem-haemopexin acquisition system (HxuCBA) 
The bovine and ovine serotype A2 M. haemolytica genomes encode the haem-
haemopexin acquisition operon hxuCBA (Lawrence et al., 2010a). In the bovine 
serotype A1 genome only the hxuA gene has been described (Gioia et al., 2006). 
The HxuCBA system was first discovered in Haemophilus influenzae (Hanson et 
al., 1992) and is an important virulence determinant in this organism (Morton et 
al., 2007) and in Haemophilus parasuis (Melnikow et al., 2005) (Fig. 1.11). The 
HxuC protein is an outer membrane TonB-dependent receptor (Cope et al., 
2001, Cope et al., 1995). The HxuB and HxuA proteins comprise a two-partner 
secretion (TPS) system, whereby HxuA is transported across the outer membrane 
by HxuB, a specific pore-forming OMP. HxuA binds to the host haem-haemopexin 
complex, and facilitates haem delivery to the cell surface via HxuC and an inner 
membrane ABC transporter (Cope et al., 1998, Cope et al., 1994). Recent 
evidence suggests that HxuA might not actually function as a haemophore in H. 
influenzae, but instead releases haem upon interaction with the haem-
haemopexin complex (Fournier et al., 2011). Furthermore, the primary activity 
of HxuA may actually be to sequester haemopexin in its inactive form, thereby 
decreasing the high-affinity binding of haem by the serum (Fournier et al., 
2011). None of the HxuCBA components have been identified at the 
transcriptomic or protein level in M. haemolytica. 
1.4.3.2.4 Siderophore uptake systems 
M. haemolytica does not produce siderophores, although genes encoding several 
proteins that are similar to siderophore uptake receptors of other Gram-negative 
bacteria have been identified. One of these proteins has significant homology to 
the N. gonorrhoeae FrpB protein that has been associated with ferric uptake 
from transferrin (Beucher and Sparling, 1995, Dyer et al., 1988) and, more 
recently, as a receptor for the ferric siderophore enterobactin (Carson et al., 
1999). N. gonorrhoeae does not synthesise siderophores but can utilise those 
produced by other bacteria (xenosiderophores) such as E. coli aerobactin (West 
and Sparling, 1987) and enterobactin (Carson et al., 1999, Rutz et al., 1991). 
This suggests the possibility that the FrpB orthologue of M. haemolytica may also 
utilise xenosiderophores in a similar manner to N. gonorrhoeae. Indeed, some 
bacterial isolates of the bovine nasopharyngeal flora have been reported to  
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Figure 1.11. Schematic diagram of the H. influenzae HxuCBA haem-
haemopexin uptake system.  
  HxuA is synthesised in the cytoplasm and translocated to the 
periplasm by the Sec translocon. HxuA is exported across the outer 
membrane into the host environment by HxuB. HxuA binds to the 
haem-haemopexin complex, releasing haem and allowing it to be 
imported back through the outer membrane via the TonB-
dependent receptor HxuC, and then subsequently transported 
across the inner membrane by an ABC transporter. 
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stimulate growth of M. haemolytica and other closely-related Gram-negative 
bacteria (Corbeil et al., 1985), possibly as a result of this mechanism.  
Transcription of the frpB gene was upregulated in a bovine serotype A1 M. 
haemolytica isolate (Roehrig et al., 2007) and in A. pleuropneumoniae (Klitgaard 
et al., 2010) under iron-restricted conditions. In A. pleuropneumoniae, FrpB has 
been demonstrated to be both immunoreactive (Liao et al., 2009) and an 
essential virulence determinant, as frpB deletion mutants are unable to colonise 
the host or cause clinical disease symptoms upon experimental infection 
(Buettner et al., 2009).  
Transcription of genes encoding proteins with homology to some of the proteins 
in the A. pleuropneumoniae ferrichrome uptake system FhuABCD (Mikael et al., 
2002) were upregulated in a bovine serotype A1 isolate under iron restricted 
conditions (Roehrig et al., 2007). Although fhuBCD genes were all upregulated, 
the putative outer membrane receptor gene fhuA was not. In contrast to FrpB, 
the FhuA protein is not an essential virulence determinant in A. 
pleuropneumoniae (Baltes et al., 2003). 
1.4.3.3 Lipoproteins (PlpABC, PlpD and PlpE) 
Several outer membrane-associated lipoproteins have been identified in M. 
haemolytica. Three contiguous genes arranged in an operon, plpABC, are 
present in all M. haemolytica and M. glucosida isolates that encode three 28-30 
kDa lipoproteins (Cooney and Lo, 1993, Murphy and Whitworth, 1993). These 
proteins are highly immunogenic (Dabo et al., 1994), and a M. haemolytica 
mutant lacking this operon was demonstrated to have increased susceptibility to 
complement-mediated killing and reduced survival in vivo (Murphy et al., 1998). 
PlpA has been demonstrated to be surface-exposed and capable of binding to 
bovine bronchial epithelial cells in vitro (Kisiela and Czuprynski, 2009). It has 
also been identified in an immunoproteomic study of the OMPs of a bovine 
serotype A1 isolate (Ayalew et al., 2010). 
Another gene, plpD, is located on a different part of the chromosome to plpABC 
and encodes a 31 kDa lipoprotein (Nardini et al., 1998). Amino acid sequence 
analysis indicates that PlpD is lipid modified at the N-terminus, but contains a C-
terminal region that is similar to that of OmpA (Nardini et al., 1998). This 
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protein is recognised by sera from calves immunised with a culture supernatant 
vaccine (Nardini et al., 1998) but its exact function is yet to be determined.  
The gene plpE is also located on a different part of the chromosome to plpABC 
and plpD and encodes a 45 kDa outer membrane lipoprotein that is present in all 
serotypes of M. haemolytica but not in M. glucosida (Pandher et al., 1998). It 
has been demonstrated that anti-PlpE antibodies promote complement-mediated 
killing of bovine serotype A1 isolates (Nardini et al., 1998, Ayalew et al., 2004). 
The addition of recombinant PlpE to a commercial vaccine also conferred 
enhanced resistance against experimental challenge in cattle compared to the 
commercial vaccine alone (Confer et al., 2003). The exact function of PlpE is 
also yet to be determined. 
1.4.3.4 Serotype-specific antigen (Ssa) 
The Ssa protein was originally designated as Ssa1 (serotype-specific antigen-1) as 
it was identified in a bovine serotype A1 M. haemolytica isolate (Gonzalezrayos 
et al., 1986, Lo et al., 1991). The ssa gene has since been discovered in all 
serotypes examined, with the exception of A8, but is absent from M. glucosida 
(Gonzalez et al., 1991). Normally only M. haemolytica isolates of serotype A2 
are identified in the upper respiratory tract of healthy cattle, and it was 
hypothesised that the Ssa protein might function as a specific adhesin in 
serotype A1 isolates which facilitates the selective colonisation of these isolates 
in the diseased bovine lung (Gonzalez et al., 1995). Ssa was later categorised as 
a classical autotransporter and a subtilisin-like serine protease (Siezen and 
Leunissen, 1997) which shares significant homology to similar proteins in other 
species including AasP of A. pleuropneumoniae (Ali et al., 2008), NalP of 
Neisseria meningitidis (Turner et al., 2002) and SphB1 of B. pertussis (Coutte et 
al., 2001), all of which act as surface maturation proteases of other 
autotransporters. A similar function has not yet been described in M. 
haemolytica. 
1.4.3.5 Neuraminidase (NanH) 
A neuraminidase protein (NanH) was detected and active in all capsular 
serotypes of M. haemolytica, but not M. glucosida (Straus et al., 1993). In M. 
haemolytica, NanH has been suggested to facilitate the colonisation of mucosal 
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surfaces (Straus et al., 1998), most likely through the modification of sialic acid 
molecules on host cells. Its primary amino acid sequence is similar to that of a 
classical autotransporter. 
1.4.3.6 Immunglobulin proteases 
Three genes encoding proteins that are orthologous to the Iga1 proteases of 
Gram-negative species including H. influenzae, N. meningitidis and N. 
gonorrhoeae, have been identified in M. haemolytica genomes (Gioia et al., 
2006, Lawrence et al., 2010a). The M. haemolytica Iga1 orthologues contain Iga1 
domains and conserved active serine protease sites that are similar to the active 
sites of H. influenzae Iga1 protease (Poulsen et al., 1992). These serine protease 
sites cleave the hinge region of host IgA antibodies, thereby eliminating their 
agglutinating ability and facilitating host colonisation (St Geme, 2000). While IgA 
protease activity has not been detected in the supernatants of M. haemolytica 
(Abdullah et al., 1992), IgG-specific protease activity was detected in partially 
purified culture supernatants (Lee and Shewen, 1996). IgG is also the primary 
secretory antibody found in the lower respiratory tract of cattle (Duncan et al., 
1972), whereas IgA is the predominant antibody in the upper respiratory tract 
(Wilkie and Markham, 1981). It is therefore possible that at least one of the Iga1 
orthologues identified in M. haemolytica actually cleaves IgG instead of IgA. The 
Iga1 protease of N. gonorrhoeae was the first classical autotransporter protein to 
be studied in detail (Pohlner et al., 1987). In neisserial species, the C-terminal 
β-barrel domain of Iga1 integrates into the outer membrane and forms a specific 
pore for the translocation of the passenger domain (containing the serine 
protease site) from the periplasm to the extracellular space (Klauser et al., 
1993, Pohlner et al., 1987). Once exposed on the bacterial surface the protein is 
able to undergo autoproteolysis (Vitovski and Sayers, 2007), thereby facilitating 
IgA cleavage at both the cell surface and in the extracellular milieu. The 
autotransporter protein NalP has also been reported to have a role in the 
modulation and processing of Iga1 in N. meningitidis at the cell surface (van 
Ulsen et al., 2003). To date, no Iga1-like proteases have been identified at the 
protein level in any M. haemolytica isolates. 
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1.4.3.7 Trimeric autotransporter adhesins 
Two putative trimeric autotransporter proteins have been identified in M. 
haemolytica genomes (Gioia et al., 2006, Lawrence et al., 2010a). One has 
similarity to the Hsf proteins of A. pleuropneumoniae and P. multocida, and the 
other has similarity to the Hia protein of H. influenzae and Hia orthologues of A. 
pleuropneumoniae and P. multocida. Roles in adherence are common to most of 
the trimeric autotransporters identified to date (Cotter et al., 2005). Indeed, 
roles in adherence to epithelial cells have been associated with Hsf in A. 
pleuropneumoniae (Auger et al., 2009) and H. influenzae (Hallstrom et al., 
2006), and also Hia in H. influenzae (Barenkamp and StGeme, 1996). Another 
gene locus, designated ahs, was also identified in a serotype A1 isolate and 
encodes a collagen-binding trimeric autotransporter purported to be involved in 
host adhesion (results obtained using recombinant Ahs) (Lo et al., 2006, 
Daigneault and Lo, 2009). Despite the presence of genes encoding these proteins 
in M. haemolytica they have not yet been identified at the protein level in any 
isolate. 
1.5 Phenotypic and genetic variation of M. haemolytica 
and M. glucosida 
1.5.1 Classification based on phenotypic relationships 
1.5.1.1 Capsular serotyping 
The serotypes of M. haemolytica isolates are determined by performing the 
indirect haemagglutination assay (IHA) using sera raised against reference 
capsular polysaccharide types (Fraser et al., 1983). To date, twelve different 
capsular serotypes have been identified in M. haemolytica (A1, A2, A5-A9, A12-
A14, A16 and A17) and one in M. glucosida (A11) (Angen et al., 1999b); however, 
untypeable isolates of both organisms are frequently isolated (Donachie et al., 
1984, Gilmour and Gilmour, 1989). Capsular serotyping of other M. haemolytica-
like isolates that are phenotypically and genetically distinct from M. 
haemolytica have been shown to possess A6, A9 and A16 capsular serotypes, 
indicating that serotyping is of limited use in the differentiation of M. 
haemolytica isolates (Angen et al., 1999b).  
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The various capsule structures of M. haemolytica have been previously 
characterised and are summarised in Table 1.2. The structure of the serotype A1 
polysaccharide is highly similar to the widely distributed ‘enterobacterial 
common antigen’ (Adlam et al., 1984). The polymer of serotype A2 
polysaccharide is colaminic acid and is identical to the capsular polysaccharides 
of N. meningitidis B and E. coli K1 (Adlam et al., 1987). Serotype A7 
polysaccharide is similar to the phosphate-containing polysaccharides of N. 
meningitidis serogroup L and H. influenzae type F (Adlam et al., 1986). It has 
been suggested that the production of similar or identical capsular structures 
among pathogenic bacteria from different genera represents a common defence 
mechanism developed through convergent evolution (Adlam, 1989). 
1.5.1.2 LPS profiles 
The LPS profiles of M. haemolytica and M. glucosida were analysed by SDS-PAGE 
(Davies and Donachie, 1996, Ali et al., 1992, Lacroix et al., 1993). Eight LPS 
types were recognised in M. haemolytica and one in M. glucosida (Davies and 
Donachie, 1996). In M. haemolytica isolates there were four different types of 
core-oligosaccharide (1-4), each either associated or not associated (A or B) with 
a single O-antigen type. There was a clear association between LPS profiles and 
capsular serotypes: serotypes A1, A5, A6, A9 and A12 with LPS type 1A, 
serotypes A2, A8, A14 and A16 with LPS types 1B and 3B, and serotypes A7 and 
A13 with LPS type 4A (Davies and Donachie, 1996). M. glucosida isolates were 
represented by a single LPS type, designated type 4C, which possessed a core 
oligosaccharide region similar to LPS type 4 but with a distinct O-antigen type 
different from that in M. haemolytica isolates (Davies and Donachie, 1996). 
1.5.1.3 OMP profiles 
The OMP profiles of M. haemolytica and M. glucosida isolates were analysed by 
SDS-PAGE (Davies and Donachie, 1996). Twenty different OMP profiles were 
recognised in M. haemolytica isolates and two in M. glucosida isolates. There 
was a clear association between the OMP profile types and capsular serotypes. 
Based on the variation in OMP profiles, the capsular serotypes of M. haemolytica 
could be sub-divided into three main groups: serotypes A1, A5, A6, A8, A9 and 
A12 with OMP type 1, serotypes A2, A14 and A16 with OMP type 2, and serotypes 
A7 and A13 with OMP type 3. The OMP profiles of M. glucosida were similar to  
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Table 1.2. Capsule structure of serotypes A1, A2, and A7 of M. 
haemolytica. 
Serotype Capsule structure Similar capsule structure in 
other pathogens 
A1 
→3)-O-(2-acetamido-2-deoxy-4-
O-acetyl-β-D-
mannopyranosyluronic acid)-
(1→4)-O-(2-acetamido-2-deoxy-β-
D-mannopyranose)-(1→ 
Enterobacterial common antigen 
A2 →2)-α-D-N-acetylneuraminic acid-(8→ (and a dextran polymer) 
N. meningitidis serogroup B E. 
coli K1 
A7 
→3)-β-2-acetamido-2-
deoxygalactopyranose-(1→3)-α-2-
acetamido-2-deoxy-6-O-
acetylglucopyranose-(1-
phosphate→ 
N. meningitidis serogroup L H. 
influenzae type F 
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those of A7 and A13 and were also considered to be of OMP type 3. Furthermore, 
there were associations between specific OMP profiles and host of origin (i.e. 
cattle or sheep). For example, serotype A1 and A6 isolates were divided into two 
distinct subgroups, OMP types, 1.1 and 1.2, which were associated with cattle 
and sheep, respectively. A similar distinction could also be made for serotype A2 
isolates (OMP types 2.1 and 2.2). The finding that bovine and ovine isolates of 
these three serotypes could be clearly differentiated based on their OMP profiles 
suggest that OMPs may contribute towards host-specificity. 
1.5.2 Classification based on genetic relationships 
1.5.2.1 Nucleotide sequence analysis of the 16S rRNA gene 
Comparative nucleotide sequence analysis of the 16S rRNA gene demonstrated 
that M. haemolytica and M. glucosida isolates represent distinct phylogenetic 
lineages (Davies et al., 1996, Angen et al., 1999a). However, due to the highly 
conserved nature of the 16S rRNA only two different alleles were identified in all 
serotypes of M. haemolytica, demonstrating the limited use of this approach for 
differentiating isolates within a species (Davies et al., 1996, Angen et al., 
1999a). Isolates of serotypes A1, A5 to A9, A12 to A14, and A16 had identical 16S 
rRNA nucleotide sequences and differed from the serotype A2 16S rRNA gene at 
only two nucleotide positions.  
1.5.2.2 Multilocus enzyme electrophoresis (MLEE) 
Multilocus enzyme electrophoresis (MLEE) is a technique which can be used to 
examine genetic diversity and structure in natural populations of bacteria, 
providing a genetic framework for the analysis of variation in phenotypic 
characteristics (Selander et al., 1986). Bacterial isolates are characterised by 
measuring variations in the electrophoretic mobility of several housekeeping 
proteins which can be directly equated to allelic variation at the corresponding 
gene loci (Selander et al., 1986). MLEE was used to analyse the genetic diversity 
and population structure of M. haemolytica and M. glucosida isolates and 
subsequently correlate variation in capsular serotypes, LPS types and OMP types 
with the underlying genetic framework (Davies et al., 1997). M. haemolytica 
isolates were classified into 22 electrophoretic types (ETs) based on allelic 
variation at 18 housekeeping gene loci. The serotype A1 and A6 isolates of ET1 
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were responsible for 75% of bovine disease cases, marking two virulent, cattle-
specific clonal groups. Similarly, the serotype A2 isolates of ET 21 and 22 were 
responsible for 40% of ovine disease cases, marking a virulent, cattle-specific 
clonal group. Bovine serotype A1 and A6 isolates and bovine serotype A2 isolates 
were phylogenetically distinct from ovine isolates of the same serotypes, 
suggesting that different subpopulations of these serotypes are associated with 
disease in the two animals. Furthermore, the MLEE data also confirmed previous 
observations (Davies and Donachie, 1996) that bovine and ovine isolates of the 
A1, A2 and A6 capsular serotypes could be consistently differentiated based on 
their OMP profiles, indicating a role in host-specificity.  
The MLEE data was consistent with previous findings of 16S rRNA sequence 
comparison (Davies et al., 1996) that M. glucosida represents a heterogeneous 
group of bacteria that are phylogenetically distinct from M. haemolytica (Davies 
et al., 1997). 
1.5.3 Evolution and host-switching in M. haemolytica 
Comparative nucleotide sequence analysis has shown that horizontal DNA 
transfer and assortative (entire gene) recombination have contributed 
significantly to the evolution of the leukotoxin operon (Davies et al., 2001, 
Davies et al., 2002), the ompA gene (Davies and Lee, 2004) and the tbpBA 
operon (Lee and Davies, 2011).  In these studies, the association of identical or 
nearly identical alleles and gene segments with divergent phylogenetic lineages 
of M. haemolytica collectively provide evidence to support the hypothesis that 
host switching of strains from cattle to sheep and vice versa have contributed to 
the emergence of new strains. In this hypothesis (Fig. 1.12) the serotype A1 and 
A6 strains, which evolved independently in sheep, were transmitted to cattle 
around the time of domestication of these animals (around 10,000 years ago). 
Similarly, the A2 strains, which evolved independently in cattle, were 
transmitted to sheep. Exchange of genetic material from the native, non-
pathogenic strains to the newly-transmitted strains allowed for their adaptation 
to their new host environment, giving rise to the pathogenic serotype A1 and A6 
strains in cattle and the pathogenic serotype A2 strains in sheep. 
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Figure 1.12. The hypothesised route of M. haemolytica host switching. 
Transmission of serotype A2 strains from cattle to sheep occurred 
around the time of animal domestication. Subsequent horizontal 
gene transfer (HGT) of genetic material from the native ovine 
strains gave rise to the pathogenic ovine serotype A2 strains (red). 
Similarly, transmission of serotype A1 and A6 strains from sheep to 
cattle and subsequent genetic exchange gave rise to the pathogenic 
bovine serotype A1 and A6 strains (red). 
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1.6 Bioinformatic tools for discriminating proteins 
located in different subcellular compartments 
Once a bacterial protein has been synthesised in the cytoplasm it can either 
remain there or be targeted to a different subcellular location. Several of the 
sorting signals that are responsible for targeting a nascent polypeptide to a 
particular location have been well characterised, including the N-terminal signal 
peptide for targeting proteins outside of the cytoplasm. Many proteins also have 
secondary structural signatures which indicate their most probable location, 
such as the transmembrane α-helical secondary structures that are found in 
Gram-negative integral inner membrane proteins and the β-barrel secondary 
structures present in Gram-negative integral OMPs. These signals and structural 
signatures are generally encoded in the amino acid sequence of the protein itself 
and can therefore be identified computationally using bioinformatics 
approaches. The availability of publicly available sequence information has 
expanded rapidly over recent years and bioinformatic prediction of such 
sequence features has become an important part of microbiological research. 
Proteins which are surface-exposed and potential vaccine targets can be rapidly 
identified bioinformatically from sequence data rather than experimental data, 
a process referred to as reverse vaccinology (Rappuoli, 2000, Vivona et al., 
2008). It is also useful to know the subcellular compartment that a protein is 
likely to be located in when designing protein isolation experiments and also for 
identifying contaminants in proteomic analyses.   
1.6.1 Prediction tools for discrimination of OMPs 
Outer membrane proteins have several unique sorting signals and structural 
signatures that allow them to be differentiated from proteins located in other 
subcellular compartments by bioinformatic predictors. These predictors can be 
categorised into three groups: β-barrel predictors, outer membrane lipoprotein 
predictors and subcellular localisation predictors. 
1.6.1.1 β-barrel predictors 
In general, two main types of structural signatures are present in Gram-negative 
integral membrane proteins, namely α-helices and β-barrels, which are 
associated with the inner and outer membranes, respectively. The prediction of 
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integral inner membrane proteins is relatively easy, as the membrane-spanning 
regions consist of easily identifiable α-helical stretches consisting of 15 to 25 
mostly non-polar amino acids (Santoni et al., 2000). In contrast, predicting 
integral OMPs is more difficult, mainly due to the membrane-spanning β-strands 
being much shorter and having highly variable properties (Koebnik et al., 2000). 
In general, the amino acids of transmembrane β-strands alternate between polar 
and non-polar, with polar residues facing the lipid bilayer and protein interfaces 
and non-polar residues facing the inside of the β-barrel. However, some non-
polar residues may also point inside the barrel, interrupting the regular 
alternation between polar and non-polar residues and making transmembrane β-
strands more difficult to identify (Schulz, 2000). Transmembrane β-strands are 
also often flanked by a layer of aromatic amino acid residues (the ‘aromatic 
girdle’) which are believed to contribute towards providing stability in the outer 
membrane (Yau et al., 1998). The majority of integral β-barrel OMPs also 
contain a C-terminal signature sequence, in which there is a phenylalanine (or 
tryptophan) residue at the C-terminal position, and hydrophilic residues at 
positions 3, 5, 7 and 9 from the C-terminus (Struyve et al., 1991). This sequence 
is required for translocation across the periplasm and correct insertion into the 
outer membrane by the BAM complex (Robert et al., 2006). 
Several bioinformatic methods have been developed for the prediction of 
integral β-barrels from protein amino acid sequences. In these methods, the 
amino acid sequence is first encoded into a feature vector and then secondly 
entered into a classification model to produce the prediction. Several web-based 
resources are available for the prediction of β-barrels, including TMB-Hunt 
(Garrow et al., 2005), TMBETADISC-RBF (Ou et al., 2008), MCMBB (Bagos et al., 
2004) and BOMP (Berven et al., 2004). 
1.6.1.2 Lipoprotein predictors 
Proteins that are targeted for secretion via the Sec translocon contain an N-
terminal signal sequence that is required for translocation across the inner 
membrane. Once in the periplasm, lipoprotein signal sequences are cleaved by 
an enzyme called signal peptidase II (SPaseII), whereas signal sequences of other 
proteins are cleaved by signal peptidase I (SPaseI). The key to bioinformatically 
predicting lipoproteins from a set of membrane proteins lies in the ability to 
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differentiate between these two signal sequences. In both lipoproteins and non-
lipoproteins, signal sequences can be divided into three regions: an n-region, an 
h-region, and a c-region (Juncker et al., 2003). Both protein types have a similar 
n-region, which is characterised by the presence of positive amino acids lysine 
and/or arginine. The h-region consists of hydrophobic amino acids and is shorter 
in lipoproteins than in non-lipoproteins. The c-region contains the signal 
peptidase recognition site and is necessary for cleavage. In lipoproteins, the c-
region contains an apolar consensus sequence of four amino acids around the 
cleavage site known as the lipobox. The most conserved amino acids in the 
lipobox are a leucine at position -3 from the cleavage site, alanine at position -2 
and glycine or alanine at position -1, although other substitutions have been 
demonstrated. A cysteine residue at position +1 is essential: LA(G,A)↓C 
(Vonheijne, 1989). In non-lipoproteins, the same region is polar and has small, 
uncharged residues at positions -3 and -1 (Vonheijne, 1989). Outer membrane 
lipoproteins can be further differentiated from inner membrane lipoproteins by 
examining the amino acid at position +2 from the cleavage site. In general, 
lipoproteins containing an aspartate residue at this position are retained at the 
inner membrane whereas those containing any other residue are translocated to 
the outer membrane (Yamaguchi et al., 1988). 
Web-based resources are available for the prediction of lipoproteins including 
DOLOP (Babu and Sankaran, 2002), LIPO (Berven et al., 2006) and LipoP (Juncker 
et al., 2003). 
1.6.1.3 Subcellular localisation predictors 
Subcellular localisation predictors are able to predict the localisation site of a 
protein from several different options. For Gram-negative bacterial proteins, 
these sites are the cytoplasm, inner membrane, periplasm, outer membrane and 
extracellular. Subcellular localisation predictors utilise many of the criteria 
described above for the differentiation of OMPs. The main advantage of using 
these predictors in conjunction with β-barrel and lipoprotein predictors is that 
they can predict if a protein is likely to have more than one localisation site. 
Several web-based Gram-negative subcellular localisation predictors are 
available including PSORTb (Gardy et al., 2003, Gardy et al., 2005), Proteome 
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Analyst (Szafron et al., 2004), CELLO (Yu et al., 2006) and SOSUI-GramN (Imai et 
al., 2008). 
1.7 Mass spectrometry (MS)-based outer membrane 
proteomics 
Mass spectrometry (MS) is the method of choice for the identification of proteins 
in simple or complex samples. Proteomics in general deals with the 
determination of complete protein sets belonging to either a whole cell (a 
proteome) or a particular subcellular compartment (a subproteome). MS-based 
proteomics has only been made possible by the availability of gene and genome 
sequence databases, modern computing and large advances in MS technology. 
Outer membrane proteomics deals specifically with the identification of all 
integral OMPs and outer membrane lipoproteins (the outer membrane 
subproteome) within the outer membrane of a given Gram-negative bacterium. 
In order to undertake comprehensive studies of the outer membrane 
subproteome, the outer membrane must first be isolated from other cellular 
components and purified in order to minimise contamination with non-OMPs. 
This can be achieved through subcellular fractionation based on the specific 
properties of cellular components from different compartments. Complementary 
MS-based proteomic approaches can then be utilised to allow comprehensive 
identification of OMPs within a purified outer membrane sample. 
1.7.1 Outer membrane isolation 
This section will summarise three of the most popular techniques for the 
isolation of Gram-negative outer membranes: selective detergent solubilisation, 
spheroplasting and sucrose density gradient centrifugation.  
1.7.1.1 Selective detergent solubilisation 
This technique involves using an appropriate detergent to selectively solubilise 
the inner membrane, leaving the outer membrane largely intact so it can be 
pelleted and isolated. Before this can occur the cell envelope must first be 
separated from the components of the cytoplasm. Cells are broken in order to 
release their cytoplasmic contents, usually through sonication or French press. 
The cell lysate is centrifuged to pellet any unbroken cells which are 
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subsequently removed. The remaining supernatant is then subjected to 
ultracentrifugation to pellet the cell envelopes. One of the earliest detergents 
used for selective inner membrane solubilisation was the non-ionic detergent 
Triton X-100, which selectively solubilised the inner membrane of E. coli in the 
presence of Mg2+ ions (Schnaitman, 1971). The mild ionic detergent N-
laurolysarcosine (Sarkosyl) was subsequently shown to selectively solubilise the 
inner membrane of E. coli in the absence of Mg2+ (Filip et al., 1973), indicating 
that the selective solubilisation ability of Triton X-100 could be explained, at 
least in part, on the basis that Mg2+ cations stabilise the outer membrane. It is 
thought that divalent cations stabilise the outer membrane by interacting with 
the hydrophobic moiety of LPS (Schindler and Osborn, 1979). Sarkosyl has been 
demonstrated to selectively solubilise M. haemolytica inner membrane proteins 
more completely than Triton X-100 (Squire et al., 1984) and yield more OMPs 
(Morton et al., 1996). Furthermore, a recent study using Campylobacter jejuni 
compared a total of nine different OMP purification protocols and found that 
selective inner membrane solubilisation using Sarkosyl produced the purest and 
most complete outer membrane preparations and was the most reproducible in 
terms of consistent identification of OMPs (Hobb et al., 2009). Sarkosyl is 
therefore a very popular choice for the isolation of OMPs in M. haemolytica 
(Davies and Donachie, 1996, McCluskey et al., 1994, Davies et al., 1994a, Davies 
et al., 1992, Kisiela and Czuprynski, 2009, Gatewood et al., 1994, Ayalew et al., 
2010) and several other Gram-negative organisms including P. multocida (Davies 
et al., 2003b, Davies et al., 2003a, Davies et al., 2004), A. pleuropneumoniae 
(Chung et al., 2007), H. influenzae (Kaur et al., 2003), C. jejuni (Hobb et al., 
2009), Shewanella oneidensis (Brown et al., 2010), Flavobacterium columnare 
(Liu et al., 2008), Coxiella burnetii (Papadioti et al., 2011), Helicobacter pylori 
(Baik et al., 2004) and Tannerella forsythia (Veith et al., 2009).  
The mechanism of action of Sarkosyl is not fully understood, but it has been 
shown to be ineffective at dispersing LPS from the both E. coli and Brucella 
abortus cell envelopes which may also be the basis for its inability to solubilise 
the outer membrane (Moriyon and Berman, 1982). The length of its alkyl chain 
also appears to be a critical factor. Sarkosyl (which has an alkyl chain of 11 
carbons) and Zwittergents 308 and 310 (alkyl chains of 8 and 10 carbons, 
respectively) are not effective in dispersing LPS in either B. abortus or E. coli, 
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whereas Zwittergents 312 and 316 (alkyl chains of 12 and 16 carbons, 
respectively) were very efficient at dispersing LPS in both bacteria (Moriyon and 
Berman, 1982). This suggests that a minimal alkyl chain length of 12 carbons is 
necessary for dispersing LPS and, therefore, that only detergents with 11 or 
fewer carbons are appropriate for the selective solubilisation of the inner 
membrane. 
1.7.1.2 Spheroplasting 
Spheroplasting involves breaking the outer membrane using lysozyme and EDTA, 
which peels away from the cell while the cytoplasmic membrane remains intact 
(i.e. the spheroplast) and is pelleted by centrifugation (Birdsell and Cota-Robles, 
1967, Hill and Sillence, 1997, Osborn and Munson, 1974, Witholt et al., 1976, 
Costerto.Jw et al., 1967). One of the limitations of this technique is that the 
outer membrane may not become completely separated from the inner 
membrane, allowing the possibility that some OMPs will not be present in the 
outer membrane fraction (Hobb et al., 2009). 
1.7.1.3 Sucrose density gradient centrifugation 
For sucrose density gradient centrifugation, a sucrose gradient is firstly created 
in a centrifuge tube whereby lower concentrations of sucrose are gently 
overlayed onto higher concentrations. Cell envelope samples are then loaded 
onto the top of the gradient and centrifuged. The membrane components move 
through the gradient until they reach the point at which their density matches 
that of the surrounding sucrose. The outer and inner membrane fractions are 
observed as separate bands within the gradient due to their different densities 
and can be subsequently isolated (Osborn et al., 1972). Additional wash steps 
using chaotropic agents such as sodium bromide and sodium carbonate can be 
further used to remove contaminants (Schluesener et al., 2005, Molloy et al., 
2000). Sucrose density gradient centrifugation is more laborious than detergent-
based techniques and is generally not an appropriate technique for preparing 
several samples at once. 
1.7.2 MS principles and instrumentation 
Before the different strategies of MS-based OMP identification are discussed, it is 
first necessary to give an overview of the principles and instrumentation of MS. A 
 49
mass spectrometer consisting of three main components: an ion source that 
transfers peptides (from enzyme-digested proteins) into the gaseous phase, a 
mass analyser that measures the mass-to-charge (m/z) ratio of the ionised 
peptides, and a detector that records the number of ions at each m/z value. 
Protein identifications from MS data are made by peptide mass fingerprinting. By 
coupling two or more mass analysers together with a collision cell, peptides can 
be further fragmented to generate MS/MS spectra and produce protein 
identifications with greater sensitivity. 
1.7.2.1 Ionisation techniques 
In order for peptides to be analysed by MS it must first be vaporised and ionised. 
The success of MS in the life sciences is largely due to the introduction of 
electrospray ionisation (ESI) (Yamashita and Fenn, 1984a, Yamashita and Fenn, 
1984b, Fenn et al., 1989, Lane, 2005) (Fig. 1.13A) and matrix-assisted laser 
desorption ionisation (MALDI) (Karas and Hillenkamp, 1988) techniques, which 
allow large, polar, thermally labile proteins to enter into the gaseous phase 
(Lane, 2005) (Fig. 1.13B).  
Peptides to be ionised by ESI are first dissolved in a solvent. This solution flows 
through a small capillary tube to which a high voltage is applied, resulting in the 
release of a fine mist of charged droplets. As the droplets migrate to the counter 
electrode they pass through a heating element, allowing the solvent to 
evaporate leaving behind multiply-charged gas-phase ions.  
MALDI sublimates and ionises samples out of a dry, crystalline matrix using laser 
pulses. Samples are co-crystallised with an excess of a matrix material that 
strongly absorbs light from a laser. The matrix expands into the gas phase as it 
absorbs light from the laser, taking with it intact peptides. 
1.7.2.2 Mass analysers 
The mass analyser measures the m/z of ionised peptides to generate 
information-rich ion mass spectra from these peptides. There are four main 
types of mass analyser used in proteomics research: time-of-flight (TOF), 
quadrupole, ion trap and Fourier transform ion cyclotron (FT-MS) analysers. 
These can be either stand alone or, in some cases, put together in tandem to 
take advantage of the different strengths of each.  
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Figure 1.13. Ionisation and peptide sample introduction processes: (A) 
matrix-assisted laser desorption/ionisation (MALDI) and (B) 
electrospray ionisation (ESI). 
Figure was adapted from Lane et al. (2005). 
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MALDI is usually combined with TOF analysers (MALDI-TOF) (Aebersold and Mann, 
2003), which determine m/z ratios by measuring the time that peptide ions take 
to move through a tube of specified length that is under vacuum (Fig. 1.14A). 
MS/MS analysis can be achieved by placing a collision cell either between two 
TOF analysers (MALDI-TOF-TOF) (Medzihradszky et al., 2000) (Fig 1.14B) or 
between a quadrupole mass filter (described below) and a TOF analyser (MALDI-
Q-TOF) (Loboda et al., 2000). Ions of a particular m/z are selected in the first 
analyser, fragmented in the collision cell by collision-induced dissociation (CID) 
and the fragments read by the second analyser. MALDI-MS has traditionally been 
used to analyse relatively simple peptide mixtures, although MALDI-MS/MS can 
now facilitate the analysis of more complex samples. 
ESI is most commonly coupled to triple quadrupoles for the generation of MS/MS 
spectra (Aebersold and Mann, 2003). A quadrupole consists of four parallel rods 
equally spaced around a central axis. One set of opposing rods have a direct 
current, the other an alternating current, producing opposing positive and 
negative fields. Peptide ions are introduced in a continuous beam along the 
central axis between the poles, and are filtered according to their m/z ratios. 
The two positive rods create a high-pass mass filter that allows ions above a 
critical m/z ratio to pass through the centre of the quadrupole. The two 
negative rods create a low-pass mass filter that allows ions below a critical m/z 
ratio to pass through the centre of the quadrupole. The two overlapping mass 
filter regions create a ‘band pass’ area of mutual stability which allows ions of a 
certain m/z ratio to pass through. Ions outside of this area of mutual stability 
are not able to pass through the quadrupole and run into the rods. The m/z ratio 
of ions that are allowed to pass through the quadrupole is proportional to the 
voltage applied to the rods. For MS/MS analysis, three quadrupoles are combined 
whereby ions of a particular m/z are selected in the first, fragmented in the 
second by CID and the fragments read by third (Fig. 1.14C). The third 
quadrupole can also be substituted with a TOF analyser (ESI–QqTOF) to perform 
MS/MS analysis (Fig. 1.14D). ESI-MS systems are normally integrated with liquid 
chromatography (LC) technology for efficient separation of peptides prior to 
analysis. 
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Figure 1.14. Examples of mass spectrometers used in proteome research: 
(A) reflector time-of-flight (TOF), (B) time-of flight/time-of-flight 
(TOF-TOF), (C) triple quadrupole, (D) quadrupole time-of-flight 
(QqTOF). 
Figure was adapted from Aebersold and Mann (2003). 
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1.7.2.3 Peptide mass fingerprinting 
Prior to analysis by MS, a protein must be digested into peptides using an 
enzyme of high specificity (such as trypsin). A highly specific enzyme ensures 
that the peptides are not too short (as almost any three or four residue peptide 
will be found in several database entries) and, if being analysed by MALDI-MS, 
that they do not fall into the low mass region (below ~500 Da) that is obscured 
by the presence of matrix peaks. After analysis by MS, a list of experimental 
peptide masses is generated that represents the peptide mass fingerprint of that 
particular protein. The protein is then identified by matching the experimental 
peptide masses to the calculated enzyme-digested peptide masses of protein 
entries on a database. Several parameters can be set prior to this database 
comparison to improve search performance. The digestion enzyme may not 
cleave the protein at all of the expected amino acid sites, therefore the number 
of missed cleavage sites can be set (usually only one or two) to allow for this. 
The range of experimental peptide mass values that are compared to the 
database can be set so that they are large enough to offer good discrimination, 
but not so large that they are likely to be peptides with missed cleavage sites. A 
peptide mass tolerance value can also be set to allow for small differences 
between experimental and theoretical peptide masses.  
Confidence in protein identification may come from having independent 
supporting evidence. For example, if the protein originated from a protein band 
at approximately 60 kDa on a one-dimension (1-D) SDS-PAGE separation of 
bacterial proteins, then the anticipated result of a peptide mass fingerprint is a 
60 kDa bacterial protein. If the protein with the closest peptide matches meets 
this expectation then the search can be deemed successful. If it is a 150 kDa 
protein from a different species then the search is likely to have failed. In 
addition to this approach, many MS search programmes provide a score for each 
protein match which reflects the significance of that match. The popular Mascot 
search engine (Perkins et al., 1999) incorporates a probability based 
implementation of the molecular weight search (MOWSE) scoring algorithm 
(Pappin et al., 1993). In Mascot, the significance level is normally set at 5%, so 
that if the score for a particular match exceeds this level there is less than a 1 in 
20 chance that the observed match is a random event.  
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One of the main drawbacks to peptide mass fingerprinting is caused by 
uncertainty in the mass of intact proteins. A protein will often undergo post-
translational modification and processing after expression, resulting in 
experimental masses that are unlikely to be the same as that of the entry in the 
protein database. A peptide mass fingerprint can therefore only provide the 
statistically most probable identification, although this is still a much more 
advanced method than simply counting peptide mass matches. Peptide mass 
fingerprinting is also mostly suited to the identification of individual proteins, 
since mixtures of proteins create multiple peptide mass fingerprints and make 
protein identification more difficult. 
1.7.2.4 MS/MS ion search  
An MS/MS ions search has a higher level of specificity compared to that achieved 
by peptide mass fingerprinting because, in addition to peptide mass, MS/MS 
provides information about peptide sequence. However, this information only 
provides detail of amino acid composition and is not easily translatable into full 
and unambiguous peptide sequences. The Mascot search engine again can be 
used to perform probability-based scoring using MS/MS data. Alternative 
software such as Sequest (Eng et al., 1994) and MS-TAG (Mann and Wilm, 1994) 
are also available for MS/MS data analyses that use cross-correlation and peptide 
sequence tag approaches, respectively. Data from MS/MS is particularly useful 
when multiple proteins are present within a sample. Furthermore, relative 
abundance of different proteins can be estimated by the Exponentially Modified 
Protein Abundance Index (emPAI), which offers relative quantification of 
proteins in a mixture based on protein coverage by the peptide matches in a 
database search result. 
1.7.3 Membrane protein identification 
There are two main approaches to the identification of membrane proteins using 
MS. The first is a combination of protein separation by 1-D SDS-PAGE or 2-DE and 
either MS or MS/MS (the gel-based approach). The second approach combines 
limited protein purification followed by MS/MS (the gel-free approach). 
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1.7.3.1 Gel-based approach 
The gel-based approach to identifying proteins by MS involves the separation of a 
complex mixture of proteins by either 1-D SDS-PAGE or 2-DE followed by 
subsequent in-gel trypsin digestion and peptide mass fingerprinting by MALDI-
TOF. MALDI-TOF-TOF can also be used to perform MS/MS, which is more 
appropriate for analysis where more than one protein is expected to be present 
in a gel slice/spot. 
One-dimensional SDS-PAGE is particularly useful for the separation of membrane 
proteins as they are readily solubilised upon heating in SDS sample buffer. The 
technique is also relatively quick and simple to perform, making it suitable for 
comparative analysis of several samples at the same time. The main 
disadvantage of 1-D SDS-PAGE is that proteins are separated only by molecular 
mass, which can result in inadequate quantification and resolution if proteins of 
similar molecular masses are present in the sample. However, relative 
quantification of different proteins within a protein band can be estimated using 
emPAI.  
Two-dimensional electrophoresis couples isoelectric focusing in the first 
dimension followed by SDS-PAGE in the second dimension to allow the separation 
of complex mixtures of proteins by isoelectric point, molecular mass, solubility 
and relative abundance. However, there are limitations to the use of this 
technique for the separation of membrane proteins. Many membrane proteins 
are not solubilised in the non-detergent isoelectric focusing sample buffer due 
their hydrophobic nature, and those that are solubilised often precipitate at 
their isoelectric point (Wu and Yates, 2003). Isoelectric focusing with 
immobilised pH gradients also results in severe protein losses on 2-D gels as 
these membrane proteins do not enter the second dimension of separation 
(Pasquali et al., 1997, Adessi et al., 1997). More general disadvantages of 2-DE 
include the large amount of sample handling that is involved, poor 
reproducibility, and the extra time and labour that is required to perform the 
technique. Due to these limitations, 1-D SDS-PAGE is considered by some to be a 
more favourable strategy than 2-DE for the separation, resolution and 
identification of membrane proteins (Gorg et al., 2004). 
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1.7.3.2 Gel-free approach 
The gel-free proteomic approaches provides a powerful alternative to gel-based 
approaches. It involves using LC-ESI-MS/MS to identify proteins in complex 
mixtures (Hunt et al., 1992). Proteins are trypsin-digested (without prior gel-
based separation) and the peptide fragments separated by one or more steps of 
LC. The peptides are then ionised by ESI and subsequently enter the mass 
spectrometer, where a mass spectrum of the peptides eluting at this time point 
is taken. A prioritised list of peptides is generated by a computer and these are 
subsequently fragmented by energetic collision with gas. The resulting MS/MS 
spectrum is recorded and used to make protein identifications. 
As with gel-based proteomic approaches the solubility of membrane proteins is 
also an issue for gel-free approaches. However, a number of methods have been 
developed to overcome this issue including the use of detergents (Han et al., 
2001), organic solvents (Blonder et al., 2002, Goshe et al., 2003) and organic 
acids (Washburn et al., 2001). The main advantage of the gel-free approach is 
that it provides comprehensive coverage of all proteins within a complex protein 
sample without the need for prior gel-based separation. It also allows for the 
identification of low abundance proteins which may not be adequately resolved 
and identified by gel-based approaches. 
1.8 Objectives of research 
The objectives of this thesis were threefold. The first objective was to 
investigate the surface-exposure and immune specificity of OmpA among bovine 
and ovine M. haemolytica isolates. This work builds upon a previous study 
(Davies and Lee, 2004) which demonstrated that the amino acid sequences 
within hypervariable loop domains of M. haemolytica OmpA were very different 
in bovine and ovine isolates but were highly conserved among isolates recovered 
from the same host species. As a result of this it was hypothesised that the 
OmpA1 and OmpA2 proteins of bovine and ovine isolates, respectively, play an 
important role in adherence and are involved in host-specificity. To achieve this 
objective, recombinant OmpA1 (rOmpA1) and OmpA2 (rOmpA2) proteins were 
over-expressed, purified and used to generate anti-OmpA1 and anti-OmpA2 
antibodies, respectively. These antibodies were then used to explore OmpA 
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surface-exposure and epitope specificity using electron microscopy and 
immunofluorescence techniques. Attempts were also made to crystallise 
rOmpA1. 
The second objective was to characterise and compare the outer membrane 
subproteomes of seven M. haemolytica isolates and one M. glucosida isolate 
(that were carefully selected to represent different host origins, disease 
statuses, capsular serotypes, OMP-types and phylogenetic lineages) after growth 
in complex medium in order to identify OMPs with putative roles in host-
specificity and virulence under standard growth conditions. Previous work has 
demonstrated that bovine serotype A1 and A6 isolates and bovine serotype A2 M. 
haemolytica isolates are genetically distinct from ovine M. haemolytica isolates 
of the same serotypes, suggesting that different subpopulations of these 
serotypes are associated with disease in the two animals (Davies et al., 1997). 
Bovine and ovine isolates of these three serotypes can also be differentiated 
based on their OMP profiles (Davies and Donachie, 1996), suggesting that certain 
OMPs are likely to be involved in host specificity and virulence. Firstly, the 
entire repertoire of encoded OMPs in the genomes of three publicly available M. 
haemolytica genomes was predicted using a simple bioinformatic framework. 
Qualitative comparisons and amino acid sequence comparisons were performed 
on the OMPs predicted among the genomes to identify those with potential roles 
in host adaptation. Secondly, complementary proteomics approaches were used 
to identify these predicted OMPs in the outer membranes of the representative 
isolates after they had been grown in complex growth medium. This comparative 
approach provided a comprehensive overview of M. haemolytica and M. 
glucosida subproteomes and insights into the roles of OMPs in host-specificity, 
virulence and mechanisms of pathogenesis. 
The third objective was to identify OMPs that were differentially expressed in 
the representative isolates after growth under in vitro conditions which were 
designed to mimic the in vivo host environment. These conditions included iron-
restriction, serum-supplementation and solid-surface growth (in the absence or 
presence of Congo red dye). This approach allowed the identification of several 
potential virulence-associated proteins, many of which were not previously 
identified after growth in complex medium alone. Furthermore, an examination 
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of the extracellular subproteome of the representative isolates was undertaken 
after growth in iron-restricted and iron-replete media. 
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2. OUTER MEMBRANE PROTEIN A (OMPA) OF 
BOVINE AND OVINE ISOLATES OF M. 
HAEMOLYTICA IS SURFACE-EXPOSED AND 
CONTAINS HOST-SPECIES SPECIFIC 
EPITOPES 
2.1 Introduction 
The Gram-negative bacterium M. haemolytica is a commensal of cattle, sheep, 
and other ruminants, but also causes bovine and ovine pneumonic pasteurellosis; 
these infections are responsible for considerable economic losses to the livestock 
industries (Frank, 1989, Gilmour and Gilmour, 1989). Twelve different capsular 
serotypes of M. haemolytica have been identified to date, but A1 and A2 are the 
most prevalent (Highlander, 2001) and strains of these serotypes are responsible 
for the majority of pneumonia cases worldwide in cattle and sheep, 
respectively. M. haemolytica consists of genetically distinct subpopulations that 
are differentially adapted to, and elicit disease in, either cattle or sheep (Davies 
et al., 1997, Davies and Donachie, 1996). The molecular basis of host-adaptation 
and host-specificity in M. haemolytica is not understood, but it is likely that 
OMPs play important roles in these processes. The publication of the genome 
sequence of a bovine serotype A1 M. haemolytica isolate (Gioia et al., 2006) 
and, more recently, of the genome sequences of bovine and ovine serotype A2 
isolates (Lawrence et al., 2010a), have revealed the presence of genes that 
encode various OMPs. Many of these proteins serve as adhesins that are involved 
in host receptor-specific binding (Daigneault and Lo, 2009) or as iron transport 
proteins (Roehrig et al., 2007). 
There is growing evidence to suggest that the OmpA protein of M. haemolytica 
functions as an adhesin (Lo and Sorensen, 2007, Kisiela and Czuprynski, 2009). 
OmpA is a highly conserved, integral, OMP of Gram-negative bacteria that has 
been implicated in a diverse range of functions in different species [reviewed in 
(Smith et al., 2007)]. It comprises an N-terminal transmembrane β-barrel 
domain embedded in the outer membrane and a C-terminal globular domain 
which extends into the periplasm to interact with the underlying peptidoglycan 
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(Demot and Vanderleyden, 1994). The N-terminal domain consists of eight 
membrane-traversing anti-parallel β-sheets and four relatively long, mobile, 
hydrophilic external loops (Pautsch and Schulz, 1998). In previous studies, 
molecular mass heterogeneity of OmpA was observed among bovine and ovine M. 
haemolytica isolates that correlated with the host of origin (Davies and 
Donachie, 1996). Subsequently, comparative nucleotide sequence analysis of the 
ompA gene from 31 M. haemolytica isolates revealed the presence of 
hypervariable domains within the four surface-exposed loops (Davies and Lee, 
2004). The amino acid sequences of these domains are very different in bovine 
and ovine isolates but are highly conserved among isolates recovered from the 
same host species (Davies and Lee, 2004). The ompA gene can be categorised 
into four distinct allelic classes, I to IV. The class I (ompA1) alleles are 
associated almost exclusively with bovine M. haemolytica isolates, whereas the 
class II to IV (ompA2 to ompA4) alleles occur only in ovine M. haemolytica 
isolates (Davies and Lee, 2004). Significantly, the ompA1- and ompA2-type 
alleles are associated with the major pathogenic lineages of bovine (ET 1) and 
ovine (ETs 21 and 22) isolates, respectively (16). Based on the distribution of the 
OmpA1 and OmpA2 proteins among bovine and ovine isolates, respectively, and 
the localisation of the amino acid variation to the tips of the four loops, it was 
hypothesised that OmpA acts as a ligand, plays an important role in adherence 
and is involved in host-specificity (Davies and Lee, 2004). Subsequently, it was 
demonstrated that OmpA is involved in the binding of serotype A1 M. 
haemolytica to bovine bronchial epithelial cells (Kisiela and Czuprynski, 2009) 
and that fibronectin is a potential host receptor molecule in cattle (Lo and 
Sorensen, 2007). 
The cell envelope of M. haemolytica is surrounded by a layer of capsular 
polysaccharide (CPS) (Adlam et al., 1984, Lo et al., 2001) which has been 
implicated in a number of functions including the adherence of the bacterium to 
alveolar surfaces (Brogden et al., 1989, Whiteley et al., 1990), inhibition of 
complement-mediated serum killing (Chae et al., 1990), and inhibition of the 
phagocytic and bactericidal activities of neutrophils (Czuprynski et al., 1989, 
Walker et al., 1985). Visibly thicker capsules have been observed in M. 
haemolytica during in vitro early log phase growth compared to stationary phase 
growth in both capsular serotype A1 (Corstvet et al., 1982) and A2 (Sutherland 
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et al., 1990) isolates. Crucially, polysaccharide capsules have been shown to 
inhibit outer membrane adhesin function in a range of capsular types in different 
bacterial species (Schembri et al., 2004, Virji et al., 1995, Shifrin et al., 2008, 
Favre-Bonte et al., 1999). Indeed, an acapsular serotype A1 M. haemolytica 
mutant was shown to have greater fibronectin-binding activity than the capsular 
parental strain, suggesting a shielding role of the capsule. In other species, CPS 
may be downregulated upon contact with host cells (Deghmane et al., 2002, 
Corcionivoschi et al., 2009, Auger et al., 2009) or as a consequence of phase 
variable expression (Krinos et al., 2001, deVries et al., 1996, Bacon et al., 
2001), thus allowing transient exposure of outer membrane adhesins. The 
shielding of OMPs, including OmpA, by CPS is likely to have important 
implications for the function of surface proteins but has yet to be investigated in 
M. haemolytica. 
The objectives of this study were twofold. First, we wished to determine if the 
M. haemolytica OmpA protein is surface-exposed or whether it is masked by the 
polysaccharide capsule under various growth conditions. Second, we wanted to 
demonstrate whether the bovine OmpA1 and ovine OmpA2 proteins are 
antigenically distinct, i.e. whether antibodies raised against each of these 
proteins interact in a strain-specific manner. This would provide clues as to 
whether these proteins are likely to interact with host-cell receptors in a host-
specific manner. To achieve these aims, recombinant OmpA1 (rOmpA1) and 
OmpA2 (rOmpA2) proteins were over-expressed, purified and used to generate 
anti-OmpA1 and anti-OmpA2 antibodies, respectively. These antibodies were 
used to explore OmpA surface-exposure and epitope specificity using electron 
microscopy and immunofluorescence techniques. In addition, attempts were 
made to determine the crystal structure of purified rOmpA1 using crystallisation 
screening methods and X-ray diffraction. 
2.2 Materials and methods 
2.2.1 Bacterial strains and growth conditions  
The M. haemolytica isolates used in this study are shown in Table 2.1. E. coli 
strains DH5α and Rosetta 2 (DE3) pLysS were obtained from Invitrogen and 
Novagen, respectively. The M. haemolytica isolates were stored at -80°C in 50%  
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Table 2.1. Properties of bovine and ovine M. haemolytica isolates. 
  
 
 Immunogold-labelling Immunofluorescence 
Isolate ETa Serotype Host Clinical Site of ompA allele     
  Species Status Origin 
  anti- anti- anti- anti- 
  rOmpA1 rOmpA2 rOmpA1 rOmpA2 
  
 
PH2 1 A1 Bovine Pneumonia Lung ompA1.1 + − + − 
PH30 1 A1 Bovine Healthy Nasopharynx ompA1.1 + − + +/− 
PH376 1 A6 Bovine Pneumonia Lung ompA1.1 + − + − 
PH540 2 A1 Bovine - Nasopharynx ompA1.2 + − + − 
PH202 21 A2 Bovine Healthy Nasopharynx ompA1.3 + − + +/− 
PH470 21 A2 Bovine Pneumonia Lung ompA1.3 + − + − 
PH494 16 A2 Ovine Pneumonia Lung ompA1.4 + − + − 
PH550 17 A2 Bovine Healthy Nasopharynx ompA1.5 + − + +/− 
PH8 6 A1 Ovine Pneumonia Lung ompA2.1 − + +/− + 
PH284 8 A6 Ovine Pneumonia Lung ompA2.1 − + +/− + 
PH66 10 A14 Ovine - Lung ompA2.1 − + +/− + 
PH56 5 A8 Ovine Pneumonia Lung ompA2.2 − + +/− + 
PH278 21 A2 Ovine Pneumonia Lung ompA2.3 − + − + 
PH292 22 A2 Ovine Pneumonia Lung ompA2.3 − + − + 
PH196 18 A2 Bovine Healthy Nasopharynx ompA3.1 − +/− − +/− 
PH296 12 A7 Ovine Pneumonia Lung ompA4.1 − +/− − +/− 
PH484 14 A7 Ovine Pneumonia Lung ompA4.1 − +/− − +/− 
PH588 15 A13 Ovine Pneumonia Lung ompA4.2 − +/− − +/− 
  
       aET = electrophoretic type (Davies et al., 1997)
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(v/v) glycerol in brain heart infusion (BHI) broth and were subcultured on BHI 
agar containing 5% (v/v) defibrinated sheep’s blood (blood agar) overnight at 
37°C. Liquid starter cultures were prepared by inoculating a few colonies into 10 
ml volumes of BHI broth and incubating overnight at 37°C with shaking at 120 
rpm. E. coli strain DH5α was grown in Luria-Bertani (LB) broth containing 54 
µg/ml carbenicillin. E. coli Rosetta 2 (DE3) pLysS was grown in LB broth 
containing 54 µg/ml carbenicillin and 34 µg/ml chloramphenicol. Both E. coli 
strains were grown at 37°C with shaking at 120 rpm. 
2.2.2 Capsule staining  
The polysaccharide capsule of M. haemolytica was demonstrated using the 
Maneval method (Corstvet et al., 1982). 
2.2.3 Preparation of chromosomal DNAs 
Bacterial cells from 1 ml of overnight culture were harvested by centrifugation 
for 1 min at 13,000 × g and washed once with 1 ml of sterile distilled H2O 
(dH2O). DNAs were prepared using an InstaGene Matrix kit (Bio-Rad) according to 
the manufacturer’s instructions and were stored at -20°C. 
2.2.4 PCR amplification and plasmid construction 
The M. haemolytica ompA gene fragments corresponding to the transmembrane 
domain of OmpA1 (amino acid positions 19 to 217) and OmpA2 (amino acid 
positions 19 to 211) were amplified by PCR from total genomic DNA from M. 
haemolytica isolates PH2 and PH278, respectively, using the following forward 
and reverse primers: 5’-AAGTTCTGTTTCAGGGCCCGCAAGCTAACACTTTCTACGCAG 
G-3’ and 5’-ATGGTCTAGAAAGCTTTAACCTTGACCGAAACGGTATG-3’. PCR products 
containing the ompA1 or ompA2 gene fragments were amplified from 
chromosomal DNA in 50 µl reaction mixes using Platinum Pfx DNA Polymerase 
(Invitrogen) with 2 mM MgSO4 and 50 pmol of each forward and reverse primer. 
PCRs were carried out in a GeneAmp PCR System 9700 (Applied Biosystems) 
thermal cycler using the following amplification parameters: initial denaturation 
at 94°C for 2 min, followed by 30 cycles of denaturation at 94°C for 15 s, 
annealing at 65°C for 30 s, and extension at 68°C for 1 min 30 s. The production 
of PCR amplicons of the expected size was confirmed by electrophoresis in a 1% 
(w/v) agarose gel and visualisation with SybrSafe (Invitrogen). The PCR 
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amplicons were purified with a QIAquick PCR Purification Kit (Qiagen) and eluted 
in 30 µl of sterile dH2O. Yields were assessed by agarose gel electrophoresis and 
the DNA stored at -20°C. The PCR products were cloned into separate pOPINF 
vectors (Oxford Protein Production Facility) (Berrow et al., 2007) according to 
the manufacturer’s instructions. The resulting plasmids, designated ompA1/His-
pOPINF and ompA2/His-pOPINF, were verified by DNA sequencing. Five 
microlitres of ompA1/His-pOPINF or ompA2/His-pOPINF were added to a tube 
containing 50 µl E. coli DH5α cells (as supplied by the manufacturer) and 
incubated on ice for 30 min. The mixtures were heated in a water bath at 42°C 
for 30 s and returned to ice for 2 min. Four hundred and fifty microlitres of GS96 
broth (QbioGene) were added to each tube, the contents mixed thoroughly and 
incubated at 37°C for 1 h. Transformant colonies were selected after plating 
onto LB agar containing 54 µg/ml carbenicillin and incubating overnight at 37°C. 
An individual colony was used to inoculate 50 ml of LB containing 54 µg/ml 
carbenicillin and grown overnight at 37°C with shaking at 170 rpm. Five 
millilitres of the overnight culture were centrifuged at 5,000 × g for 15 min at 
4°C to pellet the cells. Plasmids were recovered using a QIAprep Spin Miniprep 
Kit (Qiagen) according to the manufacturer’s instructions and eluted in 50 µl of 
sterile dH2O. Plasmid size was confirmed by electrophoresis on a 1% (w/v) 
agarose gel and visualisation with SybrSafe (Invitrogen). The DNA was stored at -
20°C.  
2.2.5 Expression of rOmpA.  
Two microlitres of ompA1/His-pOPINF or ompA2/His-pOPINF plasmids recovered 
from E. coli DH5α transformant cultures were added to a tube containing 100 µl 
E. coli Rosetta 2 (DE3) pLysS cells (Novagen) as supplied by the manufacturer 
and incubated on ice for 30 min. The bacterial cells were heated in a water bath 
at 42°C for 30 s and returned to ice for 2 min. Four hundred and fifty microlitres 
of GS96 broth were added to each tube, the contents mixed thoroughly and 
incubated at 37°C for 1 h. Transformant colonies were selected after plating 
onto LB agar containing 54 µg/ml carbenicillin and 34 µg/ml chloramphenicol 
and incubating overnight at 37°C. An individual colony was used to inoculate 15 
ml LB and grown overnight at 37°C with shaking at 120 rpm. One hundred and 
fifty microlitres of overnight culture were inoculated into 30 ml LB broth 
containing 54 µg/ml carbenicillin and 34 µg/ml chloramphenicol and incubated 
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at 37°C with shaking at 170 rpm until an OD600nm of 0.7-1.0 was achieved. Thirty 
microlitres of 1M isopropyl-β-D-thiogalactopyranoside (IPTG) was added and the 
culture incubated at 25°C with shaking at 170 rpm for a further 18 h. One and a 
half millilitres of overnight culture were centrifuged for 1 min at 13,000 × g and 
the pellet resuspended in 100 µl of sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) sample buffer. The sample was heated at 100°C for 5 
min and analysed by SDS-PAGE to check for the presence of recombinant 
protein. A second colony from the E. coli Rosetta 2 (DE3) pLysS transformant 
plate was used to inoculate 15 ml LB broth and grown overnight at 37°C with 
shaking at 120 rpm. Two millilitres of overnight culture were used to inoculate 
each of eight 2-litre Ehrlenmeyer flasks containing 1 litre of LB broth 
supplemented with 54 µg/ml carbenicillin and 34 µg/ml chloramphenicol and 
incubated at 37°C with shaking at 170 rpm until an OD600nm of 0.7-1.0 was 
achieved. One millilitre of 1M IPTG was added and the culture incubated at 25°C 
with shaking at 170 rpm for a further 18 h. 
2.2.6 Purification of recombinant OmpA proteins (rOmpA1 and rOmpA2) 
The protein purification protocol of Zhu et al. (Zhu et al., 2007) was followed, 
with modifications. Bacterial cells from each 1 litre of culture were harvested by 
centrifugation at 10,000 × g for 20 min at 4°C, resuspended in 25 ml of buffer A 
(25 mM Tris, 200 mM NaCl [pH 8.0]) and stored at -20°C. The cells from 2 litres 
of culture medium were disrupted by sonication (six cycles of 30 s on, 30 s off) 
and the lysates were centrifuged at 4,700 × g for 30 min at 4°C to pellet the 
inclusion bodies. These were resuspended in 1% Triton X-100 in buffer A and 
centrifuged at 4,700 × g for 30 min at 4°C. The inclusion bodies were solubilised 
overnight at 4°C in 50 ml of 6 M urea. The solubilised protein was added drop-
wise to 500 ml of 50 mM HEPES, 300 mM NaCl, 3% N,N-dimethyldodecylamine-N-
oxide (LDAO), 5 mM dithiothreitol (DTT) (pH 8.0) at 4°C and stirred slowly at 4°C 
for 72 h and dialysed against buffer B (50 mM Tris, 300 mM NaCl, 0.1% LDAO [pH 
7.6]). The protein solution was loaded onto a 5 ml HiTrap (GE Healthcare) 
column equilibrated with buffer B. Bound recombinant protein was eluted from 
the column using an imidazole gradient (0 - 300 mM imidazole in buffer B) and 
collected in 5 ml fractions. Protein concentrations were quantified using a 
Perkin Elmer Lambda 40 UV/VIS Spectrophotometer. Ten milligrams of eluted 
protein were loaded onto a Superdex G-200 gel filtration column (Pharmacia 
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Biotech) equilibrated with buffer B and collected in 5 ml fractions after running 
at 0.25 ml/min overnight. Concentrations of rOmpA in the collected fractions 
were determined by the modified Lowry procedure (Markwell et al., 1978). 
2.2.7 Circular dichroism spectroscopy 
Circular dichroism spectroscopy (Kelly et al., 2005) was performed to examine 
the secondary structure of refolded PH2 rOmpA1 and PH278 rOmpA2. Mean 
residue ellipticity was measured between 190 and 240 nm on a Jasco J-810 
Spectropolarimeter (Jasco, UK). Percentage estimates of secondary structure 
content (α-helix, β-strand, turn, unordered) were calculated using the modified 
CONTINLL algorithm (Provencher and Glockner, 1981, Vanstokkum et al., 1990) 
provided by the online server DICHROWEB (Lobley et al., 2002, Whitmore and 
Wallace, 2008). 
2.2.8 Anti-OmpA antibody preparation 
Purified rOmpA1 and rOmpA2 were sent to Eurogentec (Belgium; 
http://www.eurogentec.com/eu-home.html) and used to raise antibodies in 
rabbits using their 87-day Classic polyclonal antibody protocol. This protocol 
involves the injection of 0.2 mg of protein into each of two rabbits at days 0, 14, 
28 and 56. Serum bleeds were obtained before the first injection (pre-immune) 
and 38, 66, and 87 (final bleed) days after the initial injection 
2.2.9 Serum cross-absorption  
Two hundred and fifty millilitres of overnight cultures of PH2 and PH278 were 
centrifuged at 10,000 × g for 20 min at 4°C and the cells washed three times in 
50 ml phosphate buffered saline (PBS). The bacterial cells were resuspended in 5 
ml PBS and 1 ml aliquoted into each of five microfuge tubes. Each microfuge 
tube was centrifuged (13,000 × g, 3 min) to pellet the cells and the supernatants 
removed. Cells from one tube were resuspended in 1 ml of heterologous final 
bleed serum and incubated at 37°C for 30 min on an orbital shaker. The cells 
were pelleted by centrifugation and the supernatant used to resuspend the cells 
in a second microfuge tube. These were incubated at 37°C for 30 min on an 
orbital shaker. This process was repeated for the remaining three tubes. The 
cross-absorbed sera were diluted 1:5 with dH2O, filter sterilised and stored at -
80°C. 
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2.2.10 Isolation of OMPs 
Briefly, OMPs of M. haemolytica isolates PH2 and PH278 were prepared as 
described by Davies et al. (1992). Bacterial growth was stopped by chilling the 
culture medium in ice-cold water for 5 min. Bacterial cells were harvested by 
centrifuging the culture medium at 13,000 × g for 20 min at 4°C. The pellet was 
washed in 50 ml of 20 mM Tris/HCl (pH 7.2) and centrifuged at 12,000 × g for 20 
min at 4°C. The pellet was resuspended in 7 ml of 20 mM Tris/HCl (pH 7.2) and 
sonicated, on ice, for 5 min using a Soniprep sonicator (12 microns amplitude). 
The sonicated samples were brought to a total volume of 10 ml with additional 
20 mM Tris/HCl (pH 7.2) and centrifuged at 11,000 × g for 30 min at 4° C to 
remove unbroken cells. The supernatants were centrifuged at 84,000 × g at 1 h 
for 4°C in a Sorvall ultracentrifuge to pellet the cell envelopes. The gelatinous 
pellets were vigourously resuspended in 0.5 % sodium N-lauroylsarcosine 
(Sarkosyl; Sigma) for 20 min at room temperature to solubilise the cytoplasmic 
membranes and then centrifuged at 84,000 × g for 1 h at 4°C to pellet the OMs. 
The gelatinous OMs were resuspended in 20 mM Tris/HCl (pH 7.2) and 
centrifuged at 84,000 × g for 1 h at 4°C. The final pellets were resuspended in 
approximately 1 ml of 20 mM-Tris/HCl (pH 7.2). Fifty microlitre aliquots of these 
suspensions were transferred to separate tubes and their protein concentrations 
determined by the modified Lowry procedure. One hundred microlitre aliquots 
of the OM suspensions were adjusted to 2 mg/ml with 20 mM Tris/HCl (pH 7.2) 
and stored at -80°C. 
2.2.11 SDS-PAGE 
OMPs were separated by 1-D SDS-PAGE in a 12% polyacrylamide gel using the SDS 
continuous system (Laemmli, 1970) and the Hoefer SE600 electrophoresis 
equipment as previously described (Davies et al., 1992). 
2.2.12 Western blotting 
Briefly, Western-blotting was performed essentially as described by (Davies et 
al., 1994b). SDS-PAGE gels were equilibrated in transfer buffer (25mM Tris, 
192mM glycine [pH 8.3]) for 30 min and the proteins were transferred to 
nitrocellulose membranes overnight at 30 V. The nitrocellulose membranes were 
washed twice in TBS (20 mM Tris, 50 mM NaCl [pH 7.5]) for 5 min, blocked with 
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3% gelatin in TBS for 1 h and washed twice in TTBS (0.05% Tween 20 in TBS) for 5 
min each. The membranes were incubated with final bleed anti-rOmpA antibody 
diluted 1:100 in antibody buffer (1% gelatin in TTBS) for 1 h at room 
temperature and washed twice in TTBS for 5 min each. This was followed by 
incubation with secondary horse radish peroxidase-conjugated anti-rabbit 
antibody diluted 1:1000 in antibody buffer for 1 h at room temperature, two 5 
min washes in TTBS and one 5 min wash in TBS. The membranes were developed 
in a substrate solution containing 0.05% (w/v) 4-chloro-napthol (dissolved in 20 
ml of ice-cold methanol) and 0.05% (v/v) hydrogen peroxide in 100 ml of TBS. 
Development was stopped by washing the membranes in dH2O. 
2.2.13 Immunogold electron microscopy 
Bacterial cells from 25 ml volumes of 6 or 8 h BHI broth cultures, or 6 h BHI 
broth cultures containing 100 µM 2,2’-dipyridyl, were harvested by 
centrifugation at 3,500 × g for 5 min and washed once with PBS. Alternatively, 
overnight cultures of bacteria were scraped off blood agar plates and washed 
once in PBS. The washed cells were resuspended in PBS to an OD600nm of 0.4 
(equivalent to 1.0 × 108 cfu/ml). One milliliter of this suspension was 
centrifuged at 13,000 × g for 1 min and the pellet resuspended in 1 ml 4% 
paraformaldehyde in PBS (pH 7.2) for 30 min at room temperature. The cells 
were washed twice in 50 mM glycine in PBS and resuspended in 0.5 ml 0.2% 
bovine serum albumin (BSA) in PBS for 30 min. The cells were centrifuged and 
resuspended in 100 µl primary anti-rOmpA antibody (1:10 dilution) in 0.2% BSA in 
PBS, incubated for 1 h, washed three times in 0.2% BSA in PBS and finally 
resuspended in 200 µl of 0.2% BSA in PBS. Twenty microlitres of this suspension 
were dropped onto a freshly prepared Poly L-Lysine-coated Formvar carbon-
coated nickel grid, allowed to stand for 15 min and the excess fluid removed. 
The grids were floated face-down on 50 µl of secondary goat anti-rabbit IgG 
antibody conjugated to 10 nm gold particles (1:20 dilution) in 0.2% BSA in PBS 
and incubated for 1 h at room temperature. The grids were washed once in 0.2% 
BSA in PBS, three times in PBS (1 min each), and once in 1% glutaraldehyde in 
PBS (pH 7.4) for 5 min. The grids were finally washed three times with filtered 
de-ionized water (1 min each), allowed to air dry, and the bacteria visualised 
using a Zeiss 912 AB energy filtering transmission electron microscope operating 
under standard conditions at 80 kV. 
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2.2.14 Immunofluorescence staining 
Bacteria were grown overnight on blood agar, resuspended in 5 ml PBS and 
adjusted to an OD600nm of 0.5. The bacterial cells were mixed 1:1 with 8% 
paraformaldehyde in PBS (2×) for ten min. Five microlitres of bacterial 
suspension were added to each well of a multiwell microscope slide (Hendley-
Essex, UK), allowed to air dry, and incubated with 20 µl of primary anti-rOmpA 
antibody (1:100 dilution) in 0.1% BSA in PBS for 60 min at room temperature. The 
slides were washed three times in 0.1% BSA in PBS and incubated with 20 µl of 
Alexa Fluor 488 (Invitrogen) goat anti-rabbit IgG antibody (15 µg/ml in 0.1% BSA 
in PBS) for 30 min. The slides were washed three times in 0.1% BSA in PBS and 
allowed to air dry. One or two drops of fluorescence mounting medium (Dako, 
Sweden) were added to each slide, covered with a cover slip, and sealed with 
clear nail varnish. Bacteria were visualised with a Zeiss Axioskop fluorescence 
microscope. 
2.2.15 Crystallisation and X-ray analysis of rOmpA1 
Buffer B containing purified and refolded rOmpA1 was replaced with 0.6% 
tetraethylene glycol monooctyl ether (C8E4) in dH2O using a PD-10 buffer 
exchange column (GE Healthcare) and the eluted rOmpA1 protein concentrated 
to 40 mg/ml.  Crystallisation screens of rOmpA1 in 0.6% C8E4 were set up by 
mixing 1 µl protein solution and 1 µl reservoir solution in MemGold and MemSys 
crystallisation screening trays (Molecular Dimensions) using the sitting-drop 
vapour diffusion method. Full details of screening conditions are shown in 
Appendices 7.3 and 7.4. Crystals were transferred to reservoir solution 
containing a cryoprotectant, mounted on a LithoLoop (Molecular Dimensions, 
UK), and placed directly in a cold nitrogen-gas stream at 100 K. X-ray diffraction 
images were collected using the MAR345dtb image plate detector system (MAR 
Research, Germany). 
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2.3 Results 
2.3.1 Recombinant OmpA proteins are comprised predominantly of β-
sheets and exhibit heat-modifiability after heat treatment in the 
presence of SDS.   
Heat-modifiability is a characteristic property of the OmpA family of proteins 
(Reithmeier and Bragg, 1974, Nakamura and Mizushima, 1976, Beher et al., 
1980). The native form of the complete OmpA protein unfolds in the presence of 
SDS only after heat treatment at 100°C which exposes additional SDS-binding 
sites (Ohnishi et al., 1998, Dornmair et al., 1990). When analysed by SDS-PAGE, 
OmpA migrates through the gel according to its structural compactness with the 
native protein migrating faster than the fully denatured polypeptide (Dornmair 
et al., 1990, Kleinschmidt et al., 1999).  Recombinant OmpA proteins from the 
M. haemolytica bovine isolate PH2 (rOmpA1) and ovine isolate PH278 (rOmpA2) 
were successfully expressed, purified and refolded. Mass spectrometric analysis 
of gel-extracted protein bands confirmed that native and heat-modified proteins 
(described below) represented M. haemolytica OmpA (Supplementary Table 
S2.1). The rOmpA1 and rOmpA2 proteins were heated at a range of temperatures 
between 50 and 100°C for 5 min prior to SDS-PAGE and both proteins exhibited 
heat-modifiability when analysed by SDS-PAGE, although this occurred at 
different temperatures (Fig. 2.1A).  The native and heat-modified proteins 
migrated at approximately 24 and 22.5 kDa, respectively; however, PH2 rOmpA1 
unfolded at 70°C whereas PH278 rOmpA2 unfolded at 100°C (Fig. 2.1A, arrows).  
In contrast, the native and heat-modified forms of the complete OmpA protein 
recovered from the outer membrane of M. haemolytica isolates PH2 and PH278 
migrated at approximately 32 and 38 kDa, respectively, on SDS-polyacrylamide 
gels (Fig. 2.1B). In this case, the full-length OmpA protein of both isolates 
underwent heat modification at 100°C (Fig. 2.1B, arrows). The finding that 
rOmpA1 unfolds more readily at a lower temperature than rOmpA2 indicates a 
less stable structure for rOmpA1. Circular dichroism spectroscopy analysis 
predicted that the secondary structures of both recombinant proteins comprised 
predominantly β-sheets and turns, indicating that they have folded into a β-
barrel conformation similar to native M. haemolytica OmpA (Fig. 2.2). However, 
PH2 rOmpA1 has a lower β-sheet composition than PH278 rOmpA2 (33.6% and
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Figure 2.1. Heat-modifiability of recombinant and full-length OmpA proteins of M. haemolytica isolates PH2 and PH278. 
 Panels A and B represent purified recombinant proteins rOmpA1 (PH2) and rOmpA2 (PH278) and Sarkosyl-extracted OMPs of 
bovine isolate PH2 (OmpA1) and ovine isolate PH278 (OmpA2), respectively. Samples were heated for 5 min at 50, 60, 70, 
80, 90 and 100°C prior to separation by SDS-PAGE. Unmodified low-molecular-mass and heat-modified high-molecular-mass 
forms of rOmpA (A) and full-length OmpA (B) of isolates PH2 and PH278 are indicated by thick and thin arrows, 
respectively.  
B A 
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Figure 2.2. Circular dichroism spectroscopy analysis of purified rOmpA 
proteins. 
Mean residue ellipticity was measured between 190 and 240 nm for 
PH2 rOmpA1 (▲) and PH278 rOmpA2 (■). Percentage estimates of 
secondary structure content (α-helix, β-strand, turn, unordered) for 
each recombinant protein were calculated using the modified 
CONTINLL algorithm (Provencher and Glockner, 1981, Vanstokkum 
et al., 1990) provided by the online server DICHROWEB (Lobley et 
al., 2002, Whitmore and Wallace, 2008). 
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40.6%, respectively), which is consistent with the heat-modifiability results 
indicating a less stable structure for PH2 rOmpA1.  
2.3.2 Anti-rOmpA1 and anti-rOmpA2 antibodies exhibit immune-specificity 
for the homologous proteins. 
The binding specificities of the anti-rOmpA1 and anti-rOmpA2 antibodies to 
Sarkosyl-extracted OMPs and rOmpA from the bovine isolate PH2 and the ovine 
isolate PH278 were assessed by Western blotting (Fig. 2.3). Unabsorbed anti-
rOmpA1 antibodies bound to the full-length OmpA and rOmpA proteins of both 
PH2 [Fig. 2.3A(ii)] and PH278 [Fig. 2.3B(ii)]. Similarly, unabsorbed anti-rOmpA2 
antibodies bound to the full-length OmpA and rOmpA proteins of both PH2 [Fig. 
2.3A(iii)] and PH278 [Fig. 2.3B(iii)]. Significantly, no other M. haemolytica 
proteins were recognised by either antibody in the complete Sarkosyl-extracted 
OMP samples. After cross-absorption with the heterologous isolate PH278, anti-
rOmpA1 antibodies bound to PH2 OmpA and rOmpA1 [Fig. 2.3A(iv)] but not 
PH278 OmpA and rOmpA2 [Fig. 2.3B(iv)]. Similarly, anti-rOmpA2 antibodies 
cross-absorbed with the heterologous isolate PH2 bound to PH278 OmpA and 
rOmpA2 [Fig. 2.3B(v)] but not PH2 OmpA and rOmpA1 [Fig. 2.3A(v)]. However, 
the intensity of staining with the cross-absorbed antisera was noticeably weaker 
than for the unabsorbed antisera. These results indicate that the cross-absorbed 
anti-rOmpA1 and -rOmpA2 antibodies bind specifically to OmpA1 and OmpA2, 
respectively. 
2.3.3 M. haemolytica OmpA is surface-exposed and recognised by anti-
rOmpA antibodies in vitro in a strain-specific manner.  
The ability of anti-rOmpA antibodies to recognise OmpA on the surface of M. 
haemolytica was assessed by immunogold labelling (Fig. 2.4) and 
immunofluorescent staining (Fig. 2.5). Immunogold labelling demonstrated that 
the OmpA proteins of M. haemolytica isolates PH2 and PH278 are both 
recognised by unabsorbed anti-rOmpA1 [Fig. 2.4A and B(i)] and anti-rOmpA2 
[Fig. 2.4A and B(ii)] antibodies. However, cross-absorbed anti-rOmpA1 antibodies 
recognised OmpA of isolate PH2 [Fig. 2.4A(iii)] but not of isolate PH278 [Fig. 
2.4B(iii)]; conversely, cross-absorbed anti-rOmpA2 antibodies recognised OmpA 
of isolate PH278 [Fig. 2.4B(iv)] but not of isolate PH2 [Fig. 2.4A(iv)]. Antibody 
binding was evenly distributed over the surface of the bacterial cells and was  
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Figure 2.3. Western-blot analysis of anti-rOmpA antibody binding to full-
length OmpA and rOmpA of M. haemolytica isolates PH2 and 
PH278. 
Panels A and B represent protein samples from bovine isolate PH2 
and ovine isolate PH278, respectively. Lanes 1 and 2 represent 
Sarkosyl-extracted OMPs and purified rOmpA, respectively. The 
protein samples were separated by SDS-PAGE and either stained 
with Coomassie blue (i) or transferred to nitrocellulose (ii to v). 
The blotted proteins were probed with anti-rOmpA1 antibodies (ii), 
anti-rOmpA2 antibodies (iii), anti-rOmpA1 antibodies after cross-
absorption with isolate PH278 (iv) and anti-rOmpA2 antibodies after 
cross-absorption with isolate PH2 (v). This was followed by 
incubation with secondary goat horse radish peroxidase-conjugated 
anti-rabbit antibody. Molecular mass markers (in kDa) are shown on 
the right.  
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Figure 2.4. Immunogold labelling of the OmpA protein of M. haemolytica 
isolates PH2 and PH278 using anti-rOmpA antibodies. 
Panels A and B represent bovine isolate PH2 and ovine isolate 
PH278, respectively. Isolates were incubated with anti-rOmpA1 
antibodies (i), anti-rOmpA2 antibodies (ii), anti-rOmpA1 antibodies 
after cross-absorption with isolate PH278 (iii), and anti-rOmpA2 
antibodies after cross-absorption with isolate PH2 (iv). This was 
followed by incubation with secondary goat anti-rabbit IgG antibody 
conjugated with 10 nm gold particles. Isolates were visualised by 
electron microscopy. Magnification was × 10,000. 
Immunogold labelling images were produced by Dr. Mojtaba 
Noofeli. 
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Figure 2.5. Immunofluorescent staining of M. haemolytica isolates PH2 and 
PH278 using cross-absorbed anti-rOmpA1 and anti-rOmpA2 
antibodies. 
Panels A and B represent bovine isolate PH2 and ovine isolate 
PH278, respectively. Isolates were incubated with anti-rOmpA1 
antibodies after cross-absorption with isolate PH278 (i) or anti-
rOmpA2 antibodies after cross-absorption with isolate PH2 (ii). 
These were then incubated with Alexa Fluor 488 (Invitrogen) goat 
anti-rabbit IgG antibody. Bound antibodies were visualised by 
immunofluorescence microscopy. 
Immunofluorescent staining images were produced by Miss Susan 
Baillie. 
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not concentrated in any particular area. In addition, the density of labelling of 
isolate PH278 by the cross-absorbed anti-rOmpA2 antibody [Fig. 2.4B (iv)] was 
greater than that of PH2 by the cross-absorbed anti-rOmpA1 antibody [Fig. 2.4A 
(iii)] suggesting greater exposure of the OmpA2 protein in isolate PH278. 
Immunofluorescent staining confirmed that cross-absorbed anti-rOmpA1 
antibodies recognised OmpA in isolate PH2 [Fig. 2.5A(i)] but not in isolate PH278 
[Fig. 2.5B(i)], and that cross-absorbed anti-rOmpA2 antibodies recognised OmpA 
in isolate PH278 [Fig. 2.5B(ii)] but not in isolate PH2 [Fig. 2.5A(ii)]. 
* Immungold labelling and immunofluorescent staining work was carried out by 
Dr. Mojtaba Noofeli and Miss Susan Baillie, respectively, in this section and also 
in sections 2.3.4 and 2.3.5. 
2.3.4 OmpA is surface-exposed at different stages of the growth cycle and 
after growth in different media.   
Isolates PH2 and PH278 were grown for 6 h (logarithmic phase) and 18 h 
(stationary phase) in BHI broth and cells incubated with cross-absorbed anti-
rOmpA1 or anti-rOmpA2 antibodies. No differences were observed in the degree 
of antibody binding between bacteria grown for 6 and 18 h (results not shown). 
These results demonstrated that there was no appreciable difference in OmpA 
surface-exposure between logarithmic and stationary-phase cells. Isolates PH2 
and PH278 were also grown for 18 h on blood agar or in iron-restricted (100 µM 
2,2’-dipyridyl) BHI broth and cells incubated with cross-absorbed anti-rOmpA1 or 
anti-rOmpA2 antibodies. Again, no differences were observed in antibody binding 
between bacteria grown in iron-restricted BHI broth or on blood agar plates 
compared to bacteria grown in BHI broth (results not shown). Capsulation of 
bacteria grown under these various conditions was also examined by Maneval 
staining (results not shown); there were no major differences between isolates 
grown under different conditions with the exception that 18 hour stationary 
phase cultures contained cells that were less consistent in overall size and 
shape. Taken together, these results demonstrated that OmpA is not masked by 
the polysaccharide capsule and that the degree of surface-exposure remains 
relatively unchanged when bacteria are grown under different growth 
conditions. For subsequent experiments bacterial cells were grown in BHI broth 
for 6 h. *Maneval staining work was carried out by Dr. Mojtaba Noofeli. 
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2.3.5 Binding specificities of cross-absorbed anti-rOmpA1 and anti-rOmpA2 
antibodies to M. haemolytica isolates representing different OmpA 
subclasses.  
Eleven distinct ompA alleles have previously been identified among 31 M. 
haemolytica isolates; these alleles were assigned to four subclasses, ompA1 to 
ompA4 (Davies and Lee, 2004). Individual alleles within each subclass were 
designated ompA1.1, ompA1.2, etc. The binding specificities of cross-absorbed 
anti-rOmpA1 and anti-rOmpA2 antibodies to 18 M. haemolytica isolates 
representing all eleven ompA alleles were determined by immunogold labelling 
and immunofluorescent staining (Table 2.1). Five ompA1-type alleles, 
representing the class I lineage, have been identified in M. haemolytica and 
these are associated almost exclusively with bovine isolates (Davies and Lee, 
2004). The single exception, ovine isolate PH494, possesses a bovine-like LktA2-
type leukotoxin (Davies et al., 2001) in addition to a bovine-like OmpA1-type 
protein, and most likely represents a strain of bovine origin that has recently 
transferred to sheep. Anti-rOmpA1 antibodies were raised against bovine isolate 
PH2 OmpA, which possesses the ompA1.1 allele. At the amino acid level, 
OmpA1.1 is identical to OmpA1.2 and OmpA1.3; OmpA1.4 differs from OmpA1.1 
at two amino acid positions in HV1 and OmpA1.5 differs from OmpA1.1 in having 
four amino acid deletions in HV1 (Figure 2.6). Cross-absorbed anti-rOmpA1 
antibodies bound to all eight OmpA1-type M. haemolytica isolates when 
examined by both immunogold labelling and immunofluorescent staining (Table 
2.1). Cross-absorbed anti-rOmpA2 antibodies showed a negative binding response 
to all OmpA1-type isolates when examined by immunogold labelling, although 
weak fluorescence was detected in three isolates when examined by 
immunofluorescent staining (Table 2.1). 
Three ompA2-type alleles, representing the class II lineage, have been identified 
in M. haemolytica and these are associated exclusively with ovine isolates 
(Davies and Lee, 2004). Anti-rOmpA2 antibodies were raised against ovine isolate 
PH278 OmpA, which possesses the ompA2.3 allele. OmpA2.1 and OmpA2.2 are 
identical and differ from OmpA2.3 at one amino acid position in HV1 and one in 
HV3 (Figure 2.6). Cross-absorbed anti-rOmpA2 antibodies showed positive 
binding to all six OmpA2-type M. haemolytica isolates when examined by both 
immunogold labelling and immunofluorescent staining (Table 2.1). There was a  
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Figure 2.6 Distribution of variable amino acids in the transmembrane 
domains of the 11 OmpA proteins of M. haemolytica. 
The major allele classes are represented by Roman numerals I to 
IV. Amino acid positions are designated above the sequences. 
Amino acids that match those of the first sequence are represented 
by dots. Gaps are indicated by dashes. The hypervariable regions 
within surface-exposed loops 1 to 4 are designated by HV1 to HV4. 
Membrane-spanning β-strands are shaded. 
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negative binding response to all OmpA2-type isolates with cross-absorbed anti-
rOmpA1 antibodies when examined by immunogold labelling, although weak 
fluorescence was detected in four isolates by immunofluorescent staining (Table 
2.1).  
The ompA3.1 allele, also belonging to the class II lineage, is associated with the 
bovine isolate PH196. The OmpA3.1 protein was recognised by cross-absorbed 
anti-rOmpA2 (weakly) but not by anti-rOmpA1 antibodies when examined by 
immunogold labelling and immunofluorescent staining. Two ompA4-type alleles, 
representing the class III lineage, have been identified in M. haemolytica and 
these are associated with ovine serotype A7 and A13 isolates. The OmpA4-type 
proteins (OmpA4.1 and OmpA4.2) were recognised by cross-absorbed anti-
rOmpA2 (weakly) but not by anti-rOmpA1 antibodies when examined by 
immunogold labelling and immunofluorescent staining. 
2.3.6 Crystallisation of rOmpA1 
Crystals of rOmpA1 in 0.6% C8E4 detergent were obtained within 3 months of 
incubation in a MemSys crystallisation screening tray (Fig. 2.7). No crystals were 
obtained using the MemGold crystallisation screening tray. X-ray diffraction 
experiments were performed on rOmpA1 crystals from each screening condition 
shown in Fig. 2.7. None of the rOmpA1 crystals produced X-ray diffraction data, 
indicating that further optimisation of screening conditions will be necessary to 
improve crystal quality. 
2.4 Discussion 
In the present study, it has been clearly demonstrated that the OmpA protein of 
M. haemolytica is surface-exposed and able to bind anti-rOmpA antibodies in 
vitro. This was initially demonstrated in the bovine and ovine isolates PH2 and 
PH278 (Figs. 2.4 and 2.5), but was subsequently confirmed in a wide range of M. 
haemolytica isolates (Table 2.1). The degree of surface-exposure of OmpA in 
PH2 and PH278 was not affected by the stage of growth (i.e., logarithmic versus 
stationary phase) or the growth medium (i.e., blood agar and iron-replete or 
iron-restricted broth). Since a well-developed capsule was observed by Maneval 
staining in these isolates under different growth conditions, these findings 
strongly suggest that the capsule does not mask the OmpA protein since antibody  
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Figure 2.7. Crystallisation of rOmpA1 using a MemSys screening tray. 
Panels A to D represent crystals that were obtained within three 
months of incubation in (A) 0.1 M MOPS, pH 7.0, 30% v/v PEG 400; 
(B) 0.1 M MOPS, pH 7.0, 12% PEG w/v 4000; (C) 0.1 M Na HEPES, pH 
7.5, 12% w/v PEG 4000 and (D) 0.1 M sodium chloride, 0.1 M Na 
HEPES, pH 7.5, 12% w/v PEG 4000. 
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binding seemed unaffected. However, in a previous study the OmpA protein of 
an acapsular mutant was shown to have higher fibronectin-binding activity than 
the capsular parental strain (Lo and Sorensen, 2007), suggesting that the capsule 
may partially mask the protein.  
The loops of the M. haemolytica OmpA protein range from 25 to 31 amino acids 
in length (Davies and Lee, 2004) and are estimated to extend less than 10 nm 
from the bacterial surface. However, the capsule of the parental strain of the 
acapsular mutant described above has been observed by electron microscopy to 
extend almost 200 nm from the bacterial surface (McKerral and Lo, 2002). It is 
therefore puzzling as to how the loops of OmpA are recognised by antibodies 
and, presumably, by host cell molecules through a capsule of this thickness. The 
M. haemolytica capsule is structurally fragile and it is possible that in vitro 
manipulation of bacterial cells causes sloughing of the capsule in some areas 
which exposes the tips of the loops and allows antibody binding. However, 
uniform immunogold labelling clearly demonstrated that OmpA is evenly 
distributed over the bacterial cell surface. The loops of the OmpA protein of M. 
haemolytica are longer than those of the OmpA protein of E. coli (Pautsch and 
Schulz, 1998), but not as long as the loops of other OMPs such as neisserial 
opacity (Opa) proteins which can extend to over fifty amino acids in length (de 
Jonge et al., 2003). There are a number of reasons why OMPs might evolve loops 
of different lengths. The neisserial Opa proteins are involved in binding to host 
receptors and longer loops could be seen as advantageous for increasing the 
distance range to which they can bind host molecules. It is also reasonable to 
hypothesise that OMPs involved in host molecule binding might evolve loops 
which are long enough to traverse the capsule. However, this is contradicted by 
findings that long loops are still present in unencapsulated species such as N. 
gonorrhoeae and H. influenzae. Longer loops have also been correlated with 
virulence in neisserial species, where commensal organisms have shorter 
hypervariable domains (and thus shorter loops) than pathogenic species (Malorny 
et al., 1998). There is evidence to suggest that in a number of bacterial species 
the capsule can be downregulated upon contact with host cells (Deghmane et 
al., 2002, Corcionivoschi et al., 2009, Auger et al., 2009) and as a consequence 
of phase variable expression (Krinos et al., 2001, deVries et al., 1996, Bacon et 
al., 2001), thus allowing transient exposure of OMP adhesins. Also, blebbing of 
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outer membrane vesicles has been observed in several Gram-negative bacteria 
[reviewed in (Kulp and Kuehn, 2010)], allowing OMPs to traverse the capsule and 
reach the extracellular environment. These phenomena have not been 
demonstrated in M. haemolytica, although they would provide appropriate 
mechanisms for the transient exposure of OmpA and other adhesin molecules for 
host-molecule binding. 
A wider examination of the binding specificities of the cross-absorbed antibodies 
to M. haemolytica isolates representing different ompA subclasses demonstrated 
that anti-rOmpA1 antibodies recognise OmpA1-type (class I) proteins present in 
bovine isolates, but not OmpA2-type (class II) proteins that occur in ovine 
isolates. Conversely, cross-absorbed anti-rOmpA2 antibodies recognise OmpA2- 
but not OmpA1-type proteins. The ability of cross-absorbed anti-rOmpA 
antibodies to discriminate between OmpA proteins of the OmpA1 and OmpA2 
subclasses is due to the greater degree of amino acid sequence variation (within 
the hypervariable domains) between each of the two subclasses compared to the 
variation within each subclass (Davies and Lee, 2004). There are only two 
variable amino acid sites within the OmpA1-type proteins; similarly, there are 
only two variable amino acid sites within the OmpA2-type proteins. However, 
there are 18 variable amino acid sites within the transmembrane domains of 
OmpA1 and OmpA2, all of which occur within the hypervariable regions (i.e., 
HV1 to HV4) located at the distal ends of the four external loops. The greater 
degree of variation between the two OmpA subclasses, compared to within each 
subclass, is sufficient to allow the cross-absorbed antibodies to discriminate 
between the bovine OmpA1- and ovine OmpA2-type subclasses. Overall, these 
results clearly demonstrate that the OmpA1 and OmpA2 proteins are sufficiently 
different in structure and epitope specificity that they are potentially capable of 
recognising host receptor molecules of differing specificities in cattle and sheep.  
Previous studies have demonstrated that OmpA functions as a ligand, is involved 
in binding to specific host cell receptor molecules, and plays an important role 
in adherence and colonisation in a number of Gram-negative bacteria 
(Prasadarao et al., 1996, Bookwalter et al., 2008, Dabo et al., 2003, Hill et al., 
2001, Reddy et al., 1996, Millman et al., 2001, Prasadarao, 2002, Torres and 
Kaper, 2003). In particular, it has been shown that the OmpA protein of bovine 
serotype A1 isolates of M. haemolytica binds to fibronectin (Lo and Sorensen, 
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2007) and to bovine bronchial epithelial cells (Kisiela and Czuprynski, 2009). 
However, a potential role of OmpA as an adhesin has yet to be investigated in 
ovine isolates of M. haemolytica. It has been previously shown that the OmpA1 
and OmpA2 proteins are associated exclusively with bovine and ovine isolates, 
respectively, which led to the hypothesis that they are involved in binding to 
host-specific receptors in the upper respiratory tracts of these animals (Davies 
and Lee, 2004). This, in turn, might partially account for the different host-
specificities of strains carrying the OmpA1 and OmpA2 protein types. 
Importantly, the present work has extended this previous study (Davies and Lee, 
2004) by demonstrating that the binding specificities of the OmpA1 and OmpA2 
proteins are very different from each other but are conserved within bovine and 
ovine M. haemolytica isolates representing different capsular serotypes and 
evolutionary lineages; there is no association between allele/protein type and 
clinical status (Table 2.1). From the findings of the present study, it is 
reasonable to conclude that OmpA1 and OmpA2 are capable of binding to 
different receptors within cattle and sheep, respectively. Although bovine 
fibronectin has been demonstrated to be a potential receptor for the OmpA 
protein of a bovine serotype A1 strain (Lo and Sorensen, 2007), it is interesting 
that the OmpA (P5) protein of the related species H. influenzae targets a 
different molecule, namely the carcinoembryonic antigen (CEA) family of cell 
adhesion molecules. Thus, it is reasonable to speculate that different molecular 
variants or regions of fibronectin, or even different molecules, are targeted in 
cattle and sheep. The production of antibodies against OmpA1 and OmpA2, and 
the demonstration that they are highly strain and protein specific, will allow 
further studies to be performed designed to investigate the role of OmpA in the 
adherence and colonisation of M. haemolytica in cattle and sheep. 
Commercial vaccines have been produced and are important for the prevention 
of respiratory disease in both cattle and sheep (Bowland and Shewen, 2000, 
Hjerpe, 1990). Several studies have demonstrated the importance of M. 
haemolytica OMPs as surface antigens and their potential as vaccine components 
(Morton et al., 1995, Confer et al., 1995, Mosier et al., 1989, Pandher et al., 
1999, Ayalew et al., 2010). Antibodies against the immunogenic and surface-
exposed lipoprotein PlpE contribute towards host defence (Pandher et al., 1998) 
and the addition of recombinant PlpE to commercial vaccines significantly 
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enhances protection against experimental challenge (Confer et al., 2003, Confer 
et al., 2006). The incorporation of iron-regulated proteins into a vaccine was 
shown to enhance protection against experimental pasteurellosis in lambs 
(Gilmour et al., 1991). An edible vaccine that expresses a fragment of the outer 
membrane antigen GS60 has also been developed (Lee et al., 2008). Immune 
sera from cattle vaccinated with live or killed M. haemolytica cells (Mahasreshti 
et al., 1997), and immune sera from naturally infected cattle (Zeng et al., 
1999), contain antibodies that recognise OmpA. In addition, in the closely 
related species P. multocida, OmpA is the major protein that cattle produce 
antibodies to after experimental challenge (Prado et al., 2005). Clearly, OmpA is 
an important immunogen that should be considered for inclusion in M. 
haemolytica subunit vaccines. However, a critical property of any vaccine 
candidate is a high degree of amino acid conservation throughout bacterial 
populations. Hypervariability of surface-exposed loop regions is a common 
occurrence within OMPs of many bacterial species and poses a serious problem 
for vaccine design (Webb and Cripps, 1998, Duim et al., 1997, Bolduc et al., 
2000, Martin et al., 2000). It was previously demonstrated that four distinct 
OmpA classes occur within bovine and ovine M. haemolytica strains; OmpA1 and 
OmpA2 are associated with those strains that are responsible for the majority of 
disease in cattle and sheep, respectively, and have very different hypervariable 
domains within their surface-exposed loops (Davies and Lee, 2004).  In the 
present study, it has been shown that antibodies specific for the surface-exposed 
loops of OmpA1 will not recognise the same regions of OmpA2 and vice versa. 
Therefore, an animal exposed to OmpA1 will generate anti-OmpA antibodies that 
are unlikely to confer protection against M. haemolytica isolates possessing 
OmpA2 and vice versa (although some cross-reacting antibodies may be present). 
These findings clearly have important implications with regard to vaccine 
development and, in particular, to the inclusion of OmpA in subunit vaccines 
that are designed to provide universal protection against heterologous M. 
haemolytica isolates. Essentially, an OmpA-based M. haemolytica subunit 
vaccine would need to include OmpA from more than one class to provide 
universal protection against heterologous strains.  
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3. COMPARATIVE OUTER MEMBRANE 
PROTEOMIC ANALYSES OF BOVINE AND 
OVINE ISOLATES OF M. HAEMOLYTICA AND 
M. GLUCOSIDA GROWN IN COMPLEX MEDIUM 
3.1 Introduction 
The Gram-negative bacterium M. haemolytica is the etiological agent of bovine 
and ovine pneumonic pasteurellosis, infections that are responsible for 
considerable economic losses to the livestock industries (Highlander, 2001). 
Twelve different capsular serotypes of M. haemolytica have been identified to 
date. Serotype A1 isolates are most commonly associated with cases of bovine 
pneumonic pasteurellosis, although serotype A6 isolates are responsible for an 
increasing proportion of disease cases. Serotype A2 isolates are often recovered 
from the nasopharynxes of healthy cattle but seldom cause disease. In contrast, 
serotype A2 isolates are responsible for the majority of disease cases of ovine 
pneumonic pasteurellosis. A wide range of other serotypes are also associated 
with sheep, including serotypes A1 and A6, although these are recovered much 
less frequently than serotype A2 isolates. M. glucosida was previously classified 
as the A11 serotype of M. haemolytica and comprises a heterogeneous group of 
organisms with low virulence that are mainly opportunistic pathogens of sheep 
(Angen et al., 1999a, Davies et al., 1997). Bovine serotype A1 and A6 isolates 
and bovine serotype A2 M. haemolytica isolates are genetically distinct from 
ovine M. haemolytica isolates of the same serotypes, suggesting that different 
subpopulations of these serotypes are associated with disease in the two animals 
(Davies et al., 1997). Bovine and ovine isolates of these three serotypes can also 
be differentiated based on their OMP profiles (Davies and Donachie, 1996) and 
nucleotide sequence variation of the ompA gene (Davies and Lee, 2004). These 
observations suggest that certain OMPs are likely to be involved in host 
specificity and virulence. However, the mechanisms by which OMPs facilitate 
host-specific infection and disease in M. haemolytica are poorly understood. 
The outer membrane is an asymmetrical lipid bilayer comprising an inner leaflet 
of phospholipid and an outer leaflet of mainly LPS. It serves as a selective 
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barrier for the passage of nutrients and other materials into and out of the cell 
and is at the interface between bacterium and host. Two types of proteins are 
also present in the outer membrane: integral OMPs and lipoproteins. Integral 
OMPs span the outer membrane with amphipathic antiparallel β-strands that 
adopt a barrel-like conformation. Outer membrane lipoproteins are anchored to 
the outer membrane by N-terminal lipid modifications made at the inner 
membrane. The majority of proteins that are destined to be located in the outer 
membrane contain specific protein modifications, sorting signals and structural 
signatures that can be differentiated using bioinformatic prediction tools 
(Gromiha, 2005, Gromiha and Suwa, 2006, Jackups et al., 2006, Juncker et al., 
2003). These predictors have been used to identify and quantify OMPs of several 
Gram-negative bacteria (Diaz-Mejia et al., 2009, Berven et al., 2006, Boyce et 
al., 2006, Huntley et al., 2007, Viratyosin et al., 2008). A simple bioinformatic 
prediction framework encompassing three categories of bioinformatic predictors 
(and 10 prediction programmes) was recently developed to predict the total 
number of OMPs encoded in two P. multocida genomes (E-Komon et al., 2011b). 
Complementary proteomic analyses can also be implemented to identify these 
putative OMPs in outer membrane fractions isolated from the bacterial cell 
envelope. Different proteomic methods have been used to characterise the 
outer membrane subproteome of several Gram-negative bacteria (Liu et al., 
2008, Molloy et al., 2000, Cordwell et al., 2008, Veith et al., 2009). including 
the related species P. multocida (Boyce et al., 2006, E-Komon et al., 2011a) and 
A. pleuropneumoniae (Chung et al., 2007). 
In M. haemolytica, much effort has been given to comparing OMP expression 
between different isolates (Davies and Donachie, 1996, Davies et al., 1992, 
McCluskey et al., 1994, Morton et al., 1996), characterising individual OMPs 
(Davies and Lee, 2004, Nardini et al., 1998, Pandher and Murphy, 1996, Cooney 
and Lo, 1993, Lo et al., 1991), and identifying those of immunological 
importance (Pandher et al., 1999, McVicker and Tabatabai, 2002). In a recent 
study an immunoproteomic approach was used to identify potential vaccine 
candidate antigens in a bovine serotype A1 isolate (Ayalew et al., 2010). A 
number of studies have also investigated the roles of specific OMPs in M. 
haemolytica adherence to host tissue and cells (Kisiela and Czuprynski, 2009, 
Daigneault and Lo, 2009, Lo and Sorensen, 2007, De la Mora et al., 2006). 
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However, a comprehensive analysis of the M. haemolytica outer membrane 
subproteome has yet to be performed.  
The objectives of this study were twofold. First, the entire repertoire of OMPs 
encoded in the genomes of a bovine serotype A1 M. haemolytica isolate (Gioia et 
al., 2006) and two serotype A2 isolates (one bovine and one ovine) (Lawrence et 
al., 2010a) were predicted using the same bioinformatic prediction approach 
developed for P. multocida (E-Komon et al., 2011b). Comparative amino acid 
sequence analyses were also performed to identify predicted OMPs that could be 
involved in host-specific adaptation. Second, the OMPs present in the outer 
membrane fractions of seven M. haemolytica isolates which were carefully 
selected to represent different host species, disease statuses, capsular 
serotypes, OMP-types and phylogenetic lineages (Davies et al., 1997, Davies and 
Donachie, 1996) were identified and compared using a combination of gel-based 
and gel-free proteomic approaches. The outer membrane fraction of a single M. 
glucosida isolate was also investigated for comparison. This is the first study to 
provide a comparative analysis of the outer membrane subproteomes of multiple 
isolates of M. haemolytica. This comparative approach will provide insights into 
the roles of OMPs in host-specificity in bovine and ovine hosts and identity 
putative virulence determinants and mechanisms of pathogenesis.  
3.2 Materials and methods 
3.2.1 Bioinformatic prediction of genome-encoded OMPs 
The publicly available genomes of a bovine serotype A1 M. haemolytica isolate 
(GenBank ID: AASA00000000), an ovine serotype A2 isolate (GenBank ID: 
ACZX00000000) and a bovine serotype A2 isolate (GenBank ID: ACZY00000000) 
were used for all bioinformatic analyses. All M. haemolytica protein sequences 
(2695, 2682 and 2552 open reading frames from the bovine serotype A1, ovine 
serotype A2 and bovine serotype A2 genomes, respectively) were retrieved from 
NCBI. Each genome was scrutinised by bioinformatic approaches according to the 
workflow described by E-Komon et al. (2011b) to predict proteins which localise 
to the outer membrane. Each genome was analysed by three categories of 
bioinformatic prediction software, using a total of ten prediction tools. 
Subcellular localisation predictors included Proteome Analyst (Szafron et al., 
 89
2004), PSORTb (Gardy et al., 2005), CELLO (Yu et al., 2006) and SOSUI-GramN 
(Imai et al., 2008); β-barrel predictors included TMB-Hunt (Garrow et al., 2005), 
TMBETADISC-RBF (Ou et al., 2008), MCMBB (Bagos et al., 2004) and BOMP 
(Berven et al., 2004); and outer membrane lipoprotein predictors included LipoP 
(Juncker et al., 2003) and LIPO (Berven et al., 2006). A consensus prediction 
framework was followed whereby proteins that were predicted to (a) be 
localised to the outer membrane by at least two subcellular localisation 
predictors, (b) have a β-barrel conformation by at least three β-barrel predictors 
or (c) be outer membrane lipoproteins by at least one lipoprotein predictor, 
were considered to be putative OMPs. In several instances, two predicted 
proteins within a genome were determined to constitute a single functional 
protein and were therefore grouped as such. A list of putative OMPs within each 
genome was produced by integrating the results from each of the predictor 
categories. A final integrated list of putative OMPs from all three genomes was 
produced by performing BLAST searches to determine whether each putative 
OMP was present in one, two or all three genomes. When a putative OMP was 
present in only one or two genomes, a protein BLAST search was performed 
against all annotated proteins to determine whether it was actually present or 
not in these other genome(s). Similarly, nucleotide BLAST searches were 
performed against whole genome shotgun contigs (ctgs) in these other genomes 
to determine whether a gene encoding an OMP was present but had not been 
annotated. Proteins with close homology at the amino acid level in more than 
one genome were assumed to have similar functions and were assigned the same 
protein name. The putative OMPs were further scrutinised using additional 
domain, homology and literature searches to assign likely functions and to 
predict their subcellular localisations with greater confidence. Based on this 
further information, each putative OMP was assigned to one of three localisation 
categories: (1) confidently predicted OMPs, (2) putative OMPs without 
confidently predicted subcellular location, and (3) false positives. 
Physiochemical properties including molecular mass, theoretical pI, aliphatic 
index, grand average of hydropathicity (GRAVY) score, number of β-strands and 
helices, of putative OMPs were predicted by ProtParam (Gasteiger et al., 2005), 
TMHMM (Krogh et al., 2001), and TMBETA-NET (Jackups et al., 2006). 
 90
3.2.2 Bacterial isolates and growth conditions 
The eight bacterial isolates used in the present study are shown in Table 3.1. 
These included seven representative M. haemolytica isolates recovered from 
cattle (two) and sheep (five) and one M. glucosida isolate. These isolates were 
selected to represent the major clonal groups and electrophoretic types (ETs) 
that were previously identified by multilocus enzyme electrophoresis (MLEE) 
(Davies et al., 1997) (Fig. 3.1) and comparative analyses of capsular serotypes, 
OMP profile types and disease statuses (McCluskey et al., 1994, Davies and 
Donachie, 1996) (Table 3.1). Isolates were stored at -80°C in 50% (v/v) glycerol 
in brain heart infusion (BHI) broth and were subcultured on BHI agar containing 
5% (v/v) defibrinated sheep’s blood overnight at 37°C. For preparation of outer 
membrane fractions, liquid starter cultures were prepared by inoculating a few 
colonies into 15 ml volumes of BHI broth and incubating overnight at 37°C with 
shaking at 120 rpm. Eight hundred microlitres of overnight culture were used to 
inoculate a 2-litre Ehrlenmeyer flask containing 400 ml of BHI broth and 
incubated at 37°C with shaking at 120 rpm until an OD600nm of 0.8-0.9 was 
achieved. 
3.2.3 Preparation of OMPs. 
Outer membrane proteins were prepared by Sarkosyl extraction as previously 
described in section 2.2.10. 
3.2.4 Gel-based proteomic analysis 
Twenty micrograms of each OMP preparation were separated by 1-D SDS-PAGE in 
a 12% linear polyacrylamide gel using the SDS discontinuous system (Laemmli, 
1970) and the Hoefer SE600 electrophoresis equipment as previously described 
(Davies et al., 1992, McCluskey et al., 1994, Davies and Donachie, 1996, Davies 
et al., 1994a). Proteins were visualised by staining with Coomassie brilliant blue. 
A total of 444 gel pieces, including both gel bands and gel fractions without 
protein bands from all isolates were manually excised and each gel piece placed 
into separate wells of 96-well plates. Automated in-gel trypsin digests were 
completed using an Ettan Spot Handling Workstation (Amersham Biosciences) 
according to the procedure described by Bridges et al. (Bridges et al., 2008). 
Briefly, gel pieces were washed three times in 100 µl of 50 mM ammonium  
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Table 3.1. Properties of seven representative M. haemolytica isolates and 
one M. glucosida (PH344) isolate. 
Isolate Animal host 
Electrophoretic 
typea 
Capsular 
serotype 
OMP 
type 
Disease 
status 
M. haemolytica 
     
PH2 Bovine  1 A1 1.1.1 Pneumonia 
PH8 Ovine 6 A1 1.2.1 Pneumonia 
PH202 Bovine  21 A2 2.1.2 Healthy 
PH278 Ovine 21 A2 2.2.2 Pneumonia 
PH292 Ovine 22 A2 2.2.1 Pneumonia 
PH296 Ovine 12 A7 3.1.1 Pneumonia 
PH588 Ovine 15 A13 3.3.2 Pneumonia 
M. glucosida 
     
PH344 Ovine N/A A11 3.2.2 Septicaemia 
 
Figure 3.1. Evolutionary relationships of seven representative M. 
haemolytica isolates and one M. glucosida (PH344) isolate, 
based on MLEE analysis. 
Figure adapted from Davies et al. (1997). 
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bicarbonate, 50% v/v methanol and then twice in 100 µl of 75% v/v acetonitrile 
(ACN) before drying. Gel pieces were rehydrated with trypsin solution [20 µg 
trypsin/ml (Promega) in 20 mM ammonium bicarbonate] and incubated at 37°C 
for 4 h. Peptides were extracted by washing the gel pieces twice in 100 µl of 50% 
v/v ACN, 0.1% v/v trifluoroacetic acid (TFA), before being transferred in solution 
to a new 96-well plate and dried. Dried peptide samples were stored at -20°C 
until analysed by MALDI-TOF-TOF MS and/or LC-ESI-QqTOF MS. 
3.2.5 Gel-free proteomic analysis 
Outer membrane fractions were directly digested with trypsin without prior 
separation by 1-D SDS-PAGE using the methanol-aided trypsin digestion protocol 
as previously described by Bridges et al. (Bridges et al., 2008). Briefly, twenty 
microlitres of 4 mg/ml protein was resuspended in 44 µl of 50 mM ammonium 
bicarbonate and placed in a sonicator bath for 20 min (with regular vortexing), 
before being incubated at 60°C for 20 min. Samples were placed on ice for 3 min 
before adding 60 µl of methanol and incubating for a further 5 min in the 
sonicator bath with regular vortexing. Sixteen microlitres of 200 µg/ml trypsin 
(Promega) in 25mM ammonium bicarbonate was added followed by 60 µl of 
methanol. After vortexing briefly samples were incubated at 37 °C for 12-16 h. 
The digested samples were dried down in an Eppendorf SpeedVac and stored at -
20°C until analysis by mass spectrometry. 
 3.2.6 MALDI-TOF-TOF MS and data analysis 
One microlitre of peptide solution was mixed with an equivalent volume of 
matrix solution (10 mg cyano-4-hydroxycinnamic acid in 500 µl 50% ACN, 0.1% 
TFA) on a MALDI-TOF target plate. Peptides were analysed using an Applied 
Biosystems 4700 Proteomics Analyzer. MS/MS was performed on the ten most 
intense precursor ions in each peptide sample. GPS Explorer Software (Applied 
Biosciences) was used to automate submission of collected data to MASCOT for 
searching the NCBI Eubacteria protein database with methionine oxidation 
selected as a variable modification, peptide and MS/MS tolerances of 1.2 and 0.5 
Da, respectively, with one missed cleavage allowed. Only proteins identified 
with a significant MOWSE score (p<0.05) were accepted. Each peptide sample 
was analysed three times. Any unidentified peptide samples were further 
analysed by LC-ESI-QqTOF MS. 
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3.2.7 LC-ESI-QqTOF MS and data analysis 
The peptide samples obtained by gel-free trypsin-digestion were analysed by ESI-
MS on a QSTAR XL Hybrid LC/MS/MS System according to the parameters 
described in Bridges et al. (Bridges et al., 2008). Briefly, MASCOT Daemon 
Software (Matrix Science) was used to automate submission of collected data to 
MASCOT for searching the NCBI Eubacteria protein database with methionine 
oxidation selected as a variable modification, peptide and MS/MS tolerances of 
1.2 and 0.4 Da, respectively, with one missed cleavage allowed. Only proteins 
identified with a significant MOWSE score (p<0.05) were accepted. 
3.3 Results 
3.3.1 Bioinformatic prediction of OMPs in three M. haemolytica genomes. 
Ten different bioinformatic tools were used to predict putative OMPs encoded in 
the fully-sequenced genomes of three M. haemolytica isolates (bovine serotype 
A1, ovine serotype A2 and bovine serotype A2) following the bioinformatic 
workflow of E-Komon et al. (2011b). These tools were categorised into three 
groups: subcellular localisation predictors (PA, PSORTb, CELLO, SOSUI-GramN), 
β-barrel protein predictors (TMB-Hunt, TMBETADISC-RBF, BOMP, MCMBB), and 
outer membrane lipoprotein predictors (LIPO and LipoP). One hundred and sixty-
four, 174 and 163 unique protein annotations (Supplementary Tables S3.1, S3.2 
and S3.3) were predicted to be putative OMPs in the bovine serotype A1, ovine 
serotype A2 and bovine serotype A2 genomes, respectively, after following a 
consensus prediction framework and subsequently integrating the results within 
each genome. In some instances, two predicted annotations within a genome 
were deemed to comprise a single protein and were subsequently paired 
together to represent one protein. This reduced the number of putative OMPs to 
164, 168 and 154 in the bovine serotype A1, ovine serotype A2 and bovine 
serotype A2 genomes, respectively. BLAST searches were performed on putative 
OMP amino acid sequences to determine if each was present in one, two or all 
three genomes. In some instances a protein was predicted to be a putative OMP 
in one or two genomes, but was not predicted in the other genome(s) despite its 
presence in that genome(s). This most often occurred when a protein annotation 
in one proteome had been annotated so that an important signal motif, such as 
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an N-terminal signal sequence, had been excluded from the annotation and 
hence not recognised by the bioinformatic predictors. Similarly, nucleotide 
BLAST searches were also performed against whole-genome shotgun contigs in 
each genome to determine if OMP-encoding genes were present that had not 
been annotated. Proteins which fell into these categories were included in the 
predicted proteins in their respective genomes. This amended the numbers of 
putative OMPs to 196, 202 and 188 in the bovine serotype A1, ovine serotype A2 
and bovine serotype A2 genomes, respectively. A total of 217 unique putative 
OMPs were predicted across the three genomes. Of these proteins, 102 (47%), 67 
(31%) and 114 (53%) were predicted by subcellular localisation, β-barrel and 
outer membrane lipoprotein predictor categories, respectively. The 217 putative 
OMPs were further scrutinised using additional domain, homology and literature 
searches to predict the subcellular location of each protein with greater 
confidence and to remove false positives (Fig. 3.2). In this way, 93 (42.9%) 
proteins were confidently predicted to localise at the outer membrane (Table 
3.2). Seventy proteins could not be predicted with great confidence to be 
localised to a particular subcellular compartment and were likely to include 
false positives as well as some true OMPs (Supplementary Table S3.4). 
Furthermore, 54 proteins were predicted to be localised to the cytoplasm, inner 
membrane, periplasm, or extracellular compartment and were therefore 
determined to be false-positives (Supplementary Table S3.5). Of the 93 
confidently predicted OMPs, 63 (68%) were predicted by subcellular localisation 
predictors, 44 (47%) by β-barrel predictors, and 39 (42%) by outer membrane 
lipoprotein predictors (Fig. 3.3A). Eighty-nine proteins were present in the 
bovine serotype A1 genome, 92 in the ovine serotype A2 genomes and 92 in the 
bovine serotype A2 genome (Fig. 3.3B), with 88 being present among all three 
genomes. Five OMPs were present in either one or two genomes (Table 3.3). 
Ninety-two OMPs were present among both bovine and ovine genomes, of which 
four were exclusively present in both the bovine and ovine serotype A2 genomes 
One OMP (PulD), was exclusively present in only the bovine serotype A1 genome. 
There were no OMPs present exclusively in either of the serotype A2 genomes. 
The finding that there were more OMPs present in both the bovine and ovine 
serotype A2 genomes (four) than between the bovine serotype A1 genome and 
either the bovine serotype A2 genome (zero) or the ovine serotype A2 genome 
(zero) is consistent with the hypothesis of serotype A2 host switching from cattle  
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Figure 3.2. Subcellular locations of 217 putative OMPs predicted by 10 
bioinformatic prediction tools across three M. haemolytica 
genomes after further domain, homology and literature 
searches had been carried out on each protein. 
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70
23
15
15
1
Outer membrane (42.8%)
Unknown (32.3%)
Cytoplasm (10.6%)
Inner membrane (6.9%)
Periplasm (6.9%)
Extracellular (0.4%)
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Table 3.2. Functional classifications of 93 confidently predicted OMPs encoded by three M. haemolytica genomes. 
  Name Bovine A1a Ovine A2a Bovine A2a Protein function                                                                    Subb TMb Lipob Isolc 
1. Outer membrane biogenesis and integrity 
       
 
OmpA MHA_1054 COI_1980 COK_0402 Outer membrane integrity + +/− − 8 
 
Omp85 MHA_0691 COI_1174 COK_1967 Correct OMP folding and assembly + + − 8 
 
Imp/LptD MHA_0291 COI_2627 COK_0922 LPS assembly + + − 8 
 
Pal MHA_0263 COI_2595 COK_1835 Cell envelope integrity/peptidoglycan anchor + − + 8 
 
VacJ MHA_2837 COI_1320 COK_1388 Phospholipid homeostasis − − + 7 
 
LppB/NlpD MHA_1804 COI_0885 COK_0647 Cell wall formation and maintenance + + + 4 
 
RlpB/LptE MHA_0669 COI_1194 COK_1987 LPS assembly − − + 3 
 
MltC MHA_0242 COI_0470 COK_0285 Peptidoglycan maintenance and processing + − + 3 
 
ComL MHA_1560 COI_0129 COK_2068 Outer membrane biogenesis/DNA transport + − + 3 
 
MltA MHA_1133 COI_1670 COK_0590 Peptidoglycan maintenance and processing + + + 2 
 
LolB MHA_2544 COI_0062 COK_2183 Chaperone & lipoprotein transport activity + − + 
 
 
NlpE MHA_1616 COI_0339 COK_2132 Cell envelope stress response/copper homeostasis 
regulator − − +  
 
SmpA MHA_1340 COI_0370 COK_0445 Cell envelope integrity and β-barrel protein assembly − − + 
 
 
WzzB MHA_0727 COI_1084 COK_0353 Lipopolysaccharide biosynthesis + − − 
 
  MltB ctg173_107 COI_2519 COK_0949 Peptidoglycan maintenance and processing − − +   
a Proteins annotations are shaded in grey if they were not predicted by bioinformatic software but have a homologue that was predicted in another genome. 
Proteins annotations which were predicted by bioinformatic software are not shaded. Absence of protein homologue is shown by '−' 
    
b Subcellular localisation, transmembrane β-barrel and lipoprotein prediction result; '+' = predicted in all genomes; '−' = not predicted in any genome;  
 
+/−' = predicted in one/two genomes (see Supplementary tables 1-3 for specific result) 
    
c The number of representative isolates that each protein has been identified in (see Table 3 and Figure 4) 
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Table 3.2. (continued) 
  Name Bovine A1 Ovine A2 Bovine A2 Protein function Sub TM Lipo Isol 
2. Transport and receptor 
        
 
TolC MHA_1410 COI_0732 COK_0022 Protein secretion/transporter activity + + + 8 
 
OmpP1/FadL MHA_0639 COI_1221 COK_2014 Hydrophobic compound transport + + − 8 
 
Wza MHA_0527 COI_1313 COK_0141 Capsular polysaccharide transport + + + 8 
 
OmpP2-like MHA_1793 COI_0051 COK_2166 Porin/ion transport activity + + − 8 
 
FrpB MHA_2109 COI_0085 COK_0218 Receptor and transporter activities + + − 8 
 
TbpA MHA_0196 COI_2333 COK_1753 Transferrin receptor & transport + + − 7 
 
OmpP4 MHA_2158 COI_0840 COK_2233 Heme acquisition/factor V utilisation + − + 6 
 
OmpP2 MHA_0735 ctg112 COK_1380 Porin/ion transport activity + + − 4 
 
FhaC MHA_0867 COI_0226 COK_0335 Secretion of filamentous haemagglutinin (FhaB) + + − 3 
 
OmpW MHA_2399 COI_1652/3 COK_1583/4 Small hydrophobic molecule transport + − − 2 
 
TonB-dependent receptor MHA_0860 COI_1565 COK_2304 Receptor and transporter activities + + − 2 
 
HmbR1 MHA_2261 COI_2258 COK_1624 Haemoglobin receptor  + + − 2 
 
HxuB MHA_1005 COI_1367 COK_1209 Heme-hemopexin acquisition + + − 2 
 
TbpB MHA_0197 COI_2332 COK_1752 Transferrin receptor & transport + +/− + 1 
 
HxuC ctg59 COI_1368 COK_1207/8 Heme-hemopexin acquisition + + − 1 
 
TonB-dependent receptor MHA_1346 COI_1921 ctg265 Receptor and transporter activities + + − 1 
 
LamB MHA_0232 COI_2297 COK_1718 Maltoporin transport + + − 
 
 
ComE MHA_0164 COI_2362 COK_1782 DNA transport + − − 
 
 
PulD MHA_2514 − − Secretin + − − 
 
 
HxuA MHA_1004 COI_1366 COK_1210 Heme-haemopexin acquisition (Subcellular location: OM/E) − − + 
 
  FhuA ctg68 COI_1905 COK_2465 Ferric hydroxamate receptor + + −   
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 Table 3.2. (continued) 
  Name Bovine A1 Ovine A2 Bovine A2 Protein function Sub TM Lipo Isol 
 
FhuE MHA_1541 COI_0658 COK_1513 Ferric hydroxamate receptor + + − 
 
 
HmbR2 ctg86 COI_1762/3 COK_2539/40 Haemoglobin receptor  + + − 
 
 
Haemin receptor ctg61 COI_2252/3 COK_1629/30 Haemin receptor + + − 
 
 
Haemin-uptake lipoprotein MHA_2255 COI_2251 COK_1631 Haemin-uptake lipoprotein − − + 
 
 
TonB-dependent receptor ctg58 COI_0092 COK_0224 Receptor and transporter activities + − − 
 
 
TonB-dependent receptor ctg85 COI_0006 COK_0109 Receptor and transporter activities + − − 
 
 
TonB-dependent receptor ctg58 COI_0090 COK_0222 Receptor and transporter activities − + − 
 
3. Adherence 
        
 
YadA-like MHA_0302  COI_2651 COK_0897/8 Adherence + + − 2 
 
Hsf MHA_2701 COI_2393 COK_1437 Adherence + +/− − 
 
 
Hia MHA_1367 COI_1943/5 COK_2433/5  Adherence + − − 
 
 
Ahs ctg73_110_124_88 COI_1315 COK_1394 Adherence  + − − 
 
 
FhaB_1 MHA_0866 ctg15 COK_0334 Adherence (Subcellular location: OM/E) + + − 
 
 
FhaB_2 ctg89_27_137 COI_1569 COK_2300 Adherence (Subcellular location: OM/E) − + − 
 
4. Enzymatic activity 
        
 
Ssa MHA_2492 COI_0850 COK_2411 Serine protease + + − 8 
 
Iga1_2 MHA_0563 COI_2430 COK_0634 Cleavage of host mucosal antibody − + − 6 
 
Iga1_3 MHA_1965 COI_1820 COK_2480 Cleavage of host mucosal antibody +/− + − 3 
 
NanH MHA_1532 COI_0667 COK_1504 Terminal sialic acid hydrolysis from glycoconjugates + + − 4 
 
Iga1_1 MHA_2800 COI_2438 COK_1350 Cleavage of host mucosal antibody + + − 
 
 
IgA1_4 − COI_0585/6 COK_1280/81 Cleavage of host mucosal antibody + + − 
 
  GlpQ MHA_2244 COI_1297 COK_0157 Glycerophosphodiester hydrolysis  + − −   
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 Table 3.2. (continued) 
  Name Bovine A1 Ovine A2 Bovine A2 Protein function Sub TM Lipo Isol 
 NlpC/P60 MHA_1650 COI_0987 COK_0966 Cell wall hydrolysis during cell growth and division + − +  
 NlpD-like_1 MHA_1467 COI_0383 COK_1077 Metalloendopeptidase activity  + − −  
 NlpD-like_2 MHA_0321 COI_0246 COK_0129 Metalloendopeptidase activity  + − −  
 AmiC MHA_0064 COI_1886 COK_0789 Cell envelope degradation + − −  
5. Others 
        
 Bor/Iss_2 MHA_0387 COI_1469 COK_1002 Survival in animal host − − + 7 
 Bor/Iss_1 MHA_0386 COI_1470 COK_1001 Survival in animal host − − + 1 
 fHbp_1 MHA_0965 COI_1330  COK_2564/5 Binding to complement factor H − − + 4 
 fHbp_2 MHA_1406 COI_0728 COK_0018  Binding to complement factor H − − +  
 N1pI MHA_0837 COI_2516 COK_0946 Cell division − − +  
 PilF MHA_2059 COI_1784 COK_2516 Pilus assembly/stability − − +  
 EcnA − COI_0131 COK_2070 Toxin/antidote protein (cell apoptosis) − − +  
6. Unknown 
        
 PlpA MHA_1433 COI_0758 COK_0049 Unknown − − + 8 
 Possible OMP MHA_0486 COI_0902 COK_2254 Unknown + + − 8 
 Rickettsia-like surface ant. − COI_1456 COK_1118  Unknown − − + 8 
 Lpp38 MHA_2152 COI_0845 COK_2238 Unknown − − + 7 
 OMP18/16 MHA_2237 COI_2485 COK_1303 Unknown + − − 7 
 YajG − COI_0336 COK_2129 Unknown − − + 6 
 YtfM MHA_0323 COI_0250 COK_0133 Unknown + + − 6 
 Lpp/PCP/SlyB MHA_0760 COI_1053 COK_0435 Unknown − − + 6 
  HlpB MHA_2282 COI_2279 COK_1699 Unknown − − + 5 
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Table 3.2. (continued) 
  Name Bovine A1 Ovine A2 Bovine A2 Protein function Sub TM Lipo Isol 
 
PlpE MHA_1514 COI_1139 COK_0733 Unknown − − + 5 
 
Possible OMP MHA_0718 COI_2021 COK_0360 Unknown + − − 5 
 
PlpD MHA_1464 COI_0386 COK_1074 Unknown + − +/− 3 
 
PlpC MHA_1435 COI_0760 COK_0051 Unknown − − + 3 
 
LppC MHA_2734 COI_0540 COK_2366/7 Unknown + + + 2 
 
Possible OMP MHA_0964 COI_1329 COK_2563 Unknown + + − 1 
 
Possible OMP MHA_2054 COI_1788 COK_2512 Unknown − + − 1 
 
Possible OMP MHA_2761 COI_0565 COK_2341  Unknown + + − 
 
 
Possible OMP MHA_1407 COI_0729 COK_0019 Unknown + + − 
 
 
Possible OMP MHA_0862 COI_1567 COK_2302 Unknown + − − 
 
 
Skp/Omp26 MHA_0690 COI_1175 COK_1968 Unknown + − − 
 
 
OapB MHA_2703 COI_1631 COK_1107 Unknown − − + 
 
 
PlpB MHA_1434 COI_0759 COK_0050 Unknown − − + 
 
 
Autotransporter ctg108 COI_1968/9 COK_0413/4 Unknown + + − 
 
 
Autotransporter MHA_0080 COI_1870 COK_0773 Unknown + + − 
 
 
Lipoprotein MHA_1803 COI_0886 COK_0646 Unknown − − + 
 
  Lipoprotein MHA_1802 COI_0887 COK_0645 Unknown − − +   
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Figure 3.3. Distribution of 93 confidently predicted OMPs based on (A) the 
three categories of bioinformatic predictors (subcellular 
localisation, β-barrel and OM lipoprotein predictors) and (B) the 
three M. haemolytica genomes that were analysed (bovine A1, 
bovine A2, ovine A2). 
 
Table 3.3. Distribution of five confidently predicted OMPs present in only 
one or two M. haemolytica genomes. 
Confidently predicted OMP Bovine A1 Bovine A2 Ovine A2 
Iga1_4 − + + 
EcnA − + + 
Rickettsia-like surface antigen − + + 
YajG − + + 
PulD + − − 
A B 
 102 
to sheep. The two serotype A2 genomes are expected to have similar gene 
content because of their common ancestral origin. 
3.3.2 Functional classifications of confidently predicted OMPs. 
The 93 confidently predicted OMPs could be assigned to six broad functional 
categories based on information gathered from the additional searches (Fig. 3.4; 
Table 3.2). Fifteen confidently predicted OMPs were involved in outer membrane 
biogenesis and integrity, all of which were present in the three genomes (OmpA, 
Omp85, Imp/LptD, Pal, VacJ, LppB/NlpD, RlpB/LptE, MltC, ComL, MltA, LolB, 
NlpE, SmpA, WzzB and MltB). Twenty-eight confidently predicted OMPs were 
involved in transport and receptor activities, of which 27 were present in all 
three genomes (TolC, OmpP1/FadL, Wza, OmpP2-like, FrpB, TbpA, OmpP4,  
OmpP2, FhaC, OmpW, TonB-dependent receptor MHA_0860/COI_1565/ 
COK_2304, HmbR1, HxuB, TbpB, HxuC, TonB-dependent receptor 
MHA_1346/COI_1921, LamB, ComE, HxuA, FhuE, HmbR2, haemin receptor, 
haemin-uptake lipoprotein, TonB-dependent receptor COI_0092/COK_0224, 
TonB-dependent receptor COI_0006/COK_0109 and TonB-dependent receptor 
COI_0090/COK_0222). The PulD protein was present only in the bovine serotype 
A1 genome. Notably, this was the only protein out of the 93 confidently 
predicted OMPs to be present (exclusively) in only one of the three genomes 
(Fig. 3.3B). Six confidently predicted OMPs were involved in adherence (YadA-
like, Hsf, Hia, Ahs, FhaB_1 and FhaB_2), all of which were present in the three 
genomes. Eleven confidently predicted OMPs had enzymatic activity, of which 10 
were present in all three genomes (Ssa, Iga1_2, Iga1_3, NanH, Iga1_1, GlpQ, 
NlpC/P60, two NlpD-like proteins, and AmiC). A fourth Iga1-like protein (Iga1_4) 
was predicted in both the bovine and ovine serotype A2 genomes but was 
notably absent from the bovine serotype A1 genome. Seven confidently 
predicted OMPs had functions which did not fall into any of the categories 
above. These included two proteins, Bor/Iss_1 and Bor/Iss_2, which promote 
bacterial resistance to serum complement killing and virulence (Barondess and 
Beckwith, 1995), two homologues of the neisserial factor H-binding protein 
(fHbp_1 and fHbp_2) (Welsch and Ram, 2008) and a pilus assembly protein (PilF). 
The remaining twenty-six confidently predicted OMPs were of unknown function; 
24 of these were present in all three genomes. 
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Figure 3.4. Functional classifications of 93 confidently predicted OMPs 
present across three M. haemolytica genomes after domain, 
homology and literature searches were carried out on each 
protein. 
 
28
26
15
11
7
6
Transport and 
receptor (30.1%)
Unknown (28.0%) 
OM biogenesis and 
integrity (16.1%)
Enzymatic  activity 
(11.8%)
Other (7.5%)
Adherence (6.5%) 
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3.3.3 Amino acid sequence variation in confidently predicted OMPs 
 between different M. haemolytica genomes. 
In order to identify OMPs that might be involved in host-specific adaptation, 
amino acid sequence comparisons were performed on the 93 confidently 
predicted OMPs in the three different M. haemolytica genomes. The OMPs 
present among the bovine and ovine serotype A2 genomes (Fig 3.5A) showed a 
higher degree of amino acid identity to each other than to the OMPs present 
among either of these two genomes and the bovine serotype A1 genome (Fig. 
3.5B). Ninety-two confidently predicted OMPs were present in both the bovine 
and ovine serotype A2 genomes, of which 83 (92%) had an amino acid identity of 
98% and above (Fig. 3.5A). The remaining nine OMPs (PlpE, Ssa, TbpB, OmpA, 
LppC, fHbp_2, Pal, Ahs and Hia) had amino acid identities ranging from 60 to 
97% (below 98%), suggesting possible diversification that might be related to host 
adaptation (Fig. 3.5A; Table 3.4). However, only three of these proteins, OmpA, 
PlpE, and Ahs, had a higher amino acid identity when the bovine serotype A1 and 
A2 genomes were compared (Fig. 3.5B; Table 3.4). OmpA was 100% identical in 
the bovine serotype A1 and bovine serotype A2 genomes but was 95% identical 
when the genomes were compared to the ovine serotype A2 genome. PlpE was 
91% identical in the bovine serotype A1 and A2 genomes but only 60% identical 
when these genomes were compared to the ovine serotype A2 genome, 
suggesting possible horizontal gene transfer. Ahs was 100% identical in the 
bovine serotype A1 and bovine serotype A2 genomes but was 97% identical when 
these genomes were compared to the ovine serotype A2 genome. Of the 88 
confidently predicted OMPs that were present in both the bovine serotype A1 
and A2 genomes, 67 (76%) had an amino acid identity of 98% and above (Fig. 
3.5B) .  The  remain ing  21 OMPs  (TbpB,  TonB-dependent  receptor 
COI_0090/COK_0222, fHbp_2, Hsf, OmpW, Ssa, FrpB, YadA-like, PlpE, OmpP2-
like, TbpA, Pal, autotransporter COI_1968-9/COK_0413-4, possible OMP 
MHA_0862/COI_1567/COK_2302, LppC, fHbp_1, Hia, Wza, FhuA, FhaC and LolB) 
had amino acid identities ranging from 57 to 97% (below 98%) (Fig. 3.5B; Table 
3.4). With the exception of PlpE, it is possible that these proteins have little or 
no role in host adaptation, and may be able to function in cattle and sheep 
equally well. The fact that there was a higher degree of amino acid conservation 
in OMPs present between the bovine and ovine serotype A2 genomes than 
between the bovine serotype A1 genome and bovine serotype A2 genome is  
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Figure 3.5. Amino acid sequence identity of 93 confidently predicted OMPs among (A) bovine and ovine serotype A2 genomes 
and (B) bovine serotype A1 and bovine serotype A2 genomes.  
Bars are coloured based on the functional classifications of each OMP: OM biogenesis and maintenance (pink), transport and 
receptor (red), adherence (green), enzymatic activity (orange), other (yellow), unknown (blue). 
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Figure 3.5 (continued)
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Table 3.4. Confidently predicted OMPs with amino acid sequence identity 
below 98% between the bovine serotype A2 and ovine serotype 
A2 genomes and/or between the bovine serotype A1 and A2 
genomes. 
Confidently predicted OMP Bov. A2 vs. Ov. A2a 
Bov. A1 vs. 
Bov. A2a 
PlpE 60 91 
Ssa 83 83 
TbpB 92 57 
OmpA 95 100 
LppC 96 96 
fHbp_2 96 75 
Pal 96 94 
Ahs 97 100 
Hia 97 96 
OmpP2-like 98 92 
FhuA 98 97 
TonB-dependent receptor ctg58/COI_0090/COK_0222 99 70 
FrpB 99 84 
TbpA 99 94 
Possible OMP MHA_0862/COI_1567/COK_2302 99 96 
FhaC 99 97 
LolB 99 97 
Wza 100 96 
Autotransporter ctg108/COI_1968-9/COK_0413-4 100 95 
Hsf 100 78 
OmpW 100 82 
YadA-like 100 85 
fHbp_1 100 96 
Proteins with higher percentage amino acid sequence identity between the bovine serotype A1 and 
A2 genomes than between the bovine serotype A2 and ovine serotype A2 genomes are shaded in 
grey. 
aPercentage amino acid sequence identity. 
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further evidence to support the hypothesis of serotype A2 host switching from 
cattle to sheep.  
3.3.4 Identification of M. haemolytica OMPs by gel-based and gel-free 
approaches. 
The outer membrane fractions of seven M. haemolytica isolates and one M. 
glucosida isolate were extracted using the Sarkosyl extraction technique and 
analysed using gel-based and gel-free approaches. A 1-D SDS-polyacrylamide gel 
showing the OMP profiles of the representative isolates is shown in Fig. 3.6. 
A total of 98 different proteins were identified using a combination of gel-based 
and gel-free approaches, of which 55 were classified as OMPs (Table 3.5). Fifty 
of these OMPs were confidently predicted to be OMPs using the bioinformatic 
prediction approach (Table 3.2). However, five proteins, LemA, HbpA, OapA, 
RlpA and CsgG were not predicted by the bioinformatic approach but were 
indicated by literature searches to be OMPs. Henceforth, the 50 confidently 
predicted OMPs and the five proteins described above will collectively be 
referred to together as OMPs.  
Fifty-seven different proteins were identified using the gel-based approach. 
Forty-four of these were OMPs (Table 3.5; Figure 3.6), of which 21 were 
predicted to be β-barrel proteins, 11 were predicted to be outer membrane 
lipoproteins, 6 were predicted to be both β-barrel proteins and outer membrane 
lipoproteins and six were not predicted to be either (Fig. 3.7). Eighty-seven 
different proteins were identified using the gel-free approach. Forty-seven of 
these were OMPs (Table 3.5), of which 18 were predicted to be β-barrel 
proteins, 18 were predicted to be outer membrane lipoproteins, five were 
predicted to be both β-barrel proteins and outer membrane lipoproteins and six 
were not predicted to be either (Fig 3.7). A total of thirty-six OMPs were 
identified by both gel-based and gel-free methods. The gel-based approach 
exclusively identified eight OMPs that were not identified by the gel-free 
approach: Iga1_2, possible OMP MHA_0718/COI_2021/COK_0360, LppB/NlpD, 
HmbR1, HxuB, TonB-dependent receptor MHA_1346/COI_1921, possible OMP 
MHA_2054/COI_1788/COK_2512 and CsgG. Of these proteins, five were predicted 
to be β-barrel proteins, one was predicted to be both a β-barrel protein and an 
outer membrane lipoprotein and two were not predicted to be either (Fig. 3.7).  
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Figure 3.6. One-dimensional SDS-PAGE separation of outer membrane 
fractions from seven M. haemolytica isolates and one M. 
glucosida isolate.  
Numbered proteins were identified by proteomic analysis (Table 
3.5). Twenty micrograms of protein were loaded into each lane. 
Protein bands were stained with Coomassie brilliant blue.  
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Table 3.5. Proteins identified in the outer membrane fractions of seven representative isolates of M. haemolytica and one 
isolate of M. glucosida (PH344) using a combination of gel-based and gel-free proteomic approaches. 
    
    
        
   Protein identifications in different isolatesd 
No.a 
Subcellular 
Localisationb TMc Lipoc Bovine A1 Ovine A2 Bovine A2 Name  
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1. Confidently predicted OMPs                  
1 OM +/− − MHA_1054 COI_1980 COK_0402 OmpA + + + + + + + + 8   
2 OM + − MHA_0691 COI_1174 COK_1967 Omp85  + + + + + + + + 8   
3 OM + − MHA_0291 COI_2627 COK_0922 Imp/LptD + + + + + + + + 8   
4 OM + + MHA_1410 COI_0732 COK_0022 TolC + + + + + + + + 8   
5 OM − + MHA_0263 COI_2595 COK_1835 Pal + + + + + + + + 8   
6 OM + − MHA_2492 COI_0850 COK_2411 Ssa + + + +1 + + + + 8   
7 OM + − MHA_0639 COI_1221 COK_2014 OmpP1/FadL + + + + + + +1 + 8   
8 OM − + MHA_1433 COI_0758 COK_0049 PlpA + + + +2 +2 + +2 + 8   
9 OM + + MHA_0527 COI_1313 COK_0141 Wza +2 + +2 + + + + +2 8   
10 OM + − MHA_0486 COI_0902 COK_2254 Possible OMP +2 +2 +2 +2 +2 +2 +1 +2 8   
11 OM + − MHA_1793 COI_0051 COK_2166 OmpP2-like + +1 +1 + + + +1 +1 8   
12 OM + − MHA_2109 COI_0085 COK_0218 FrpB + +1 + + + + + + 8   
13 OM − + − COI_1456 COK_1118 Rickettsia-like surface antigen +2 +2 +2 +2 +2 +2 +2 +2 8   
 
Proteins that were predicted to be putative OMPs by the ten bioinformatic predictors are grey-shaded. 
aNumbers correspond to the location of the protein on Figure 3.6 if identified by gel-based proteomics. 
bConfidently predicted subcellular locations; 'OM' = outer membrane; 'P' = periplasm; 'IM' = inner membrane; 'C' = cytoplasm; 'E' = extracellular; 'U' = unknown. 
cTransmembrane β-barrel and lipoprotein prediction result; '+' = predicted in all genomes; '−' = not predicted in any genome; '+/−' = predicted in one/two genomes 
(see Supplementary Tables S3.1, S3.2 and S3.3 for specific result). 
dTwo proteomics methods were compared; '+1' = proteins identified by gel-based method; '+2' = proteins identified by gel-free method; '+' = proteins identified by 
both methods; '−' = no identification. 
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Table 3.5. (continued) 
    
    
        
    Protein identifications in different isolates 
No. 
Subcellular 
location TM Lipo Bovine A1 Ovine A2 Bovine A2 Name  
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14 OM     MHA_0704 COI_1162 COK_1955 LemA +1 +1 +1 + + +1 +1 +1 8 
15 OM − + MHA_0387 COI_1469 COK_1002 Bor/Iss_2 + + +2 − +2 + +2 + 7 
16 OM − + MHA_2152 COI_0845 COK_2238 Lpp38 +2 +2 +2 +2 +2 +2 − + 7 
17 OM + − MHA_0196 COI_2333 COK_1753 TbpA + + + +1 + + − + 7 
18 OM − + MHA_2837 COI_1320 COK_1388 VacJ +2 + − +2 +2 + +2 +2 7 
19 OM − − MHA_2237 COI_2485 COK_1303 OMP18/16 +1 +1 +1 +1 + − +1 +1 7 
20 OM − + MHA_2158 COI_0840 COK_2233 OmpP4 +2 +2 +2 − − +2 +2 + 6 
21 OM − + − COI_0336 COK_2129 YajG +2 +2 +2 +2 +2 +2 − − 6 
22 OM + − MHA_0323 COI_0250 COK_0133 YtfM +1 + +1 + − +1 − +1 6 
23 OM − + MHA_0760 COI_1053 COK_0435 Lpp/PCP/SlyB +1 − +1 +1 +2 +1 − +1 6 
24 OM + − MHA_0563 COI_2430 COK_0634 Iga1_2 +1 +1 +1 − +1 +1 − +1 6 
25 OM − + MHA_2282 COI_2279 COK_1699 HlpB + + − − +1 + +1 − 5 
26 OM − + MHA_1514 COI_1139 COK_0733 PlpE + +2 − − +2 +2 − +2 5 
27 OM − − MHA_0718 COI_2021 COK_0360 Possible OMP +1 − +1 +1 +1 − +1 − 5 
28 OM/P/IM   MHA_1007 COI_1369 COK_1206 HbpA − + + +2 − +2 − +2 5 
29 OM + − MHA_0735 ctg112 COK_1380  OmpP2  + + − − − + − + 4 
30 OM + − MHA_1532 COI_0667 COK_1504 NanH +1 + − + +1 − − − 4 
31 OM − + MHA_0965 COI_1330 COK_2564/5  fHbp_1 +1 + +1 − +1 − − − 4 
32 OM + + MHA_1804 COI_0885 COK_0647 LppB/NlpD − − +1 +1 +1 +1 − − 4 
33 OM − + MHA_0669 COI_1194 COK_1987 RlpB/LptE +2 +2 +2 − − − − − 3 
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Table 3.5. (continued) 
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Subcellular 
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34 OM − +/− MHA_1464 COI_0386 COK_1074 PlpD +2 +2 − − − +2 − − 3 
35 OM − + MHA_0242 COI_0470 COK_0285 MltC − +2 − − +2 − − +2 3 
36 OM − + MHA_1560 COI_0129 COK_2068 ComL − +2 +1 − − + − − 3 
37 OM + − MHA_0867 COI_0226 COK_0335 FhaC − + − +1 +1 − − − 3 
38 OM − + MHA_1435 COI_0760 COK_0051 PlpC − − +2 − − +2 − +2 3 
39 OM + − MHA_1965 COI_1820 COK_2480 Iga1_3 − − + + − + − − 3 
40 OM + + MHA_1133 COI_1670 COK_0590 MltA +2 − − + − − − − 2 
41 OM − − MHA_2399 COI_1652/3 COK_1583/4 OmpW − + − − − − + − 2 
42 OM + + MHA_2734 COI_0540 COK_2366/7 LppC − + − − − +1 − − 2 
43 OM + − MHA_0302  COI_2651 COK_0898 YadA-like protein − − + − + − − − 2 
44 OM + − MHA_0860 COI_1565 COK_2304 TonB-dependent receptor − − − − + + − − 2 
45 OM + − MHA_2261 COI_2258 COK_1624 HmbR1 − − +1 − − +1 − − 2 
46 OM + − MHA_1005 COI_1367 COK_1209 HxuB − − +1 − +1 − − − 2 
47 OM   MHA_2702 COI_1630 COK_1108 OapA − − − +2 − +2 − − 2 
48 OM +/− + MHA_0197 COI_2332 COK_1752 TbpB − + − − − − − − 1 
49 OM + − MHA_0964 COI_1329 COK_2563 Possible OMP − +2 − − − − − − 1 
50 OM − + MHA_0386 COI_1470 COK_1001 Bor/Iss_1 − +2 − − − − − − 1 
51 OM + − ctg59 COI_1368 COK_1207/8 HxuC − − − − − − − +2 1 
52 OM + − MHA_1346 COI_1921 ctg265 TonB-dependent receptor − − − − − +1 − − 1 
53 OM + − MHA_2054 COI_1788 COK_2512 Possible OMP − − − − − − +1 − 1 
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Table 3.5. (continued) 
    
    
        
      Protein identifications in different isolates 
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location TM Lipo Bovine A1 Ovine A2 Bovine A2 Name 
 
P
H
2
 
 
P
H
8
 
 
P
H
2
0
2
 
 
P
H
2
7
8
 
 
P
H
2
9
2
 
 
P
H
2
9
6
 
 
P
H
3
4
4
 
 
P
H
5
8
8
 
 
T
o
t
a
l
 
 
54 OM   MHA_0470 COI_0918 COK_2270 RlpA − − − − − − +2 − 1 
55 OM   − − − CsgG − − − − − − +1 − 1 
2. Proteins without confident localisation prediction 
           
56 U + + MHA_2025 COI_1815 COK_2485 Hypothetical protein + + + + + +2 + + 8   
57 U   MHA_2087 COI_1609 COK_1902 Hypothetical protein + +2 + +1 +1 − − − 5   
58 U   MHA_1782 COI_0313 COK_0888 Hypothetical protein − +2 +2 +2 − +2 − +2 5   
59 U − + MHA_0761/2 COI_1052 COK_0436 Hypothetical protein − − +1 +1 − +1 − +1 4   
60 U   MHA_2789 COI_2198 COK_1686 PqiB − − +2 − − +2 − − 2   
61 U − + MHA_0804 COI_2411 COK_1455 Patatin − − − − − +2 − − 1   
62 U − + MHA_0452 ctg39 ctg44 Hypothetical protein − +1 − − − − − − 1   
63 U   MHA_1898 COI_0630 COK_1217 LysM domain protein − − +2 − − − − − 1   
64 U   MHA_1828 COI_2056 COK_0536 Hypothetical protein − − − +2 − − − − 1   
65 U   − COI_2639 COK_0910 Hypothetical protein − − − − +2 − − − 1   
66 U   MHA_0324 COI_0251 COK_0134 Hypothetical protein − − − − − +2 − − 1   
3. Non-outer membrane localised proteins 
            
67 P + − MHA_0371 COI_1485 COK_0985 AcrA_1 +1 +1 + + +1 + − + 7   
68 IM   MHA_1448 COI_0774 COK_0064 YajC +2 +2 + + + +2 − +2 7   
69 IM   MHA_1228 COI_1149 COK_1941 PntA − +2 +2 +2 +2 +2 +1 +2 7   
70 C   MHA_2176 COI_1521 COK_1096 EF1A +1 + +1 +2 + + − + 7   
71 C     MHA_1682 COI_0958 COK_1425 RplB +2 − +2 +2 − +2 +2 +2 6   
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Table 3.5. (continued) 
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72 IM +/− + MHA_0528 COI_1312 COK_0142 Wzf − + +2 − +1 + − − 4 
73 IM   MHA_0370 COI_1486 COK_0984 AcrB − − − +1 − + +2 +2 4 
74 C   MHA_1040 COI_1994 COK_0388 RplA − +2 +2 − − +2 − +2 4 
75 C   MHA_1552 COI_0122 COK_2061 RplT − +2 +2 − − +2 +2 − 4 
76 IM − + MHA_1287 COI_1274 COK_0180 AtpF − +2 − +1 − − − +2 3 
77 IM   MHA_1625 COI_0002 COK_0113 LctP +2 +2 − +2 − − − − 3 
78 C   MHA_0315 COI_0240 COK_0123 RpsB +2 − − − − − +2 +1 3 
79 C   MHA_1041 COI_1993 COK_0389 RplK − − − − − +2 +2 +2 3 
80 IM   ctg147 COI_1296 COK_0158 GlpT − +2 − − − − − +2 2 
81 C   MHA_2378 COI_1451 COK_1123 RplE − +2 − − − − +2 − 2 
82 C   MHA_1678 COI_0962 COK_1421 RplP − +2 − − − − − +2 2 
83 C   MHA_2371 COI_1444 COK_1130 RplO − +2 − − − − +2 − 2 
84 C   MHA_2364 COI_1437 COK_1137 RplQ − − − − − − +2 +2 2 
85 P − + MHA_0980 COI_1345 COK_2582 YgiW − − − +2 − − − − 1 
86 P − + MHA_2224 COI_2497 COK_1291 NikA/DppA/OppA − − − − − +2 − − 1 
87 E + − MHA_0254 COI_0481 COK_0274 LktA − − − − − − +2 − 1 
88 IM − + − COI_2478 COK_1310 NhaC +2 − − − − − − − 1 
89 IM   MHA_1656 COI_1498 COK_0973 GltP − +2 − − − − − − 1 
90 IM   MHA_1795 COI_2038 COK_1899 PtnC − +2 − − − − − − 1 
91 IM     MHA_2180 COI_2587 COK_1843 CydA − − − +2 − − − − 1 
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Table 3.5. (continued) 
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92 IM   MHA_1822 COI_1555 COK_1560 TatA − − − − − − − +2 1 
93 IM   MHA_2518 COI_1395 COK_1180 FtsN − − − − − − − +1 1 
94 IM   MHA_1229 COI_1148 COK_1940 PntB − +2 − − − − − − 1 
95 C   MHA_0822 COI_0990 COK_0963 RpsA − +2 − − − − − − 1 
96 C   MHA_2178 COI_1637 COK_1101 RpsG − +2 − − − − − − 1 
97 C   MHA_0991 COI_1354 COK_2591 RpmB − +2 − − − − − − 1 
98 C     MHA_1029 COI_2005 COK_0376 RplL − − − − − − − +2 1 
  
  
  
 Total number of proteins identified 42 62 48 44 41 54 35 48  
  
  
  
  Total number of OMPs identified  33 39 34 29 33 37 24 29  
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Figure 3.7. Distribution of 55 OMPs identified by proteomic analyses based 
on gel-based and/or gel-free approaches and bioinformatic 
prediction of a β-barrel and/or outer membrane (OM) lipoprotein. 
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The gel-free approach exclusively identified 11 OMPs that were not identified by 
the gel-based approach (Rickettsia-like surface antigen, YajG, RlpB/LptE, PlpD, 
MltC, PlpC, OapA, possible OMP MHA_0964/COI_1329/COK_2563, Bor/Iss_1, HxuC 
and RlpA). Of these, two were predicted to be β-barrel proteins, seven were 
predicted to be outer membrane lipoproteins and two were not predicted to be 
either. 
The subcellular localisations of eleven identified proteins could not be 
confidently predicted, and therefore remain unknown (Table 3.2; Supplementary 
Table S3.4). Four of these proteins (hypothetical protein MHA_2025/COI_1815/ 
COK_2485, hypothetical protein MHA_0761/COI_1052/COK_0436, patatin, and 
hypothetical protein MHA_0452) were putative OMPs predicted by the three 
categories of bioinformatic predictors but could not be confirmed as OMPs or 
false-positives after additional searches. The remaining seven proteins were not 
predicted by the bioinformatic approach, and additional searches could not 
confidently predict their subcellular locations. 
Thirty-two identified proteins were confidently predicted to be localised to 
cellular compartments other than the outer membrane and were therefore 
classified as false-positives (Table 3.5; Supplementary Table S3.5). Seven of 
these proteins were putative OMPs predicted by the three categories of 
bioinformatic predictors, but were confirmed as false positives after additional 
searches. These included three periplasmic proteins (AcrA_1, YgiW and 
NikA/DppA/OppA), three inner membrane proteins (Wzf, AtpF and NhaC) and the 
secreted leukotoxin protein LktA. The remaining twenty-five proteins were not 
predicted by the bioinformatic approach, but additional searches confirmed 
their localisation in compartments other than the outer membrane. Thirteen of 
these were ribosomal proteins located in the cytoplasm (RplB, RplA, RplT, RpsB, 
RplK, RplE, RplP, RplO, RplQ, RpsA, RpsG, RpmB and RplL). The other twelve 
were inner membrane proteins (YajC, PntA, AcrB, LctP, GlpT, GltP, PtnC, CydA, 
TatA, FtsN and PntB) and the cytoplasmic EF1A protein. 
In addition to the identification of OMPs in the outer membrane described 
above, whole cell envelope fractions of the eight representative isolates were 
also analysed by the gel free approach to determine whether any OMPs were lost 
as a result of the inner membrane solubilisation. One hundred and thirty two 
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unique proteins were identified among whole cell envelope fractions 
(Supplementary Table 3.6), of which 56 were identified among outer membrane 
fractions. The remaining 76 proteins were mainly comprised of inner membrane 
and periplasmic proteins and did not contain any confidently predicted OMPs 
that were not already identified among outer membrane fractions. This indicates 
that OMPs are not lost as a result of inner membrane solubilisation. 
3.3.5 Comparison of OMPs identified by proteomic approaches that are 
associated with different host species and phylogenies. 
The total number of OMPs identified in each of the seven M. haemolytica 
isolates varied from 29 (isolates PH278 and PH588) to 39 (PH8) (Table 3.5); 
twenty-four OMPs were identified in the M. glucosida isolate (PH344). Forty-one 
OMPs were identified in both bovine and ovine M. haemolytica isolates (Fig. 
3.8). Of these, 20 were also identified in the M. glucosida isolate. Ten OMPs 
(MltC, FhaC, LppC, TonB-dependent receptor MHA_0860/COI_1565/COK_2304, 
OapA, TbpB, possible OMP MHA_0964/COI_1329/COK_2563, Bor/Iss_1, HxuC, 
TonB-dependent receptor MHA_1346/COI_1921) were identified exclusively in 
ovine M. haemolytica isolates. Three OMPs (possible OMP MHA_2054/COI_1788/ 
COK_2512, RlpA and CsgG) were identified exclusively in the M. glucosida ovine 
isolate and one OMP (OmpW) was identified exclusively in both an ovine M. 
haemolytica isolate and the M. glucosida isolate. No OMPs were identified 
exclusively in the M. haemolytica bovine isolates and there were no proteins 
identified exclusively in both the bovine M. haemolytica isolates and the M. 
glucosida isolate. With the exception of CsgG, which was an A. 
pleuropneumoniae orthologue, all of the OMPs identified in ovine M. 
haemolytica isolates and the M. glucosida isolate were present in either the 
bovine serotype A1 or bovine serotype A2 genomes. Therefore, these proteins 
may be present in bovine isolates but were not detected by proteomics approach 
used in this study. Alternatively, they may be expressed under different growth 
conditions. The putative bovine host-specific protein PulD that was predicted in 
the bovine serotype A1 genome was not identified in any representative isolates. 
These findings show that it has not been possible to establish any clear link 
between any of the identified OMPs and host-specificity. 
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Figure 3.8. Distribution of 55 OMPs identified by proteomic analyses based 
on identification in bovine M. haemolytica isolates, ovine M. 
haemolytica isolates and/or an M. glucosida isolate.  
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Fourteen OMPs were identified in all eight representative isolates (OmpA, 
Omp85, Imp/LptD, TolC, Pal, Ssa, OmpP1/FadL, PlpA, Wza, possible OMP 
MHA_0486/COI_0902/COK_2254, OmpP2-like, FrpB, Rickettsia-like surface 
antigen and LemA), indicating core functions in both M. haemolytica and M. 
glucosida. Hypothetical protein MHA_2025/COI_1815/COK_2485 was also 
identified in all eight isolates but did not have a confidently predicted location. 
Furthermore, two OMPs were identified in all seven M. haemolytica isolates 
(Lpp38 and TbpA) but not in the M. glucosida isolate, indicating core functions in 
M. haemolytica but, not necessarily, in M. glucosida. 
There appeared to be a clear association between OmpP2 and isolates of 
serotypes A1, A7 and A13, but not of A2. The OmpP2 porin was identified by 
both gel-based and gel-free proteomic approaches in the serotype A1 isolates 
PH2 and PH8, the serotype A7 isolate PH296 and the serotype A13 isolate PH588. 
However, OmpP2 was not identified in any of the serotype A2 isolates or the M. 
glucosida isolate. In contrast, the OmpP2-like porin was identified in all eight 
representative isolates and exhibited considerable molecular mass variation.  
The four putative trimeric autotransporters, YadA-like, Hsf, Hia and Ahs, were 
confidently predicted OMPs in all three genomes. However, the Hsf, Hia and Ahs 
proteins were not detected in any of the isolates. The YadA-like protein was 
identified in only two serotype A2 isolates, PH202 and PH292, by both gel-based 
and gel-free proteomic approaches. The protein was identified in the uppermost 
section of the polyacrylamide gel at the interface between the stacking and 
resolving gel, indicating that the trimeric β-barrel domain does not undergo 
dissociation into its monomeric subunits during boiling in SDS sample buffer and 
cannot pass into the resolving gel. This is consistent with similar findings for Ahs 
(Daigneault and Lo, 2009) and other trimeric autotransporters (Sheets et al., 
2008). 
The three M. haemolytica genomes each encoded three confidently predicted 
OMPs (Iga1_1, Iga1_2 and Iga1_3) that are homologous to the H. influenzae and 
N. meningitidis autotransporter Iga1, an IgA protease. A fourth Iga1-like protein, 
Iga1_4, was present only in the serotype A2 genomes. Iga1_1 and Iga1_4 were 
not detected in any of the eight representative isolates. Iga1_2 was detected by 
gel-based methods only in six isolates (PH2, PH8, PH202, PH292, PH296 and 
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PH588). The expected molecular mass of the Iga1_2 protein after removal of the 
N-terminal signal sequence is 152.9 kDa (data not shown), but all identified 
Iga1_2 proteins had an apparent molecular mass of approximately 35 kDa when 
resolved by 1-D SDS-PAGE. Examination of the mass spectrometry data for Iga1_2 
showed better coverage and a greater degree of confidence for identified 
peptides in the C-terminal β-barrel domain (data not shown), suggesting that the 
N-terminal passenger domain might have been proteolytically cleaved. Iga1_3 
was identified by both gel-based and gel-free methods in isolates PH202, PH278 
and PH296 at an apparent molecular mass of 156 kDa, which is consistent with 
the expected molecular mass after removal of the N-terminal signal peptide. 
Iga1_3 of a lower molecular mass was not identified, suggesting that Iga1_3 does 
not undergo cleavage and remains intact on the cell surface. Similarly, the Ssa 
protein was identified at 97 kDa in all isolates, but was also identified at 66.4 
and 64.0 kDa in isolate PH2. This suggests that Ssa may also undergo a similar 
cleavage process in this isolate. 
Three OMPs (possible OMP MHA_2054/COI_1788/COK_2152, RlpA and CsgG) were 
identified exclusively in the M. glucosida isolate PH344. Rare lipoprotein A 
(RlpA) was present in the three M. haemolytica genomes analysed by 
bioinformatics. Therefore, it is possible that RlpA is expressed in M. haemolytica 
but was simply not detected by proteomics. CsgG is an outer membrane 
lipoprotein (Loferer et al., 1997) required for the secretion and stabilisation of 
two other proteins, CsgA and CsgB (yet to be identified in M. glucosida), which 
form curli amyloid fibres on the extracellular surface. These fibres have been 
implicated in a number of processes including biofilm formation, attachment and 
invasion of host cells, interaction with host proteins and activation of the 
immune system (Barnhart and Chapman, 2006). Given that CsgG was identified 
by proteomics only in the M. glucosida isolate and that it was absent in the three 
M. haemolytica genomes analysed by bioinformatics, it is reasonable to suggest 
that this protein is expressed solely in M. glucosida and not in M. haemolytica.  
Although 55 OMPs were identified by proteomic approaches, there remained 43 
confidently predicted OMPs that were not identified; 15 were predicted to be β-
barrel proteins, 15 were predicted to be outer membrane lipoproteins and 13 
were not predicted to be either. Of these 43 unidentified proteins, five are 
involved in outer membrane biogenesis and integrity (LolB, NlpE, SmpA, WzzB 
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and MltB), twelve have transport and receptor activities (LamB, ComE, PulD, 
HxuA, FhuA, FhuE, HmbR2, haemin receptor, haemin-uptake lipoprotein, and 
three TonB-dependent receptors), five are involved in adherence (Hsf, Hia, Ahs, 
FhaB_1 and FhaB_2) and seven have enzymatic activity (Iga1_1, Iga1_4, GlpQ, 
NlpC, NlpD-like_1, NlpD-like_2 and AmiC protein). Fourteen confidently 
predicted OMPs with other or unknown functions were also not identified 
(fHbp_2, N1pI, PilF, EcnA, three possible OMPs, Omp26, OapB, PlpB, two 
autotransporter proteins and two lipoproteins). 
3.4 Discussion 
A bioinformatic workflow developed for P. multocida (E-Komon et al., 2011b) 
was used to identify outer membrane-localised proteins in the genomes of three 
M. haemolytica isolates (a bovine serotype A1 isolate and bovine and ovine 
serotype A2 isolates). Using this approach, 93 confidently predicted OMPs were 
identified across the three genomes, representing 3.3%, 3.4% and 3.6% of the 
bovine serotype A1, ovine serotype A2 and bovine serotype A2 genomes, 
respectively. These figures are lower than those obtained for the P. multocida 
avian genome (4.8% of the proteome) (E-Komon et al., 2011b) and that of the 
closely related A. pleuropneumoniae genome (4.3% of the proteome) (Chung et 
al., 2007); however, the genomes of these organisms contain fewer open reading 
frames (2015 and 2241, respectively) than any of the three M. haemolytica 
genomes analysed in this study (between 2552 and 2695 open reading frames). 
Likely functions were assigned to 67 (72%) of the 93 confidently predicted OMPs. 
Further information is required to characterise the functions of the remaining 26 
proteins.  
A greater number of confidently predicted OMPs were present exclusively in 
both the bovine and ovine serotype A2 genomes than between either of these 
two genomes and the serotype A1 genome. Furthermore, amino acid sequence 
comparisons demonstrated that OMPs present in the bovine and ovine serotype 
A2 genomes show a higher degree of identity in relation to each other than to 
proteins in the bovine serotype A1 genome. The greater similarities between the 
two serotype A2 outer membrane subproteomes are consistent with a previous 
study of genetic diversity within the M. haemolytica population (Davies et al., 
1997) and a previous comparative genomic study (Lawrence et al., 2010b). 
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These findings provide further evidence to suggest that bovine and ovine 
serotype A2 isolates of M. haemolytica have a common ancestral origin and have 
recently switched from one host to another. Three OMPs, OmpA, PlpE and Ahs, 
shared amino acid identity that was significantly greater between the bovine 
serotype A1 and A2 genomes than between either of these two genomes and the 
ovine serotype A2 genome. In a previous study, comparative nucleotide 
sequence analysis of the ompA gene revealed hypervariable regions in the distal 
tips of the surface-exposed loops (Davies and Lee, 2004). These regions vary 
considerably between bovine and ovine isolates but are highly conserved among 
isolates from each host species and it was suggested that OmpA is involved in 
binding to host-specific cell receptor (Davies and Lee, 2004). The exact function 
of PlpE is currently unknown; however, anti-PlpE antibodies have been 
demonstrated to promote complement-mediated killing of bovine serotype A1 
isolates (Ayalew et al., 2004, Nardini et al., 1998) and the addition of 
recombinant PlpE to a commercial vaccine also confers enhanced resistance 
against experimental challenge in cattle compared to the commercial vaccine 
alone (Confer et al., 2003). Ahs has the predicted structural architecture of a 
trimeric autotransporters and has been demonstrated to bind collagen in vitro 
(Daigneault and Lo, 2009). A higher percentage similarity in PlpE and Ahs 
between bovine serotype A1 and bovine serotype A2 genomes, compared to 
either of these and the ovine serotype A2 genome, suggests that these two 
proteins may have a role in host adaptation. 
Using a combination of MALDI-TOF-TOF and LC-ESI-QqTOF mass spectrometry, a 
total of 55 OMPs were identified among the eight representative isolates of M. 
haemolytica and M. glucosida. Fifty of these proteins were confidently predicted 
by the bioinformatic prediction approach. The other five identified proteins, 
LemA, HbpA, OapA, RlpA and CsgG were not predicted by the bioinformatic 
approach but were indicated to be OMPs after subsequent literature searches. 
The LemA protein was identified in all eight representative isolates and is a 
homologue of the LemA protein originally identified in the Gram positive 
bacterium Listeria monocytogenes, a facultative intracellular pathogen (Lenz et 
al., 1996). The function of this protein is currently unknown, although the N-
terminus is thought to be surface-exposed on the outside of the bacterium. The 
HbpA protein has been identified in association with the outer membrane of 
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other Pasteurellaceae species (Hanson and Hansen, 1991, Hanson et al., 1992, 
Garrido et al., 2003) and has been implicated in the importation of both haem 
and glutathione (Vergauwen et al., 2010, Hanson and Hansen, 1991, Hanson et 
al., 1992). In H. influenzae, opacity-associated protein A (OapA) has been 
demonstrated to be a cell envelope protein that is required for efficient 
colonisation of the nasopharynx in an infant rat model (Weiser et al., 1995) and 
contributes to epithelial cell binding (Prasadarao et al., 1999). This protein was 
identified in only two ovine serotype A2 isolates (PH278 and PH296). In E.coli, 
rare lipoprotein A (RlpA) is thought to link the outer membrane to peptidoglycan 
during cell division (Arends et al., 2010). The CsgG protein, which was not 
present in any of the three M. haemolytica genomes analysed by bioinformatic 
analysis, was identified by searching against a genome of the closely related 
species A. pleuropneumoniae. The CsgG protein is involved in the secretion of 
amyloid fibres and may have a role in biofilm formation (Robinson et al., 2006). 
Thirty-six OMPs were identified by both gel-based and gel-free methods, 
whereas eight were identified exclusively by the gel-based method and 11 by the 
gel-free method. The gel-based method identified a higher proportion of β-
barrel proteins than outer membrane lipoproteins. Conversely, the gel-free 
method identified a higher proportion of outer membrane lipoproteins than β-
barrel proteins. These findings are consistent with the results of E-Komon et al. 
(E-Komon et al., 2011a) and further reinforce the importance of using 
complementary approaches to maximise total proteomic coverage of OMPs. 
Furthermore, no additional OMPs were identified after gel-free analysis of whole 
cell envelope fractions. This indicated that no OMPs were lost as a result of 
inner membrane solubilisation and further demonstrated the reliability of 
Sarkosyl as an appropriate selective solubilisation detergent. 
No OMPs were identified exclusively in bovine M. haemolytica isolates. This is 
not surprising given that only one of the 93 confidently predicted OMPs, PulD, 
was present exclusively in a bovine M. haemolytica genome. Fourteen OMPs 
were identified in the ovine M. haemolytica and M. glucosida isolates that were 
not identified in the bovine M. haemolytica isolates. Even though these proteins 
represent potential ovine-specific proteins, all but one (CsgG, an A. 
pleuropneumoniae orthologue detected exclusively in the M. glucosida isolate) 
were present in either the bovine serotype A1 or A2 genomes. Therefore, either 
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the proteomics approaches failed to identify these proteins or they may be 
expressed under different growth conditions.  
A recent study using immunoproteomic analyses identified 132 immunoreactive 
proteins in the outer membrane fraction of a serotype A1 M. haemolytica isolate 
from a bovine host (Ayalew et al., 2010). Of these, 35 proteins were identified 
in the outer membrane fractions of eight representative isolates in the present 
study (Supplementary Table S3.7). However, according to the bioinformatic 
analyses performed in this study, 25 of the 35 proteins were OMPs, one was a 
hypothetical protein of unknown function, and nine were false-positives. The 
immunoproteomic analyses failed to identify the remaining 30 OMPs identified in 
the present study or any of the 43 confidently predicted OMPs that were not 
identified in the present study. However, seven proteins (HbpA, MltC, ComL, 
OmpW, LppC, TonB-dependent receptor MHA_0860/COI_1565/ COK_2304 and 
TbpB) were identified that were not identified in the bovine serotype A1 M. 
haemolytica isolate (PH2) used in the present study, although these proteins 
were identified in one or more of the other representative isolates. The 
approaches used in the present study and in the study of Ayalew et al. (Ayalew 
et al., 2010) can potentially discriminate between those OMPs which are 
surface-exposed and immunogenic and those which are not. 
Fourteen OMPs (Table 3.5) were identified in all eight representative isolates, 
suggesting core functions in the biology of M. haemolytica and M. glucosida. One 
of these proteins, the Ssa autotransporter protein, is a subtilisin-like serine 
protease which shares significant identity with similar autotransporters in other 
species including AasP of A. pleuropneumoniae (Ali et al., 2008), NalP of N. 
meningitidis (van Ulsen et al., 2003, Turner et al., 2002) and SphB1 of B. 
pertussis (Coutte et al., 2001), all of which act as surface maturation proteases. 
This function has not yet been determined for Ssa, or indeed any other M. 
haemolytica OMP, but may be appropriate given that some surface-exposed 
proteins have not been identified in as many isolates as expected. For example, 
the transferrin-binding proteins A and B (TbpA and TbpB) are OMPs involved in 
the uptake of iron from host transferrin. TbpA is an integral TonB-dependent 
transporter and was identified in all seven representative M. haemolytica 
isolates (but not in M. glucosida isolate PH344). However, TbpB is a surface-
exposed lipoprotein and was identified in only one isolate. Both OMPs are 
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encoded in the same operon and are expected to be expressed in similar 
quantities, but it would appear that TbpB is largely absent from the outer 
membrane of most isolates. One explanation is that TbpB is lost from the outer 
membrane during the extraction process. However, the NalP protein of N. 
meningitidis has recently been found to cleave lactoferrin-binding protein B 
(LbpB), a close homologue of TbpB, from the bacterial cell surface (Roussel-
Jazede et al., 2010). Therefore, an alternative explanation for the apparent 
absence of TbpB is that Ssa is cleaving this protein from the bacterial cell 
surface, as has been shown for NalP. Interestingly, in isolate PH2, Ssa was 
identified at 66.4 and 64.0 kDa in addition to its expected molecular mass of 97 
kDa. Autocatalytic processing of passenger domains is a characteristic of NalP 
(van Ulsen et al., 2003) and SphB1 (Coutte et al., 2001), but not of AasP (Ali et 
al., 2008), therefore it is possible that Ssa in isolate PH2 possesses similar 
autocatalytic ability. Differences in Ssa amino acid sequences among the 
representative isolates might explain why this was only observed in one isolate. 
Furthermore, the ssa gene was previously considered to be absent from M. 
glucosida isolates (Gonzalez et al., 1991), yet its expression at the outer 
membrane has been clearly demonstrated in the present study. 
Two other serine protease autotransporters were also identified. These were 
Iga1_2 (in two bovine and four ovine isolates) and Iga1_3 (in one bovine and two 
ovine isolates), which are orthologous to Iga1 in the human pathogens N. 
meningitidis and H. influenzae. In these pathogens, Iga1 cleaves host mucosal 
IgA1 antibody, destroying its agglutinating activity and facilitating bacterial 
colonisation by immunoevasion. While IgA protease activity has not been 
detected in the supernatants of M. haemolytica (Abdullah et al., 1992), IgG-
specific protease activity was detected in partially purified culture supernatants 
(Lee and Shewen, 1996). IgG is also the predominant secretory antibody found in 
the lower respiratory tract of cattle (Duncan et al., 1972), whereas IgA is the 
predominant antibody in the upper respiratory tract (Wilkie and Markham, 
1981). It is therefore possible that at least one of the Iga1 orthologues identified 
in M. haemolytica actually cleaves IgG instead of IgA. In N. meningitidis and H. 
influenzae, the Iga1 protease passenger domain is released from the outer 
membrane-embedded β-barrel domain by autoproteolysis. Interestingly, the 
findings of the present study suggest that proteolysis occurs in Iga1_2, but not in 
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Iga1_3, even though both contain an active serine protease site. One explanation 
is that Iga1_3 does not contain a self-recognition sequence for autoproteolytic 
cleavage and therefore remains as a full length protease anchored to the cell 
surface by the β-barrel domain. Alternatively, proteolysis may be mediated by 
another surface-exposed protein. In  N. meningitidis, Iga1 can be proteolytically 
cleaved by NalP (van Ulsen et al., 2003), therefore it is possible that M. 
haemolytica Ssa has a role in the proteolytic cleavage of M. haemolytica Iga1-
like proteins. 
Four trimeric autotransporters were predicted in the bioinformatic analyses 
(YadA-like, Hsf, Hia and Ahs), all of which have putative roles in adhesion to host 
molecules. However, only expression of the YadA-like protein was confirmed in 
one bovine and one ovine serotype A2 isolates (by both gel-based and gel-free 
approaches). This is the first case of a trimeric autotransporter being detected 
at the proteomic level in M. haemolytica. The Hsf and Hia proteins have been 
discussed previously in M. haemolytica (Gioia et al., 2006), although their exact 
functions have not yet been characterised. The Ahs protein has previously been 
reported to be involved in collagen binding (Daigneault and Lo, 2009) and to be 
transcribed in vivo (Lo et al., 2006) in a serotype A1 isolate from a bovine host, 
although this protein was not identified in any of the representative isolates of 
the present study.  
In the present study, 32 proteins were identified that were predicted to be 
localised to cellular compartments other than the outer membrane (Table 3.5). 
The possibility cannot be ruled out that some of these proteins may have 
secondary functions at the outer membrane, or indeed be true OMPs, even 
though they were predicted to be located elsewhere. For example, the haem-
binding protein HbpA was identified in the outer membrane fractions of five M. 
haemolytica isolates (Table 3.5) but has a C-terminal motif which indicates that 
it is a lipoprotein anchored to the inner membrane. However, in the closely-
related species H. influenzae, HbpA has been identified in both inner membrane 
and outer membrane fractions (Hanson and Hansen, 1991, Hanson et al., 1992), 
and has been suggested to be involved in the shuttling of material between the 
two membranes. The identification of HbpA in this study also suggests a likely 
function at the outer membrane of M. haemolytica, hence its inclusion as an 
OMP. Another protein, Lpp38, was identified in all seven M. haemolytica isolates 
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and has an amino acid sequence that is 55% identical (70% when conservative 
amino acid substitutions are included) to the periplasmic E. coli protein PotD 
which is involved in polyamine transport. Lpp38 would have been considered to 
be a periplasmic protein had it not been for experimental evidence that 
demonstrated partial exposure of Lpp38 on the surface of M. haemolytica 
(Pandher and Murphy, 1996). This illustrates that even though an identified 
protein is very similar to another protein in a different species it does not 
necessarily have the same function and/or subcellular location as that protein.  
Forty-three of the 93 confidently predicted OMPs across the three genomes were 
not identified by proteomic analyses. It is possible that some of these proteins 
are actually present in the outer membrane but only at low levels which are 
insufficient to permit detection by the methods used in this study. The 
expression of OMPs also differs when isolates are grown under conditions that 
mimic the in vivo host environment. A previous study examined gene expression 
changes in a M. haemolytica serotype A1 isolate when grown in iron-restricted 
conditions to mimic the paucity of iron in the host lung (Roehrig et al., 2007). 
Several genes encoding OMPs were upregulated, including four confidently 
predicted OMPs that were not identified in the present study: haemin receptor, 
HmbR2, fHbp-like_2 and possible OMP MHA_2761/COI_0565/COK_2341 (Roehrig 
et al., 2007). Expression of several M. haemolytica OMPs was also affected by 
the addition of different antibiotics to the growth medium (Nardini et al., 1998). 
It is therefore important to consider the effect that different growth conditions 
have on OMP expression when attempting to characterise outer membrane 
subproteomes. 
In summary, a comprehensive bioinformatic workflow was implemented to 
predict the outer membrane subproteomes of three M. haemolytica genomes 
from isolates with different capsular serotypes and host origins. Subsequently, a 
total of 55 OMPs were identified from the outer membrane fractions of seven M. 
haemolytica isolates, together with a single M. glucosida isolate, which are 
representative of different phylogenetic lineages (ETs), capsular serotypes and 
host origins. Many of these OMPs are associated with particular isolates and/or 
capsular serotypes and have been identified at the protein level for the first 
time. Despite not being able to establish involvement in host-specific adaptation 
for the OMPs identified in this study, it will serve as a springboard for further 
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research into the roles of these diverse proteins in the pathobiology of M. 
haemolytica. 
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4.  COMPARATIVE OUTER MEMBRANE 
PROTEOMIC ANALYSES OF BOVINE AND 
OVINE ISOLATES OF M. HAEMOLYTICA AND 
M. GLUCOSIDA GROWN UNDER VARIOUS IN 
VITRO CONDITIONS DESIGNED TO MIMIC THE 
IN VIVO HOST ENVIRONMENT 
4.1 Introduction 
M. haemolytica colonises the nasopharynx and tonsils of healthy cattle and 
sheep, but under the context of immune suppression (induced by stress or 
concurrent viral infection) bacteria rapidly increase in number and gain access 
to the lungs and trachea via aerosolised droplets and cause pneumonia (Gilmour 
and Gilmour, 1989, Frank, 1989). In most opportunistic pathogens, certain 
proteins associated with virulence are only expressed during infection in target 
tissues (Mekalanos, 1992). Therefore, it is likely that M. haemolytica only 
expresses certain virulence-associated proteins when growing in the upper 
respiratory tract of healthy animals and the lungs of pneumonic hosts, or under 
conditions which closely mimic this microenvironment. 
An essential prerequisite of successful respiratory tract colonisation by M. 
haemolytica is being able to adapt to an environment containing very low levels 
of free iron. With the exception of some lactobacilli (Weinberg, 1997, Bruyneel 
et al., 1989, Duhutrel et al., 2010) iron is an essential micronutrient to all 
bacteria. It is a cofactor in the catalytic core of enzymes involved in a diverse 
range of cellular processes such as respiration and nucleic acid synthesis and 
repair. However, iron concentration is tightly regulated in host tissues as it can 
cause oxidative damage if present in excess amounts. Thus, in host tissues nearly 
all iron is sequestered by high-affinity iron-binding proteins such as transferrin, 
lactoferrin, ferritin, haemoglobin and other compounds. To overcome these low 
iron levels, bacteria which reside on respiratory tract mucosa have evolved a 
number of iron acquisition systems. These include the secretion of siderophores 
(small molecules with high affinity for iron) and the expression of outer 
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membrane receptors specific for iron-containing host proteins (Wandersman and 
Delepelaire, 2004). In M. haemolytica, iron can be obtained from host 
transferrin via the outer membrane-located transferrin binding proteins A and B 
(TbpA and TbpB) (Ogunnariwo et al., 1997, Lee and Davies, 2011). Additional 
OMPs present in the published M. haemolytica genomes are also predicted to 
have roles in iron acquisition, including components of a putative haem-
haemopexin acquisition system (Gioia et al., 2006, Lawrence et al., 2010a). 
Microarray analysis of gene regulation under iron-restricted conditions has been 
completed in a single bovine serotype A1 M. haemolytica isolate which 
demonstrated the upregulation of transcripts encoding other receptors for the 
transport of haem, haemoglobin and, possibly, siderophores (Roehrig et al., 
2007). However, a comparative proteomic analysis of OMP expression in several 
M. haemolytica isolates under iron-restricted conditions is still lacking. 
M. haemolytica is also likely to encounter host serum factors contained in the 
fibrinous exudate which leaks into the lungs as a result of lung tissue damage 
caused by virulence factors including leukotoxin (Czuprynski et al., 1991, Yoo et 
al., 1995b, Stevens and Czuprynski, 1996, Sun et al., 1999) and 
lipopolysaccharide (Keiss et al., 1964, Li and Clinkenbeard, 1999). These serum 
factors include complement, antibodies, hormones and other host proteins which 
may interact with the bacterial cell surface. In other Gram-negative organisms 
serum components have been demonstrated to interact with and modulate the 
expression of OMPs (Hellman et al., 2000, Johansson et al., 2003). 
It is believed that biofilm formation is a mechanism by which several Gram-
negative mucosal pathogens establish long-term colonisation in the host (Luke et 
al., 2007, Hall-Stoodley et al., 2006, Kaplan et al., 2004, Lam et al., 1980, 
Greiner et al., 2005, Yi et al., 2004). However, at present there is only limited 
evidence of biofilm formation in M. haemolytica (Olson et al., 2002, Haig, 2011). 
M. haemolytica resides in the respiratory tract via surface-associated growth on 
host tissues. Previous studies have demonstrated in vitro binding of M. 
haemolytica to epithelial cells (Kisiela and Czuprynski, 2009, Clarke and Morton, 
2000, Galdiero et al., 2002, Vilela et al., 2004) and implicated several OMPs as 
host adhesion molecules, including outer membrane protein A (OmpA) (Kisiela 
and Czuprynski, 2009, Lo and Sorensen, 2007, Davies et al., 2001) and Ahs 
(Daigneault and Lo, 2009). Some genes that are potentially involved in 
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adherence and biofilm synthesis have been demonstrated to be upregulated 
during adhesion to epithelial cells in the closely-related bacteria A. 
pleuropneumoniae (Auger et al., 2009). Surface-associated growth, as opposed 
to planktonic growth, may result in the differential expression of OMPs involved 
in biofilm formation and adherence to host tissues.  
A comprehensive comparative proteomic analysis of OMPs expressed by several 
representative M. haemolytica isolates and one M. glucosida isolate after in 
vitro growth in complex growth medium was completed in the previous chapter. 
In the present chapter, using a similar comparative proteomic approach, the 
outer membrane subproteomes of the same representative isolates were 
characterised after in vitro growth under conditions that were designed to 
mimic the in vivo pneumonic lung microenvironment. These conditions included 
growth in iron-restricted complex growth medium, serum-supplemented tissue 
culture media and growth on solid-surface agar (in the absence or presence of 
the dye Congo red). This approach has allowed the identification of several 
virulence-associated proteins, many of which have not previously been identified 
in these organisms. Furthermore, an examination of the extracellular 
subproteome of the representative isolates was undertaken after growth in iron-
restricted and iron-replete complex growth media to identify secreted proteins 
and OMPs fragments that could have been proteolytically cleaved from the 
bacterial cell surface. 
4.2 Materials and methods 
4.2.1 Bacterial isolates and growth conditions 
The eight bacterial isolates used in this study have been described previously in 
section 3.2.2. Isolates were stored at -80°C in 50% (v/v) glycerol in brain heart 
infusion broth (BHIB) and were subcultured on BHI agar (BHIA) containing 5% 
(v/v) defibrinated sheep blood overnight at 37°C. For growth under iron-
restricted conditions, optimum concentrations of the iron chelator 2,2’-dipyridyl 
were determined (to the nearest 10 µM)  for each isolate from growth rate 
experiments where growth, in the presence of increasing concentrations of 2,2’-
dipyridyl, was followed spectrophotometrically at 660 nm. The optimum 
concentration of 2,2’-dipyridyl for each isolate was deemed to be the maximum 
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concentration at which a cell density of 0.8 OD660nm was achieved within a 12 h 
period. For outer membrane preparations after growth in iron-restricted 
conditions, liquid starter cultures were prepared by inoculating a few colonies 
into 15 ml volumes of BHIB and incubating overnight at 37°C with shaking at 120 
rpm. Eight hundred microlitres of overnight culture were used to inoculate a 2-
litre Ehrlenmeyer flask containing 400 ml of BHIB and the optimum final 
concentration of 2,2’-dipyridyl and incubated at 37°C with shaking at 120 rpm 
until an OD600nm of 0.8-0.9 was achieved (mid-log phase) or for 18 h (stationary 
phase). For outer membrane preparations under serum-supplemented 
conditions, liquid starter cultures were prepared by inoculating a few colonies 
into 15 ml volumes of BHIB and incubating overnight at 37°C with shaking at 120 
rpm. Six hundred microlitres of overnight culture were used to inoculate 1-litre 
Ehrlenmeyer flasks containing 300 ml of either (a) Dulbecco’s Modified Eagle 
Medium (DMEM) containing 4.5 g glucose/L, 110 mg sodium pyruvate/L and L-
glutamine (Sigma), (b) RPMI-1640 containing L-glutamine and NaHCO3 (Sigma) or 
(c) Medium 199 (M199) containing Earle’s salts and L-glutamine (Gibco), (d) 270 
ml of the three aforementioned media supplemented with 30 ml of either 
decomplemented (56 °C for 30 min) foetal calf serum (FCS) (Sigma) or sheep 
serum (SS) (Sigma), and (e) 300 ml of either complete decomplemented FCS, SS 
or newborn calf serum (NCS). The flasks were incubated at 37 °C with shaking at 
120 rpm until an OD600nm of 0.8-0.9 was achieved. For outer membrane 
preparations of bacteria after growth on solid surface agar, bacterial suspensions 
were prepared by resuspending 6-12 colonies in 3 ml of sterile PBS in a bijou. 
One hundred microlitres of this suspension was spread over each of 24 BHIA 
plates, or 24 BHIA plates supplemented with Congo red dye at 0.8 g/L (BHIACR) 
and incubated for 24 h at 37°C. Cells were scraped off with a sterile plastic 
inoculating loop and resuspended in 50 ml of 20 mM Tris, pH 7.2. For outer 
membrane preparations after growth in BHIB containing Congo red (BHIBCR), 
liquid starter cultures were prepared by inoculating a few colonies into 15 ml 
volumes of BHIB and incubating overnight at 37°C with shaking at 120 rpm. Eight 
hundred microlitres of overnight culture were used to inoculate a 2-litre 
Ehrlenmeyer flask containing 400 ml of BHIB supplemented with Congo red dye 
at 0.8 g/L (BHIBCR) and incubated at 37°C with shaking at 120 rpm until an 
OD600nm of 0.8-0.9 was achieved. For extracellular protein preparations, liquid 
starter cultures were prepared by inoculating a few colonies into 15 ml volumes 
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of BHIB and incubating overnight at 37°C with shaking at 120 rpm. Four hundred 
microlitres of overnight culture were used to inoculate a 1-litre Ehrlenmeyer 
flask containing 200 ml of BHIB in the absence or presence of the optimum final 
concentration of 2,2’-dipyridyl and incubated at 37°C with shaking at 120 rpm 
until stationary phase growth had been achieved (12 h and 18 h for iron-replete 
and iron-restricted growth, respectively). 
4.2.2 Preparation of OMPs. 
Outer membrane proteins were prepared by Sarkosyl extraction as previously 
described in section 2.2.10 
4.2.3 Preparation of extracellular proteins 
The extracellular proteins were prepared as described previously (Xia et al., 
2008, Nandakumar et al., 2006) with some modifications. Cells were removed by 
centrifugation at 10,000 × g for 20 min at 4°C. Forty millilitres of the clear 
supernatant were collected, passed through a 0.2 µm filter, mixed with an equal 
volume of ice cold 20% (w/v) TCA in acetone for 3 h at -20°C. The precipitate 
was collected by centrifugation at 5,500 × g for 20 min at 4°C. The precipitated 
protein pellet was washed twice with ice cold acetone to remove TCA and air-
dried. The final pellets were resuspended in approximately 500 µl of 20 mM 
Tris/HCl (pH 7.2). Fifty microlitre aliquots of these suspensions were transferred 
to separate tubes and their protein concentrations determined by the modified 
Lowry procedure. One hundred microlitre aliquots of the extracellular protein 
suspensions were adjusted to 4 mg/ml with 20 mM Tris/HCl (pH 7.2) and stored 
at -80°C. Eighty micrograms of each extracellular protein preparation were 
separated by 1-D SDS-PAGE 
4.2.4 Gel-based proteomic analysis of OMPs 
Twenty micrograms of each OMP preparation were separated by 1-D SDS-PAGE as 
previously described in section 3.2.4. Gel pieces were manually excised and 
digested with trypsin as previously described in 3.2.4. Peptides were analysed by 
LC-ESI MS/MS as previously described in section 3.2.7 using either the QSTAR XL 
Hybrid LC/MS/MS system or the Bruker amaZon ETD system (coupled to the 
Dionex UltiMate 3000 nano LC).  
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4.2.5 Gel-free proteomic analysis of OMPs 
Outer membrane fractions were directly digested with trypsin without prior 
separation by 1-D SDS-PAGE as previously described in 3.2.5. Peptides were 
analysed by LC-ESI MS/MS using the QSTAR XL Hybrid LC/MS/MS as previously 
described in section 3.2.5. 
4.2.6 Gel-based analysis of extracellular proteins 
Eighty micrograms of each extracellular protein preparation were separated by 
1-D SDS-PAGE as previously described in section 3.2.4. 
4.2.7 Gel band quantification 
Gel images were scanned using the GeneScan (Syngene) gel documentation 
system. Band quantification was performed using GeneTools (Syngene). 
4.3 Results 
4.3.1 Identification of M. haemolytica and M. glucosida OMPs which 
undergo changes in expression after growth in iron-restricted 
conditions. 
To understand how OMPs are involved in the adaptation of M. haemolytica and 
M. glucosida to the low levels of free iron in the host respiratory tract, 
representative isolates were grown in the presence of 2,2’-dipyridyl, an iron-
chelating agent that has been used in several previous studies to create iron-
restricted conditions (Paustian et al., 2001, Merrell et al., 2003, McHugh et al., 
2003, Klitgaard et al., 2010, Roehrig et al., 2007). In order to obtain sufficient 
cells for outer membrane extraction, a concentration of 2,2’-dipyridyl was 
chosen for each representative isolate that gave significant growth-rate 
reduction (indicating iron-restriction), but which still allowed the growth of 
relatively high cell numbers. These were determined by following the growth of 
each representative isolate spectrophotometrically at 660 nm in BHIB in the 
presence of increasing concentrations of 2,2’-dipyridyl until a concentration had 
been reached that still allowed mid-log phase growth (OD660nm 0.8-0.9) to be 
achieved within 12 h. As has been noted previously in M. haemolytica (Davies et 
al., 1992), growth of each representative isolate was inhibited within a very 
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narrow range of concentrations. Interestingly, the different isolates displayed a 
broad range of tolerances towards growth in the presence of 2,2’-dipryridyl (Fig. 
4.1). The seven M. haemolytica isolates grew to mid-log phase within 12 h at 
2,2’-dipryridyl concentrations ranging between 120 and 245 µM; the M. glucosida 
isolate grew to mid-log phase within 12 h at a 2,2’-dipryridyl concentration of 
310 µM (Table 4.1). OMP profiles of these isolates grown to mid-log phase in iron 
replete BHIB (Fig. 4.2A) were compared with those of the same isolates grown in 
presence of the optimum concentrations of 2,2’-dipryridyl (Fig. 4.2B). 
In comparison to growth in iron-replete BHIB (Fig. 4.2A), the OMP expression 
profiles of all isolates were dramatically altered after growth in iron-restricted 
BHIB (Fig. 4.2B). In particular, upregulation of several high molecular mass 
proteins was observed. A total of 72 unique proteins were identified among the 
outer membrane fractions of the representative isolates after growth in iron-
restricted BHIB using a combination of gel-based and gel-free approaches (Table 
4.2). Fifty-nine of these proteins were previously identified in the previous 
chapter after growth in iron-replete BHIB, and included 38 OMPs, 5 proteins of 
unknown location, and 16 proteins predicted to be localised to cellular 
compartments other than the outer membrane. The other 13 proteins were not 
previously identified under growth in iron-replete BHIB and are possible 
virulence-associated proteins. Eight of these proteins were confidently predicted 
to be OMPs and included a putative haemin receptor, LamB (the substrate-
specific maltoporin), FhuA (a putative ferrichrome receptor), autotransporter 
MHA_0080/COI_1870/ COK_0773 (function unknown), EcnA (possibly involved in 
programmed cell apoptosis), HmbR2 (a putative haemoglobin receptor), HxuA (a 
putative haemophore involved in haem-haemopexin uptake) and Iga1_4 (an Iga1-
like protease). The subcellular localisations of two identified proteins with 
unknown functions (hypothetical protein MHA_1307/COI_1292/COK_0162 and 
lipoprotein MHA_2737/COI_0543/COK_2363) could not be confidently 
determined. The remaining three identified proteins (PenP, NqrC and RpsP) were 
predicted to be localised to cellular compartments other than the outer 
membrane. 
The expression of several OMPs was increased in all eight representative isolates 
after growth in iron-restricted BHIB compared to iron-replete BHIB. There was a 
1.1- to 5.1-fold increase in the expression of TbpA (number 17; Fig 4.2B) among  
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Figure 4.1. Growth curves of seven M. haemolytica isolates and one M. 
glucosida isolate in BHIB in the absence or presence of various 
concentrations of the iron chelator 2,2’-dipyridyl. 
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Table 4.1. Properties of seven representative M. haemolytica isolates and 
one M. glucosida (PH344) isolate, and the final 2,2’-dipyridyl 
concentrations used to create iron-restricted growth conditions 
for each isolate. 
 
Isolate Animal host 
Electro-
phoretic 
type 
Capsular 
serotype 
OMP 
type 
Disease 
status 
2,2’-dipryridyl 
concentration 
(mM) 
M. haemolytica 
      
PH2 Bovine  1 A1 1.1.1 Pneumonia 160 
PH8 Ovine 6 A1 1.2.1 Pneumonia 200 
PH202 Bovine  21 A2 2.1.2 Healthy 170 
PH278 Ovine 21 A2 2.2.2 Pneumonia 120 
PH292 Ovine 22 A2 2.2.1 Pneumonia 175 
PH296 Ovine 12 A7 3.1.1 Pneumonia 245 
PH588 Ovine 15 A13 3.3.2 Pneumonia 190 
M. glucosida 
      
PH344 Ovine N/A A11 3.2.2 Septicaemia 310 
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Figure 4.2. One-dimensional SDS-PAGE separation of outer membrane fractions from seven M. haemolytica isolates and one M. 
glucosida isolate after growth to mid-log phase in (A) iron-replete and (B) iron-restricted BHIB.  
Numbered proteins were subsequently identified by proteomic analysis (Table 4.2).  
A B 
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Table 4.2. Proteins identified in the outer membrane fractions of seven representative isolates of M. haemolytica and one 
isolate of M. glucosida (PH344) after mid-log phase growth in iron-restricted BHIB using a combination of gel-based 
and gel-free proteomic approaches. 
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1. Proteins previously identified in iron-replete BHIB                   
1 OM +/− − MHA_1054 COI_1980 COK_0402 OmpA +2 +2 +2 +2 +2 +2 +2 +2   
2 OM + − MHA_0691 COI_1174 COK_1967 Omp85  + + + + + + +2 +   
3 OM + − MHA_0291 COI_2627 COK_0922 Imp/LptD + + + + + + + +   
4 OM + + MHA_1410 COI_0732 COK_0022 TolC + + + + + + +1 +   
5 OM − + MHA_0263 COI_2595 COK_1835 Pal +2 +2 +2 +2 +2 +2 +2 +2   
6 OM + − MHA_2492 COI_0850 COK_2411 Ssa + + + +1 + + + +   
7 OM + − MHA_0639 COI_1221 COK_2014 OmpP1/FadL + + + + + + +2 +   
8 OM − + MHA_1433 COI_0758 COK_0049 PlpA +2 +2 +2 +2 − − +2 +2   
9 OM + + MHA_0527 COI_1313 COK_0141 Wza +2 +2 +2 +2 − +2 − −   
10 OM + − MHA_0486 COI_0902 COK_2254 Possible OMP +1 +1 +1 +1 +1 +1 +1 +1   
11 OM + − MHA_1793 COI_0051 COK_2166 OmpP2-like − − +2 +2 +2 +2 − +2   
12 OM + − MHA_2109 COI_0085 COK_0218 FrpB + + + + + + + +   
Proteins that were bioinformatically predicted to be putative OMPs are grey-shaded. 
aNumbers correspond to the location of the protein in Figure 4.2B if identified by gel-based proteomics. 
bConfidently predicted subcellular locations; 'OM' = outer membrane; 'P' = periplasm; 'IM' = inner membrane; 'C' = cytoplasm; 'E' = extracellular; 'U' = unknown 
cTransmembrane β-barrel and lipoprotein prediction result; '+' = predicted in all genomes; '−' = not predicted in any genome; '+/−' = predicted in one/two 
genomes (see Supplementary Tables S3.1, S3.2 and S3.3 for specific result). 
dTwo proteomics methods were compared; '+1' = proteins identified by gel-based method; '+2' = proteins identified by gel-free method; '+' = proteins identified 
by both methods; '−' = no identification. 
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Table 4.2. (continued) 
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13 OM − + − COI_1456 COK_1118 Rickettsia-like antigen +2 +2 +2 +2 +2 +2 +2 +2 
14 OM   MHA_0704 COI_1162 COK_1955 LemA − − − − +2 − − − 
16 OM − + MHA_2152 COI_0845 COK_2238 Lpp38 +2 +2 +2 − +2 +2 − +2 
17 OM + − MHA_0196 COI_2333 COK_1753 TbpA + + + +1 + + + + 
18 OM − + MHA_2837 COI_1320 COK_1388 VacJ − − − +2 +2 − − − 
19 OM − − MHA_2237 COI_2485 COK_1303 OMP18/16 − − − +2 − +2 − − 
20 OM − + MHA_2158 COI_0840 COK_2233 OmpP4 +2 − − − − − +2 +2 
21 OM − + − COI_0336 COK_2129 YajG +2 +2 +2 − +2 − − +2 
22 OM + − MHA_0323 COI_0250 COK_0133 YtfM +1 − − − − − − − 
25 OM − + MHA_2282 COI_2279 COK_1699 HlpB +2 − − − +2 +2 − − 
26 OM − + MHA_1514 COI_1139 COK_0733 PlpE + +2 +2 − +2 − − +2 
28 IM/P/OM   MHA_1007 COI_1369 COK_1206 HbpA − + + +2 +2 +1 − +2 
29 OM + − MHA_0735 ctg112 COK_1380  OmpP2  + +1 − − − +2 − + 
30 OM + − MHA_1532 COI_0667 COK_1504 NanH + + +1 + +1 − − +1 
33 OM − + MHA_0669 COI_1194 COK_1987 RlpB/LptE +2 − − +2 − − − − 
34 OM − +/− MHA_1464 COI_0386 COK_1074 PlpD +2 +2 − − − − − +2 
35 OM − + MHA_0242 COI_0470 COK_0285 MltC − +2 − − − − − − 
38 OM − + MHA_1435 COI_0760 COK_0051 PlpC +2 +2 − − − − − − 
40 OM − + MHA_1133 COI_1670 COK_0590 MltA +2 +2 − − − − − − 
41 OM − − MHA_2399 COI_1652/3 COK_1583/4 OmpW − − − − − +1 +1 − 
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Table 4.2. (continued) 
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44 OM − − MHA_0860 COI_1565 COK_2304 TBDR − − − − − +1 − − 
45 OM − − MHA_2261 COI_2258 COK_1624 HmbR1 + + + +1 + + + + 
46 OM + − MHA_1005 COI_1367 COK_1209 HxuB − + + + + + − + 
47 OM   MHA_2702 COI_1630 COK_1108 OapA − +2 − − − − − +2 
48 OM +/− + MHA_0197 COI_2332 COK_1752 TbpB +2 + +2 − − +2 +2 +2 
51 OM + − ctg59 COI_1368 COK_1207/8 HxuC − + + + + + − + 
56 U + + MHA_2025 COI_1815 COK_2485 Hypothetical protein +2 +2 +2 +2 +2 +2 +2 +2 
57 U   MHA_2087 COI_1609 COK_1902 Hypothetical protein +2 +2 − − − − − − 
58 U   MHA_1782 COI_0313 COK_0888 Hypothetical protein − − − +2 − − − − 
59 U − + MHA_0761/2 COI_1052 COK_0436 Hypothetical protein − − − − − − +2 − 
63 U   MHA_1898 COI_0630 COK_1217 LysM domain protein − +2 − − − − − − 
67 P + − MHA_0371 COI_1485 COK_0985 AcrA_1 +2 − − − − − − + 
68 IM   MHA_1448 COI_0774 COK_0064 YajC +2 +2 +2 +2 − +2 − − 
69 IM   MHA_1228 COI_1149 COK_1941 PntA +2 +2 +2 − − − − − 
70 C   MHA_2176 COI_1521 COK_1096 EF1A +2 − − − − − − − 
71 C   MHA_1682 COI_0958 COK_1425 RplB +2 +2 − − − − − +2 
73 IM   MHA_0370 COI_1486 COK_0984 AcrB − − − +2 − − − − 
74 C   MHA_1040 COI_1994 COK_0388 RplA − +2 − − − − − − 
75 C   MHA_1552 COI_0122 COK_2061 RplT +2 − − − − − − − 
78 C     MHA_0315 COI_0240 COK_0123 RpsB − − − − − − − +2 
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Table 4.2. (continued) 
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80 IM   ctg147 COI_1296 COK_0158 GlpT +2 − − − − − − − 
81 C   MHA_2378 COI_1451 COK_1123 RplE − +2 − − − − − − 
84 C   MHA_2364 COI_1437 COK_1137 RplQ − − +2 − − − − − 
87 E + − MHA_0254 COI_0481 COK_0274 LktA +2 − − − − − − − 
89 IM   MHA_1656 COI_1498 COK_0973 GltP +2 +2 − − − − − +2 
95 C   MHA_0822 COI_0990 COK_0963 RpsA +2 − − − − − − − 
97 C   MHA_0991 COI_1354 COK_2591 RpmB +2 − − − − − − − 
2. Proteins identified exclusively in iron-restricted BHIB 
          
99 OM + − ctg61 COI_2252/3 COK_1629/30 Haemin receptor − +1 + − − +1 +2 −   
100 OM + − MHA_0232 COI_2297 COK_1718 LamB − − − + + − − +1   
101 OM + − ctg68 COI_1905 COK_2465 FhuA − − − − + +1 +2 −   
102 OM  + − MHA_0080 COI_1870 COK_0773 Autotransporter − +1 − +1 +1 − − −   
103 OM − + − COI_0131 COK_2070 EcnA − − +2 − − − − −   
104 OM + − ctg86 COI_1762/3 COK_2539/40 HmbR2 − − − − − − +2 −   
105 OM/E − + MHA_1004 COI_1366 COK_1210 HxuA − +1 − − − − − −   
106 OM + − − COI_0585/6 COK_1280/81 Iga1_4 − − − − − − +1 −   
107 U − + MHA_2737 COI_0543 COK_2363 Lipoprotein − +2 − − − − − −   
108 U   MHA_1307 COI_1292 COK_0162 Hypothetical protein − +2 − − − − − −   
109 E   − − − PenP +2 − − − − − − −   
110 IM     MHA_2767 COI_0571 COK_2335 NqrC +2 − − − − − − −   
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Table 4.2. (continued) 
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111 C     MHA_2535 COI_1411 COK_1164 RpsP − +2 − − − − − − 
  
  
 
 
 
Total number of proteins identified 42 43 29 28 27 28 22 32 
  
  
 
 
  
Total number of OMPs identified  27 31 25 24 26 26 20 27 
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M. haemolytica isolates and a 23-fold increase in the M. glucosida isolate PH344. 
Expression changes in TbpB could not be quantified due to its close proximity to 
other proteins on the 1-D SDS PAGE gel; however, it was identified in six isolates 
after growth in iron-restricted BHIB whereas it was identified in only one isolate 
after growth in iron-replete BHIB. There was a 4.6 to 14.8-fold increase in the 
expression of the putative haemoglobin receptor HmbR1 (number 45, Fig. 4.2B) 
among M. haemolytica isolates and an 18.8-fold increase in the M. glucosida 
isolate. Another putative haemoglobin receptor, HmbR2, was also identified by 
the gel-free approach in the M. glucosida isolate PH344 that had not been 
previously identified after growth in iron-replete BHIB [although transcripts of 
the gene encoding this protein were previously shown to be upregulated in a 
bovine serotype A1 M. haemolytica isolate under iron-restriction (Roehrig et al., 
2007)]. In the previous chapter, the putative siderophore receptor FrpB was 
identified in a protein band of approximately 69 kDa in all eight representative 
isolates after growth in iron-replete BHIB (number 12; Fig 4.2A). After growth in 
iron-restricted BHIB, expression of FrpB (number 12; Fig 4.2B) increased 11.8- 
and 14.6-fold in isolates PH2 and PH344, respectively. FrpB was also identified in 
the other six isolates but other proteins were identified alongside it including 
HxuC, haemin receptor, FhuA and autotransporter MHA_0080/COI_1870/ 
COK_0773. Despite the presence of these other proteins, FrpB was consistently 
identified with the high protein scores and emPAI values, indicating that it is a 
predominantly expressed protein in these bands. 
HxuB and HxuC, the outer membrane components of a putative haem-
haemopexin uptake system, were identified by both gel-free and gel-based 
proteomic approaches in all isolates except for the bovine serotype A1 M. 
haemolytica isolate PH2 and the M. glucosida isolate PH344. Expression of a 
band containing HxuB (number 46; Fig. 4.2B) increased 3.5- to 17.4-fold among 
these isolates. The putative haem/glutathione transporter HbpA (number 28; 
Fig. 4.2B) was also identified in the same protein band as HxuB in isolates PH8, 
PH202 and PH296 but at much lower protein scores and emPAI values than HxuB, 
indicating that HxuB is the predominantly expressed protein in these bands. The 
expression change in HxuC (number 46; Fig. 4.2B) could not be quantified due to 
its close proximity to other proteins, including FrpB, on the 1-D SDS-PAGE gel. 
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HxuA (number 105; Fig. 4.2B) was identified only in isolate PH8 in a very faint 
protein band.  
Expression of a protein band that contained the putative fatty acid transporter 
FadL (number 7; Fig 4.2B) increased 1.8-, 1.4-, 2.6-, and 3.9-fold in serotype A2 
isolates PH202, PH278, PH292 and in serotype A7 isolate PH296, respectively, 
after mid-log phase growth in iron-restricted BHIB. Possible OMP 
MHA_0486/COI_0902/COK_2252 (number 10; Fig 4.2B) was also identified in the 
same protein band as FadL in the seven M. haemolytica isolates but at much 
lower protein scores and emPAI values than FadL, indicating that FadL is the 
predominantly expressed protein in these bands. Interestingly, after growth to 
stationary phase in iron-restricted BHIB this protein band was expressed at levels 
below that observed after mid-log phase growth in iron-replete BHIB in all 
isolates (Supplementary Fig. S4.1), indicating a more important role for FadL 
during mid-log phase iron-restricted growth than at stationary phase. 
There was a 2.4-, 2.2-, 1.4- and 1.8-fold increase in the expression of the porin 
OmpP2 (number 29; Fig. 4.2B) in isolates PH2, PH8, PH296 and PH588, 
respectively. This protein was found to be absent from the outer membranes of 
serotype A2 isolates PH202, PH278, PH292 and M. glucosida isolate PH344 after 
growth in iron-replete BHIB, and was still absent in the present study after 
growth in iron-restricted BHIB. This is consistent with the finding that the ompP2 
gene is either absent or truncated in serotype A2 isolates (Lawrence et al., 
2010a). Expression of the other major porin OmpP2-like (number 11; Fig. 4.2B) 
was relatively unchanged in all isolates. 
A 157 kDa protein band that was not previously identified under iron-replete 
conditions in any of the representative isolates was present exclusively in M. 
glucosida isolate PH344 under iron-restricted conditions. This protein was 
identified as Iga1_4 by gel-based proteomics (number 106; Fig 4.2B), and 
represents the first Iga1-like protease identified in M. glucosida.  
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4.3.2 Identification of M. haemolytica OMPs which undergo changes in 
expression after growth in serum-supplemented tissue culture media 
and complete serum. 
During an M. haemolytica infection, fibrinous exudate leaks into the lungs as a 
result of vascular and pulmonary damage to host tissue. In order to determine 
what influence this exudate may have on the expression of OMPs in the 
pneumonic lung, M. haemolytica outer membranes were extracted from four M. 
haemolytica isolates (PH2, PH8, PH202 and PH278) after growth in tissue culture 
media in the presence or absence of serum (which has a composition similar to 
that of lung exudate). Fig. 4.3 shows the OMP profiles of the bovine (PH2) and 
ovine (PH8) serotype A1 isolates (Fig. 4.3A) and the bovine (PH202) and ovine 
(PH278) serotype A2 isolates (Fig. 4.3B) after growth to mid-log phase in DMEM 
in the absence or presence of either 10% FCS or SS. Outer membranes were also 
extracted after growth in M199 and RPMI in the absence or presence of 10% FCS 
or SS, and also in complete FCS, SS and NCS (Supplementary Figures S4.2 and 
S4.3). A total of 103 unique proteins were identified among the four isolates 
under all growth conditions using a combination of gel-based and gel-free 
proteomic approaches (Table 4.3). Sixty of these proteins were previously 
identified after growth in iron-replete BHIB, and included 42 OMPs, 3 proteins of 
unknown location, and 15 proteins predicted to be localised to cellular 
compartments other than the outer membrane. The remaining 43 proteins that 
were not previously identified after growth in iron-replete BHIB included five 
OMPs, seven proteins of unknown location, and 31 proteins predicted to be 
localised to cellular compartments other than the outer membrane. The five 
OMPs were the haemin receptor, LamB, Hsf (a putative adhesin/serum-
resistance protein), PlpB (function unknown), and possible OMP 
MHA_0862/COI_1567/COK_2302 (function unknown). Both the haemin receptor 
and LamB had been previously identified after growth in iron-restricted BHIB. 
Possible OMP MHA_0862/COI_1567/COK_2302 was identified in isolates PH2, PH8 
and PH202 after growth in DMEM alone, and also in isolate PH202 after growth in 
RPMI alone. PlpB and Hsf were the only OMPs that were identified exclusively 
after growth in the presence of serum. PlpB was identified in the bovine isolates 
PH2 and PH202 only after growth in complete FCS.  
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Figure 4.3. One-dimensional SDS-PAGE separation of outer membrane 
fractions from (A) bovine (PH2) and ovine (PH8) serotype A1 M. 
haemolytica isolates, and (B) bovine (PH202) and ovine (PH278) 
serotype A2 M. haemolytica isolates after growth in DMEM only, 
DMEM + 10% FCS and DMEM + 10% SS.  
OMP profiles after growth in iron-replete and iron-restricted BHIB 
are also shown for comparison. Numbered proteins were 
subsequently identified by proteomic analysis (Table 4.3). Twenty 
micrograms of protein were loaded into each lane. Protein bands 
were stained with Coomassie brilliant blue. 
 
B 
A 
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Table 4.3. Proteins identified in the outer membrane fractions of four M. haemolytica isolates (PH2, PH8, PH202 and PH278) 
after growth in DMEM, RPMI and M199 in the absence of presence of 10% FCS or SS, and in total FCS, SS and NCS. 
 
 
Proteins that were bioinformatically predicted to be putative OMPs are grey-shaded. 
aNumbers correspond to the location of the protein in Figure 4.3 if identified by gel-based proteomics. 
bConfidently predicted subcellular locations; 'OM' = outer membrane; 'P' = periplasm; 'IM' = inner membrane; 'C' = cytoplasm; 'E' = extracellular; 'U' = 
unknown. 
cTransmembrane β-barrel and lipoprotein prediction result; '+' = predicted in all genomes; '−' = not predicted in any genome; '+/−' = predicted in one/two 
genomes. 
dTwo proteomics methods were compared; '+1' = proteins identified by gel-based method; '+2' = proteins identified by gel-free method; '+' = proteins 
identified by both methods; '−' = no identification. 
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Table 4.3. (continued) 
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Table 4.3. (continued) 
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Table 4.3. (continued) 
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Table 4.3. (continued) 
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Table 4.3. (continued) 
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Hsf was identified only in ovine serotype A1 isolate PH8 after growth in RPMI + 
10% FCS, M199 + 10% FCS and complete NCS.  
Of the seven identified proteins that were of unknown location, lipoprotein 
MHA_2737/COI_0543/COK_2363 was the only one to be identified only under 
growth conditions containing serum. It was identified only in isolate PH8 after 
growth in M199 containing 10% FCS and also in complete FCS. The remaining six 
proteins were identified either in tissue culture media or both tissue culture 
media and serum-supplemented media. 
Three of the 31 identified proteins predicted to be localised to cellular 
compartments other than the outer membrane were identified only under 
growth conditions containing serum: PenP, MglC and UraA. PenP, a penicillinase, 
was identified in isolate PH2 after growth in complete FCS; this protein was also 
identified in the same isolate after growth under iron-restricted conditions. MglC 
and UraA, inner membrane proteins involved in galactose and uracil transport, 
respectively, were identified in isolates PH2, PH8 and PH202 only after growth in 
serum-supplemented conditions. 
In the four isolates examined, growth in DMEM resulted in OMP profiles that were 
similar to those observed after growth in iron-restricted BHIB. This is most likely 
due to the fact that iron in DMEM is available only in the form of ferric nitrate 
(Conrad, 2007) and is not a favourable iron source for M. haemolytica. In 
serotype A1 isolate PH8, growth in DMEM supplemented with FCS or SS resulted 
in an OMP profile which resembled that observed after growth in iron-replete 
BHIB (Fig 4.2A). This suggests that isolate PH8 is able to acquire iron from serum 
of both cattle and sheep. A similar observation was made for isolate PH2, 
although some iron-acquisition proteins including TbpA and FrpB are still 
expressed at higher levels after growth in the presence of serum from either 
animal compared to growth in iron-replete BHIB. In the serotype A2 isolates, it 
appears that there is a correlation between the host of origin and the ability to 
acquire iron more readily from serum of the same host. In the bovine serotype 
A2 isolate (PH202), the protein band containing the putative siderophore 
receptor FrpB (number 12; Fig. 4.3) is expressed at higher levels after growth in 
the presence of SS than that of FCS, indicating a greater ability to acquire iron 
from serum of cattle than sheep. Conversely, in the ovine serotype A2 isolate 
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(PH278), the protein band containing the FrpB protein is expressed at a higher 
level after growth in the presence of FCS than that of SS, indicating a greater 
ability to acquire iron from serum of sheep than cattle. This is particularly 
interesting considering that PH202 and PH278 belong to the same ET and are 
identical in terms of their housekeeping genes.  
In a previous study, a 98 kDa protein band was identified in the OMP profiles of 
two M. haemolytica isolates after growth in NCS (Davies et al., 1992), although 
the identity of this protein was not determined. Furthermore, expression of this 
protein was not repressed after the addition of FeCl3 to the NCS, indicating that 
its expression was not iron-regulated (Davies et al., 1992). In the present study, 
this protein was identified as the leukotoxin protein LktA (number 87; Fig. 4.3). 
It was identified in a 98 kDa protein band in isolates PH2, PH8 and PH202 after 
growth in tissue culture media containing 10% SS and in complete NCS by gel-
based proteomic analysis. It was also identified in isolates PH278 by gel-free 
proteomic analysis under the same growth conditions.  
4.3.3 Identification of M. haemolytica and M. glucosida OMPs which 
undergo changes in expression after growth on solid-surface BHIA in 
the absence or presence of Congo red dye. 
In order to identify OMPs that are potentially involved in mediating surface-
associated growth and possible biofilm formation, the OMP profiles of the eight 
representative isolates were examined after 24 h growth on BHIA (Fig. 4.4). The 
OMP profiles were not too dissimilar to that observed after growth in iron-
replete BHIB (Fig. 4.2A). Several iron-acquisition OMPs were identified including 
HmbR1, HxuB and HxuC, although they were expressed at lower levels than that 
observed after growth in iron-restricted BHIB. Expression of these OMPs is most 
likely due to locally available iron being depleted by high cell densities and also 
the slower diffusion of this nutrient through solid medium compared to liquid 
medium. Gel-based proteomic analysis revealed no new proteins identified in 
any of the isolates that had not been identified in iron-replete or iron-restricted 
BHIB.  
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Figure 4.4. One-dimensional SDS-PAGE separation of outer membrane 
fractions from seven M. haemolytica isolates and one M. 
glucosida isolate after growth on BHIA for 24 h.  
Numbered proteins were subsequently identified by proteomic 
analysis. Twenty micrograms of protein were loaded into each lane. 
Protein bands were stained with Coomassie brilliant blue. 
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Gel-free proteomic analysis resulted in poor coverage of identified proteins and 
was therefore not included. 
The seven M. haemolytica isolates and the M. glucosida isolate were grown on 
BHIA supplemented with 0.8 g/L Congo red (BHIACR). Within 24 h, in all isolates, 
the agar surrounding areas of growth had turned from red to black and there 
were black dots in the centres of individual colonies (Fig. 4.5). However, after 
incubation between 48 and 72 h the colonies turned a deep red colour, 
suggesting that it was only the underlying agar that turned black within 24 h and 
not the colonies themselves.  
To determine any physiological effect that Congo red might be having on OMP 
expression, outer membrane fractions were extracted after 24 h growth on 
BHIACR. Outer membrane protein profiles were virtually identical to those 
observed after growth on BHIB (Fig. 4.4), except for the presence of previously 
unseen protein bands in the upper molecular mass region of the gel (Fig. 4.6). 
Two protein bands were present at 131 and 135 kDa in all M. haemolytica 
isolates but not in the M. glucosida isolate. Iga1_1 (number 151; Fig. 4.6) and 
Iga1_2 (number 24; Fig. 4.6) were identified in these bands in one and six 
isolates, respectively, but given the close proximity of the bands it was not 
possible to determine which protein was contained in which protein band. 
Another OMP, the putative filamentous haemagglutinin FhaB_1 (number 150; Fig. 
4.6), was identified in a 159 kDa protein band in isolate PH8. Iga1_3 (number 39; 
Fig. 4.6) was also identified at 146 kDa in isolates PH292 and PH588. This protein 
had been identified in the previous chapter in isolates PH202, PH278 and PH296 
after growth in iron-replete BHIB. The Iga1_1, Iga1_2 and FhaB_1 proteins were 
also visible when isolates were grown in BHIB supplemented with Congo red dye 
(Fig. 4.6) indicating that expression of these OMPs is dependent on the presence 
of Congo red dye and not on solid-surface growth. 
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Figure 4.5. Colony phenotypes of seven M. haemolytica isolates and one M. 
glucosida isolate after growth on BHIACR for 18, 24, 48 and 72 h. 
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Figure 4.6. One-dimensional SDS-PAGE separation of outer membrane 
fractions from seven M. haemolytica isolates and one M. 
glucosida isolate after growth on BHIACR for 24 h. The OMP 
profiles of M. haemolytica isolate PH2, PH8, PH202 and PH278 
after growth to mid-log phase in BHIBCR are also shown.  
Twenty micrograms of protein were loaded into each lane. Protein 
bands were stained with Coomassie brilliant blue. 
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4.3.4 Comparison of OMPs identified among different growth conditions. 
A total of 55 OMPs were identified in the previous chapter after growth in iron-
replete BHIB. In the present study, a further thirteen OMPs were identified using 
a range of different growth conditions (Fig 4.7; Table 4.4). Six OMPs (FhuA, 
autotransporter MHA_0080/COI_1870/COK_0773, EcnA, HmbR2, HxuA and 
Iga1_4) were identified exclusively after growth in iron-restricted BHIB. Possible 
OMP MHA_0862/COI_1567/COK_2302 was identified exclusively after growth in 
tissue culture media alone. Two OMPs (Hsf and PlpB), were identified exclusively 
after growth in media containing serum. The haemin receptor was identified 
after growth in both iron-restricted BHIB and tissue culture media alone. The 
maltoporin LamB was identified after growth in iron-restricted BHIB, tissue 
culture media only and in media containing serum. Iga1_1 and FhaB_1 were 
identified exclusively after growth in the presence of Congo red dye (not shown 
in Fig. 4.7).  
4.3.5 Extracellular protein expression after growth in iron-replete and iron-
restricted BHIB. 
The present work has provided evidence to suggest that proteolytic cleavage 
occurs in the passenger domains of OMPs such as Iga1_2 and Ssa. Furthermore, 
the finding that HxuA is only present in the outer membrane of one isolate after 
growth in iron-restricted BHIB suggests that it is a secreted protein. To identify 
these proteins in the extracellular medium and gain an understanding of the 
overall extracellular subproteome of M. haemolytica, proteins from cell-free 
culture supernatants were precipitated and analysed by 1-D SDS-PAGE after 
growth to stationary phase in iron-replete (Fig. 4.8A) and iron-restricted (Fig. 
4.8B) BHIB. Supernatants from stationary phase growth were used because only 
limited protein was obtained from supernatants after growth to mid-log phase 
(results not shown). This finding is consistent with what has been observed for 
extracellular proteins of other bacteria in the stationary phase (Voigt et al., 
2006, Gohar et al., 2002, Xia et al., 2008, Kim et al., 2005). Similar to OMP 
expression profiles, the extracellular protein profiles of the representative 
isolates differ considerably after growth in iron-restricted BHIB compared to 
iron-replete BHIB. Proteins have not yet been identified by proteomic 
approaches, but will be in future experiments. 
  162 
 
Figure 4.7. Distribution of 66 OMPs identified by proteomic approaches 
after growth in iron-replete BHIB (grey shaded), iron-restricted 
BHIB, tissue culture media only and/or media containing serum. 
 
 
  
163
Table 4.4. Names and putative functions of OMPs that were identified under different growth conditions that were not identified 
after growth in iron-replete BHIB. 
No.a Name Function 
Iron-restricted 
BHIB 
Tissue culture 
media only 
Media 
containing sera BHIACR 
99 Haemin receptor Haemin receptor + + − − 
100 LamB Maltoporin transport + + + − 
101 FhuA Ferric hydroxamate receptor + − − − 
102 Autotransporter Unknown + − − − 
103 EcnA/B  Programmed cell apoptosis + − − − 
104 HmbR2 Haemoglobin receptor + − − − 
105 HxuA Haem-haemopexin acquisition + − − − 
106 Iga1_4 Cleavage of host mucosal antibody + − − − 
112 Possible OMP Unknown − + − − 
113 Hsf Adherence/serum resistance − − + − 
114 PlpB Unknown − − + − 
150 FhaB_1 Adherence  − − − + 
151 Iga1_1 Cleavage of host mucosal antibody − − − + 
aNumbers correspond to the location of the protein in Figures 4.2, 4.3, 4.4 and 4.6 if identified by gel-based proteomics. 
'+' = identified in at least one isolate; '−' = not identified in any isolates.
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Figure 4.8. One-dimensional SDS-PAGE separation of extracellular proteins from seven M. haemolytica isolates and one M. 
glucosida isolate after growth to stationary phase in (A) iron-replete and (B) iron-restricted BHIB.  
Eighty micrograms of protein were loaded into each lane. Protein bands were stained with Coomassie brilliant blue. 
 B A 
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4.4 Discussion 
In the present study, the OMP expression profiles of seven representative M. 
haemolytica isolates and one M. glucosida isolate were examined after growth 
under several in vitro conditions designed to mimic the in vivo pneumonic lung 
microenvironment. Subsequently, a combination of proteomic approaches were 
used to identify new OMPs and determine which OMPs were differentially 
expressed under these conditions, indicating potential roles in virulence and 
host-specificity. 
Growth in iron-restricted conditions 
Firstly, the tolerances of the representative isolates to growth in increasing 
concentrations of the iron chelator 2,2’-dipyridyl were examined in order to 
determine the maximum concentration at which each isolate could grow to mid-
log phase. Interestingly, isolates PH2 and PH278, which represent groups of 
pathogenic isolates that cause the majority of disease cases in cattle and sheep, 
respectively, tolerated the lowest levels of 2,2’-dipyridyl (160 and 120 µM, 
respectively). One might expect that the most pathogenic isolates would be able 
to tolerate higher levels of 2,2’-dipyridyl than weakly pathogenic isolates. Also, 
notably, the weakly pathogenic M. glucosida isolate was able to grow at the 
highest concentration of 2,2’-dipyridyl (310 µM). These findings suggest that the 
ability to tolerate increasing concentrations of 2,2’-dipyridyl could be inversely 
correlated with virulence in these species.  
Under iron-restricted growth conditions, eight OMPs were identified that were 
not previously identified under growth in iron-replete BHIB. These were a 
haemin receptor, LamB, FhuA, autotransporter MHA_0800/COI_1870/COK_0773, 
EcnA, HmbR2, HxuA and Iga1_4. The haemin receptor and putative haemoglobin 
receptor HmbR2 have been described previously in a bovine M. haemolytica 
isolate after iron-restricted growth (Roehrig et al., 2007). LamB is a putative 
maltoporin involved in substrate-specific uptake of maltodextrins. The 
autotransporter contains a C-terminal translocator domain that is characteristic 
of other autotransporters but its function is currently unknown. EcnA, shares 45% 
amino acid identity with the EcnA protein of E. coli. In E. coli, the ecnA and 
ecnB genes comprise the two-gene entericidin locus, whereby EcnB ‘the toxin’ 
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and EcnA ‘the antitoxin’ contribute programmed cell apoptosis (Bishop et al., 
1998). During the course of balanced growth, EcnB is constantly neutralised by 
EcnA; however, metabolic changes brought about by nutrient stress disturbs this 
balance and EcnB ‘poisons’ the cell, allowing surviving cells to use the lysis 
products for nourishment. A counterpart EcnB protein was not predicted in M. 
haemolytica genomes by bioinformatics, therefore it can only be speculated as 
to whether M. haemolytica EcnA functions in a similar manner to E. coli EcnA. 
Iga1_4 was identified exclusively in M. glucosida and represents the first Iga1-
like protease to be identified in this species under iron-restricted conditions. 
Members of this protein family were identified in the previous chapter in all M. 
haemolytica isolates after growth in iron-replete BHIB, but not in M. glucosida. 
HxuA and FhuA are described in further detail below in the context of their 
respective expression systems. 
Under iron-restricted growth conditions, protein components of a putative 
HxuCBA haem-haemopexin utilization system were identified in several M. 
haemolytica isolates. This system was first discovered in H. influenzae (Hanson 
et al., 1992) and is an important virulence determinant in this organism (Morton 
et al., 2007) and in H. parasuis (Melnikow et al., 2005). HxuC is a TonB-
dependent receptor protein (Cope et al., 2001, Cope et al., 1995). HxuB and 
HxuA comprise a two-partner (TPS) system, whereby HxuA (the TpsA protein) is 
transported across the outer membrane by HxuB (the TpsB protein) (Cope et al., 
1995). HxuA binds the haem-haemopexin complex and facilitates haem delivery 
to the cell surface via HxuC (Cope et al., 1994, Cope et al., 1998). Recent 
evidence suggests that HxuA might not actually function as a haemophore in H. 
influenzae, but instead releases haem upon interaction with the haem-
haemopexin complex (Fournier et al., 2011). Furthermore, the primary activity 
of HxuA may actually be to sequester haemopexin in its inactive form, thereby 
decreasing the high-affinity binding of haem by the serum (Fournier et al., 
2011). In the present study, HxuB and HxuC were expressed in the outer 
membranes of all M. haemolytica isolates except for the bovine serotype A1 
isolate PH2, and the M. glucosida isolate PH344, after growth in iron-restricted 
BHIB. In the previous chapter, HxuB and HxuC were identified after growth in 
iron-replete BHIB in two (PH202 and PH292) and one (PH588) isolates, 
respectively, but at much lower expression levels than that observed after 
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growth in iron-restricted BHIB. HxuA was identified in only one M. haemolytica 
isolate (PH8) under the same conditions, although in a very faint protein band. 
In H. influenzae, HxuA has been identified as both surface-associated (Fournier 
et al., 2011) and released into the culture medium (Wong et al., 1995). The 
amino acid sequences of HxuA in the three M. haemolytica genomes contain two 
conserved cysteine residues at their C-terminus that have been demonstrated to 
be essential for the cell-surface anchoring of TpsA proteins in other 
microorganisms (Jacob-Dubuisson et al., 2004, Buscher et al., 2006, Fournier et 
al., 2011). It is therefore surprising that HxuA was absent (with the exception of 
one isolate) from M. haemolytica outer membrane fractions and suggests that 
HxuA is released from the cell surface. This is the first study to report HxuCBA 
expression in the outer membrane of M. haemolytica. The presence of HxuCBA 
has not previously been reported in M. haemolytica because outer membrane 
studies have almost exclusively examined the expression of OMPs in bovine 
serotype A1 isolates (Ayalew et al., 2010, Lo et al., 2006, Roehrig et al., 2007) 
which, according to the findings presented here, do not express a functional 
HxuCBA system. Results from the present study, and the failure to detect 
HxuCBA expression in other bovine serotype A1 isolate studies (Ayalew et al., 
2010, Lo et al., 2006, Roehrig et al., 2007), indicate that the HxuCBA system is 
not expressed in bovine serotype A1 M. haemolytica isolates, nor in M. glucosida 
isolates, but is expressed under iron-restricted conditions in all other isolates 
examined in this study. 
Expression of the putative siderophore receptor FrpB was significantly 
upregulated in two isolates (PH2 and PH344) and was predominantly expressed 
among other OMPs in an upregulated protein band in the remaining six isolates 
under iron-restricted growth conditions. Transcription of the frpB gene has 
previously been shown to be upregulated in a bovine serotype A1 M. haemolytica 
isolate (Roehrig et al., 2007) and in the closely related species A. 
pleuropneumoniae (Klitgaard et al., 2010) under iron-restriction conditions. In 
A. pleuropneumoniae FrpB has been demonstrated to be both immunoreactive 
(Liao et al., 2009) and an essential virulence determinant, as frpB deletion 
mutants are unable to colonise the host or cause clinical disease symptoms upon 
experimental infection (Buettner et al., 2009). The function of FrpB in M. 
haemolytica, M. glucosida and A. pleuropneumoniae is currently unknown. 
   
 168
However, in N. gonorrhoeae it has been associated with ferric iron uptake from 
transferrin (Dyer et al., 1988, Beucher and Sparling, 1995) and, more recently, 
as a receptor for the ferric siderophore enterobactin (Carson et al., 1999). N. 
gonorrhoeae does not synthesise siderophores but can utilise those produced by 
other bacteria (xenosiderophores), such as E. coli aerobactin (West and Sparling, 
1987) and enterobactin (Rutz et al., 1991, Carson et al., 1999). M. haemolytica 
and M. glucosida do not produce their own siderophores either, suggesting the 
possibility that these species may utilise xenosiderophores via FrpB in a similar 
manner to N. gonorrhoeae and other Gram-negative bacteria (Thulasiraman et 
al., 1998). Indeed, some bacterial isolates of the bovine nasopharyngeal flora 
have been reported to stimulate the growth of M. haemolytica and other closely 
related Gram-negative species, possibly as a result of this mechanism (Corbeil et 
al., 1985). Another putative siderophore receptor, FhuA, which shares 24% 
identity with the A. pleuropneumoniae FhuA protein, was also identified in three 
M. haemolytica isolates (PH292, PH296 and PH344) under iron-restricted 
conditions. In M. haemolytica serotype A2 genomes, the fhuA gene and fhuCDB 
genes that encode attendant proteins are arranged in an operon with the same 
structure as that in A. pleuropneumoniae (Mikael et al., 2002). In A. 
pleuropneumoniae, FhuA is involved in the uptake of the hydroxamate 
siderophore ferrichrome and, in contrast to FrpB, is not required for virulence 
(Baltes et al., 2003). Given that the annotations of the FrpB and FhuA proteins 
of M. haemolytica have been allocated solely based on sequence homologies, 
and the previous finding that M. haemolytica is unable to utilise either 
exogenous enterobactin or ferrichrome under iron-limited conditions (Reissbrodt 
et al., 1994, Graham and Lo, 2002), it is likely these proteins do not function as 
enterobactin and ferrichrome receptors, respectively, but are involved in the 
uptake of other as yet unknown molecules. Indeed, M. haemolytica FhuA 
actually shares greater identity (34%) with the E. coli FhuE protein than A. 
pleuropneumoniae FhuA. FhuE is a receptor for ferrioxamine B (Sauer et al., 
1990, Hantke, 1983), a siderophore which has been demonstrated to support M. 
haemolytica growth under iron-restricted conditions (Reissbrodt et al., 1994) 
and may be a more appropriate substrate for M. haemolytica FhuA binding. 
Expression of the FadL protein increased after growth to mid-log phase under 
iron-restricted conditions in several isolates; however, expression returned to 
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below baseline levels after growth to stationary phase under iron-restricted 
conditions. The function of FadL (also referred to as OmpP1) in M. haemolytica 
is not known. In E. coli, FadL is an OMP involved in the uptake of long-chain 
fatty acids (LCFAs) through the outer membrane (Black et al., 1987). LCFAs and 
their derivatives are important for a wide variety of cellular processes, including 
fatty acid and phospholipid synthesis, membrane permeability and enzyme 
activation (Black and DiRusso, 2003). Upregulation of genes encoding enzymes 
that metabolise LCFAs have been observed during the early stages of infection 
with Salmonella enterica (Mahan et al., 1995), indicating that transport of LCFAs 
is also important from a pathophysiological perspective. During bacterial 
infections, high concentrations of LCFAs (including arachidonic acid) are found in 
the extracellular inflammatory milieu that are released from host cells. It has 
been suggested that subsequent uptake of arachidonic acid by FadL might 
suppress the local inflammatory immune response and hence confer bacteria 
with an advantage during early colonisation of the host (Black and DiRusso, 
2003). If FadL were to have a similar role in M. haemolytica then this might 
explain why expression of FadL is increased during mid-log phase growth 
(representing early stage infection) in several isolates, but not at stationary 
phase growth (representing late stage infection). The M. haemolytica leukotoxin 
stimulates the release of arachidonic acid and its derivatives from host 
neutrophils (Wang et al., 1998, Clinkenbeard et al., 1994). Therefore, an 
increase in FadL expression may limit inflammatory immune responses and 
prevent lung tissue damage during early colonisation. The observation that FadL 
is present in the outer membrane at much lower levels after iron-restricted 
stationary phase growth compared to iron-restricted mid log phase growth also 
raises the question of how this OMP and others are removed from the outer 
membrane when they are no longer required. Several Gram-negative organisms 
release outer membrane through the production of outer membrane vesicles 
(OMVs) (Kulp and Kuehn, 2010), and FadL-like proteins have been identified in 
OMVs released by N. meningitidis (Uli et al., 2006, Vaughan et al., 2006, Vipond 
et al., 2006, Williams et al., 2007), Pseudomonas aeruginosa (Bauman and 
Kuehn, 2006), Moraxella catarrhalis (Schaar et al., 2011). OMV release has not 
yet been demonstrated in M. haemolytica but may provide an appropriate 
mechanism by which FadL and other OMPs are discarded from the outer 
membrane. 
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Growth in the presence of serum 
Four representative M. haemolytica isolates were grown in three different tissue 
culture media (DMEM, RPMI and M199) in the presence or absence of 10% FCS and 
10% SS, and also in complete FCS, SS and NCS.  Two OMPs, Hsf (in one ovine 
isolate) and PlpB (in the two bovine isolates), were identified only after growth 
in media supplemented with serum. Both of these proteins were not identified 
after growth in iron-replete and iron-restricted BHIB.  
In the human respiratory tract pathogen H. influenzae, Hsf is associated with 
attachment to epithelial cells (Barenkamp and StGeme, 1996) and is considered 
to be major nonpilus adhesin (StGeme et al., 1996). A gene whose product has 
high homology to the H. influenzae Hsf protein was also found to be upregulated 
in A. pleuropneumoniae after contact with porcine lung epithelial cells (Auger et 
al., 2009). Hsf also confers serum-resistance on H. influenzae isolates by binding 
the extracellular matrix molecule vitronectin, a regulator of the terminal 
pathway of complement activation (Hallstrom et al., 2006). Vibronectin-binding 
proteins have also been identified in other Gram-negative bacteria including 
DsrA of Haemophilus ducreyi (Elkins et al., 2000, Leduc et al., 2009) and Usp of 
M. catarrhalis (Attia et al., 2006). Bacteria are shielded from complement 
attack when coated with vitronectin and, furthermore, can use the molecule as 
a bridge to cross-link other bacterial cells and to bind integrin receptors on host 
cells (Singh et al., 2010). M. haemolytica encounters host serum factors, 
including complement, as a result of lung tissue inflammation caused by the 
onset of disease (Ackermann and Brogden, 2000). Therefore, the Hsf-like protein 
identified in the present study under serum-supplemented and complete serum 
growth conditions may contribute to the protection of M. haemolytica in the 
presence of host serum. 
PlpB is encoded in an operon containing the genes for two other similar 
lipoproteins, PlpA and PlpC (Cooney and Lo, 1993). Each of these proteins are 
immunogenic and recognised by serum from calves that have been naturally 
exposed or vaccinated with M. haemolytica cells (Dabo et al., 1994). A M. 
haemolytica mutant lacking the plpABC operon was also more susceptible to 
bovine complement-mediated killing (Murphy et al., 1998). Both PlpA and PlpC 
were identified in the previous chapter in the outer membranes of several M. 
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haemolytica isolates after growth in iron-replete BHIB. It is therefore surprising 
that PlpB has not identified alongside PlpA and PlpC given that the three 
proteins are expected to be expressed in equal quantities. The function of PlpB 
is currently unknown; however, PlpA has recently been demonstrated to be 
surface-exposed and capable of binding to bovine bronchial epithelial cells in 
vitro (Kisiela and Czuprynski, 2009).  
The leukotoxin protein, LktA, was identified in outer membrane fractions of 
isolates PH2, PH8, PH202 and PH278 when grown in the presence of 10% SS, and 
in complete SS and NCS. LktA is a member of the repeats-in-toxin (RTX) 
exoprotein family produced by a variety of Gram-negative bacteria (Linhartova 
et al., 2010) and is a key virulence factor in the pathogenesis of pneumonic 
pasteurellosis (Chang et al., 1987, Maheswaran et al., 1993, Petras et al., 1995, 
Sutherland, 1985, Sutherland and Donachie, 1986). Surface-association of LktA 
has not previously been demonstrated in M. haemolytica, but has been shown in 
RTX proteins of other Gram-negative bacteria. The adenylate cyclase toxin of B. 
pertussis remains surface-associated following secretion, due to interaction with 
the filamentous haemagglutinin (Zaretzky et al., 2002). A putative filamentous 
haemagglutinin (FhaB_1) was identified in the present study in the outer 
membrane fraction of one isolate (PH8) after growth on BHIACR, but LktA was not 
concurrently identified. The leukotoxin of the closely-related organism 
Actinobacillus actinomycetemcomitans (LtxA) is both secreted as soluble protein 
(Kachlany et al., 2000, Kachlany et al., 2002) and retained at the bacteria cell 
surface within membranous vesicles and by electrostatic association with nucleic 
acids on the bacterial cell surface (Lally et al., 1991, Berthold et al., 1992, Ohta 
et al., 1991, Tsai et al., 1984, Kato et al., 2002). Paradoxically, in contrast to 
the finding in the present study of M. haemolytica LktA surface-association in 
the presence of serum, the LtxA protein of A. actinomycetemcomitans is 
released from the cell surface in the presence of serum (Johansson et al., 2003), 
although the mechanism of release has not been established. Several possible 
mechanisms might explain why M. haemolytica LktA is surface-associated in the 
presence of serum. Firstly, serum components which bind to the surface of M. 
haemolytica may also bind LktA and retain it on the surface. Secondly, the 
presence of serum may somehow disrupt the secretion of LktA into the 
extracellular medium leading to accumulation of LktA at the cell surface. 
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Thirdly, the presence of serum may stimulate outer membrane blebbing, 
whereby vesicles containing LktA are both released from the cell and retained at 
the cell surface. Furthermore, it is possible that LktA is normally associated with 
the outer membrane in vivo (or under conditions which in vivo conditions) but 
does not associate with the membrane when grown in vitro in complex growth 
media alone. 
Growth on solid-surface agar 
Surface-associated growth on BHIA resulted in mild expression of OMPs that were 
previously strongly upregulated under iron-restricted growth conditions 
(including FrpB, HmbR1, HxuB and HxuC) as has been observed for other Gram-
negative bacteria grown on solid surfaces (Wang et al., 2004, Sampathkumar et 
al., 2006, Pysz et al., 2004). It has previously been suggested that immobilised 
growth, as opposed to growth in liquid culture, represents more physiologically 
appropriate baseline growth conditions and that iron-acquisition systems 
expressed during surface-associated growth may be more appropriately viewed 
as a repression of these systems during growth in liquid media (Sampathkumar et 
al., 2006). There were no new OMPs identified in any of the representative 
isolates after growth on BHIA that had not been identified in iron-replete or 
iron-restricted BHIB. Furthermore, no OMPs with roles in biofilm formation, such 
as those encoded in the Tad (tight adherence) locus of P. multocida (E-Komon et 
al., 2011a) and other organisms (Tomich et al., 2007) have been identified in the 
present study. Therefore, despite limited previous evidence of biofilm formation 
in M. haemolytica (Haig, 2011, Olson et al., 2002), this study has not been able 
to provide evidence of biofilm-producing ability in the representative isolates 
examined. 
Congo red dye is well known for its ability to bind highly aggregative and 
insoluble β-sheet-rich amyloid fibres found in several living organisms (Chapman 
et al., 2002, Fowler et al., 2007). It is also commonly used to differentiate 
between slime-producing and non-slime producing strains of Staphylococci, 
which result in black and pink colonies, respectively, when grown on agar that 
contains the dye  (Freeman et al., 1989, Jain and Agarwal, 2009, Arciola et al., 
2002, Arciola et al., 2006). It can also be used to differentiate between virulent 
and avirulent strains of several Gram-negative bacteria (Deneer and Potter, 
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1989, Daskaleros and Payne, 1987, Stugard et al., 1989, Ishiguro et al., 1985, 
Prpic et al., 1983). Notably, in Shigella flexneri, the presence of Congo red can 
stimulate the release of Ipa type III effector proteins (Parsot et al., 1995), 
regulate membrane protein expression (Sankaran et al., 1989) and is associated 
with increased infectivity in HeLa cells (Daskaleros and Payne, 1987). Despite 
these virulence-associated observations made across a broad range of organisms, 
the mechanism by which this dye achieves these effects is still unclear. A 
previously unknown effect of Congo red on the expression of high-molecular 
mass OMPs in M. haemolytica was demonstrated in the present study. Two high 
molecular mass OMPs, Iga1_1 and Iga1_2, were identified in all M. haemolytica 
isolates after growth in the presence of Congo red. Another high molecular mass 
protein, the filamentous haemagglutinin protein FhaB_1, was also identified in 
one isolate after growth in the presence of Congo red. These three proteins all 
contain domains which are expected to extend into the extracellular milieu and 
undergo subsequent proteolytic cleavage, yet each was identified at their intact 
molecular mass after growth in the presence of Congo red. Indeed, Iga1_2 was 
identified in the previous chapter at 37 kDa after growth in iron-replete BHIB in 
the absence of Congo red, indicating that the extracellular domain of this 
protein is normally cleaved from the cell surface. This suggests that, rather than 
regulating the expression of these OMPs at the genetic level, Congo red might be 
interfering with their post-translational processing at the bacterial cell surface. 
Consistent with this is the suggestion that the enhanced secretion of S. flexneri 
effector proteins in the presence of Congo red is most likely due to the 
interference of the dye with the Type III secretion needle tip complex which 
controls effector protein release (Bahrani et al., 1997). At present, it can only 
be speculated as to how Congo red interferes with the processing of M. 
haemolytica OMPs. One explanation is that the dye is binding directly to these 
OMPs, preventing autoproteolysis and allowing them to remain intact at the cell 
surface. Alternatively, Congo red may bind to and inhibit the function of another 
as yet undefined surface-associated protein which is involved in the processing 
of these proteins. In neisserial species, Iga1 proteases are capable of 
autoproteolysis (Pohlner et al., 1987, Vitovski and Sayers, 2007) and can also be 
processed by the autotransporter NalP (van Ulsen et al., 2003). Similarly, B. 
pertussis expresses a filamentous haemagglutinin protein which is released from 
the cell surface by the autotransporter SphB1 (Coutte et al., 2001, Coutte et al., 
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2003). Both NalP and SphB1 are members of the subtilisin-like protease family 
(Siezen and Leunissen, 1997) and share significant identity with serotype-specific 
antigen (Ssa), an autotransporter which has been identified in the outer 
membrane of all M. haemolytica and M. glucosida isolates examined to date. It 
is possible that Ssa could be responsible for releasing the surface-exposed 
domains of Iga1-like proteases and FhaB_1 from the cell surface. Further 
experimentation will be required to determine the actual mechanism by which 
Congo red allows these OMPs to remain surface-associated. 
Extracellular protein expression 
To complement the information obtained about OMP expression, putative 
proteolytic cleavage of OMPs and putative secretion of HxuA, an examination of 
the extracellular subproteomes of the eight representative isolates was 
performed. Extracellular proteins were precipitated from cell-free culture 
supernatant after growth to stationary phase in iron-replete and iron-restricted 
BHIB. The extracellular protein profiles of the eight isolates appear to be as 
complex as their OMP profiles, and differed considerably after growth in iron-
replete and iron-restricted medium. In E. coli, a proteomic analysis of the 
extracellular subproteomes of two isolates demonstrated that periplasmic and 
OMPs accounted for the majority of released proteins during stationary phase 
growth (Xia et al., 2008). Furthermore, the expression levels of porins OmpF and 
OmpC in the outer membrane did not change significantly between different cell 
growth densities, suggesting that these proteins are continuously secreted into 
the medium, possibly by OMV blebbing (Xia et al., 2008). Another possibility is 
that the extracellular proteins were the products of cell lysis, although this was 
proved not to be the case for E. coli (Xia et al., 2008). A proteomic analysis of 
the M. haemolytica extracellular subproteome is still to be completed. 
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5. FINAL DISCUSSION 
The first objective of this study was to examine the surface-exposure of OmpA 
and to demonstrate whether the OmpA proteins from bovine (OmpA1) and ovine 
(OmpA2) isolates are antigenically distinct. This was achieved by examining 
whether antibodies that were raised against recombinant OmpA1 (rOmpA1) and 
OmpA2 (rOmpA2) proteins could interact with OmpA in a strain-specific manner. 
Recombinant OmpA1 and rOmpA2 were successfully expressed, purified and used 
to generate anti-rOmpA1 and anti-rOmpA2 antibodies, respectively. 
Immunogold-electron microscopy and immunofluorescence techniques clearly 
demonstrated that OmpA1 and OmpA2 are surface exposed, and are not masked 
by the polysaccharide capsule, in a selection of M. haemolytica isolates of 
various serotypes and grown under different growth conditions. An examination 
of the binding specificities of anti-rOmpA antibodies to M. haemolytica isolates 
representing different OmpA subclasses revealed that cross-absorbed anti-
rOmpA1 antibodies recognised OmpA1-type proteins but not OmpA2-type 
proteins; conversely, cross-absorbed anti-rOmpA2 antibodies recognised OmpA2-
type proteins but not OmpA1-type proteins. The results of this study have 
therefore clearly demonstrated that OmpA1 and OmpA2 are surface-exposed and 
could potentially bind to different receptors in cattle and sheep. This work 
builds significantly upon what was previously known about M. haemolytica OmpA 
(Davies and Lee, 2004) but also raises some interesting questions to be 
addressed by future investigations. In particular, how are the loops of OmpA 
recognised by anti-rOmpA antibodies when the capsule is expected to mask 
them? This conundrum might be explored in future work by examining the 
possible roles of phase variable capsule expression and outer membrane vesicle 
blebbing on the exposure of OMPs to the host environment. Furthermore, the 
anti-rOmpA antibodies produced in this work could also be used in host epithelial 
cell binding assays to definitively demonstrate that M. haemolytica OmpA1 and 
OmpA2 are capable of selectively binding to different receptors within cattle 
and sheep, respectively. Preliminary crystallisation experiments determined a 
range of conditions under which protein crystals were produced; however, no X-
ray diffraction data could be obtained. Further optimisation of these conditions 
might yield higher quality crystals under which structural data can be obtained. 
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The second objective of this study was to provide a comparative analysis of the 
outer membrane subproteomes of several isolates of M. haemolytica and M. 
glucosida in order to identify those that are possibly involved in host-specific 
adaptation and virulence. This objective was achieved in two parts. First, the 
entire repertoire of OMPs encoded in three M. haemolytica genomes was 
predicted using a simple bioinformatic framework. This yielded a total of 93 
confidently predicted OMPs which were assigned to six broad functional 
categories: outer membrane biogenesis and integrity, transport and receptor, 
adherence, enzymatic activity, other and unknown. The majority of these 
proteins (88) were present among all three genomes. There were no proteins 
present exclusively in the ovine genome, and only one protein (PulD) was 
exclusively present in a bovine genome (serotype A1). Furthermore, amino acid 
sequence comparisons were performed to identify OMPs present among bovine 
and ovine genomes that may be adapted to either cattle or sheep. Only three 
OMPs, OmpA, PlpE, and Ahs, had greater amino acid sequence identity between 
bovine genomes than between one of the bovine genomes and the ovine 
genome. A possible role in host-specific adaptation has already been suggested 
for OmpA (Davies and Lee, 2004), but has not yet been demonstrated for PlpE or 
Ahs. Several other OMPs (Table 3.4) also had divergent amino acid sequences 
among the genomes that were apparently unrelated to host-specificity. The 
bovine and ovine serotype A2 genomes were more similar both in the number of 
OMPs present in the two genomes and amino acid conservation of OMPs than 
between either of these two genomes and the bovine serotype A1 genome. This 
reflects the common ancestral origin of the bovine and ovine serotype A2 
isolates and provides further evidence to support previous work which 
hypothesised the host-switching of this serotype from cattle to sheep (Davies et 
al., 1997, Davies et al., 2001, Davies and Lee, 2004, Davies et al., 2002).  
Second, complementary proteomic approaches were used to identify and 
compare the OMPs present in the outer membrane fractions of seven M. 
haemolytica isolates and one M. glucosida isolate. Complementary proteomic 
approaches identified a total of 55 unique OMPs. Fifty of these proteins were 
confidently predicted by the bioinformatic approach, representing 54% of the 
confidently predicted outer membrane subproteome. Five identified OMPs 
(LemA, HbpA, OapA, RlpA and CsgG) were not predicted by the bioinformatic 
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approach but were considered likely to be OMPs after literature searches on 
these proteins were carried out. Eleven OMPs (MltC, FhaC, LppC, TonB-
dependent receptor MHA_0860/COI_1565/COK_2304, OapA, TbpB, possible OMP 
MHA_0964/COI_1329/COK_2563, Bor/Iss_1, HxuC, TonB-dependent receptor 
MHA_1346/COI_1921 and OmpW) were identified among ovine M. haemolytica 
isolates that were not identified among bovine M. haemolytica isolates; 
however, the genes encoding these OMPs were identified in the genomes of 
bovine isolates, suggesting that they are possibly expressed under different 
growth conditions. There were no OMPs identified exclusively in bovine M. 
haemolytica isolates. The putative bovine-specific OMP, PulD, was not identified 
in any of the representative isolates. Despite the lack of evidence for roles in 
host-specific adaptation of identified OMPs, the results of this objective have 
produced a comprehensive overview of the outer membrane subproteomes of M. 
haemolytica and M. glucosida isolates that can be used to identify individual 
OMPs to be studied in further detail. Comparative nucleotide sequence analysis 
of genes encoding selected OMPs, such as PlpE and Ahs, should elucidate further 
evidence of host-specific adaptation, as has previously been determined for 
OmpA (Davies and Lee, 2004). Furthermore, the identified Ssa and Iga1_2 
autotransporter proteins showed evidence of proteolytic processing, a 
phenomenon that has not previously been described in M. haemolytica. A 
possible role in proteolytic processing of other OMPs at the bacterial cell surface 
was hypothesised for Ssa. This was based upon on its similarity to NalP of N. 
meningitidis (Turner et al., 2002, van Ulsen et al., 2003), AasP of A. 
pleuropneumoniae (Ali et al., 2008) and ShpB1 of B. pertussis (Coutte et al., 
2001), which are involved in proteolytic processing of other OMPs in these 
species. Studies using ssa gene knockout and partial deletion mutants of M. 
haemolytica should further elucidate the exact function of Ssa. 
The third and final objective of this study was to characterise the outer 
membrane subproteomes of the same representative isolates and identify 
differentially expressed OMPs after in vitro growth under conditions that were 
designed to mimic the in vivo host environment. A further 13 confidently 
predicted OMPs (Table 4.4) were identified under either iron-restricted, serum-
supplemented or Congo red-supplemented growth conditions (or a combination 
of the three), that were not identified under iron-replete growth conditions. 
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Expression of several OMPs that were previously identified after growth in iron-
replete media increased after growth in iron-restricted conditions. One of the 
most significant findings was that components of an HxuCBA haem-haemopexin 
acquisition system were upregulated in all representative M. haemolytica 
isolates, except for bovine serotype A1 isolate PH2, after growth under iron-
restricted conditions. It is interesting that isolate PH2, a virulent disease isolate, 
should be lacking this system as it is a known virulence determinant in H. 
influenzae (Morton et al., 2007) and H. parasuis (Melnikow et al., 2005). There 
was also no expression of HxuCBA in the M. glucosida isolate after growth under 
iron-restricted conditions. This study is the first to describe the expression of 
this system in M. haemolytica outer membranes and demonstrates the great 
advantage of comparative analyses over that of individual isolates. With the 
exception of studies by this author’s research group, the majority of previous M. 
haemolytica outer membrane studies have focused almost exclusively on bovine 
serotype A1 isolates. This is probably due to the fact that these isolates are 
responsible for most cases of bovine pneumonic pasteurellosis and are of greater 
interest to animal health practitioners and vaccine developers. The present 
study has demonstrated that comparative examination of several isolates, as 
opposed to individual isolates, provides a broader knowledge of the M. 
haemolytica species as a whole and is more conducive to identifying novel 
proteins. Further study is warranted for the HxuCBA system, and other putative 
virulence-associated OMPs which were upregulated after growth in iron-
restricted medium including FrpB (a putative siderophore receptor), HmbR1 (a 
putative haemoglobin receptor) and FadL (a putative LCFA transporter). 
Biological uptake assays which examine the specificities of different 
siderophores, haemophores and transferrins might also further elucidate roles in 
host-specificity for these OMPs. 
Association of the leukotoxin with the outer membrane was demonstrated in 
four M. haemolytica isolates (PH2, PH8, PH202 and PH278) grown in the 
presence of serum. This is a significant finding, as leukotoxin is considered to be 
the major virulence factor in M. haemolytica pathogenesis and has not 
previously been considered to associate with the outer membrane. The LtxA 
protein of A. actinomycetemcomitans can be retained at the surface of this 
organism in membrane vesicles and by electrostatic association with the 
   
 179
membrane (Lally et al., 1991, Berthold et al., 1992, Ohta et al., 1991, Tsai et 
al., 1984, Kato et al., 2002). Interestingly though, in the presence of serum, 
LtxA is released from the bacterial surface via an unknown mechanism 
(Johansson et al., 2003). It will be worthwhile to establish if M. haemolytica 
leukotoxin attaches to the outer membrane by a similar mechanism as A. 
actinomycetemcomitans and, alternatively, if normally present in the outer 
membrane in vivo, its mechanism of detachment from the outer membrane in 
vitro. 
One of the more serendipitous discoveries of this study was that OMPs with 
putative cleavable passenger domains appear to be stabilised in the presence of 
Congo red dye. Two OMPs, Iga1_1 and Fhab_1 were identified on 1-D SDS-PAGE 
gels at their intact molecular mass after growth in the presence of Congo red. 
However, these proteins were not identified under identical growth conditions in 
the absence of the dye. Another protein, Iga1_2, was also identified at its 
expected intact molecular mass after growth in the presence of Congo red. This 
protein that had been identified at a much lower-than-expected molecular mass 
after growth under identical growth conditions in the absence of the dye. These 
findings suggest that Congo red somehow interrupts extracellular passenger 
domain processing, allowing the proteins to remain intact at the cell surface. 
This finding is interesting not only from the point of view of this project, but 
also from a general microbiological perspective. It is feasible that bacterial 
growth in the presence of Congo red could be used as a general method of 
preventing proteolytic changes to OMPs at the cell surface, allowing examination 
of the outer membrane subproteome prior to these changes occurring. It would 
be interesting in future investigations to determine the mechanism by which the 
dye achieves these effects. 
An investigation of the extracellular subproteomes of the eight representative 
isolates under iron-replete and iron-restricted growth conditions was performed. 
This was prompted by findings that suggested some OMPs, including Iga1_2 and 
Ssa, undergo proteolytic cleavage of their passenger domains which are released 
from the bacterial surface. Also, the putative haemophore HxuA was only 
identified in the outer membrane fraction of one isolate (PH8) after growth 
under iron-restricted conditions, suggesting that it is secreted. One-dimensional 
SDS-PAGE separation of extracellular protein fractions demonstrated that the 
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extracellular subproteome is as complex as the outer membrane subproteome. 
Due to limitations of resources no MS data were obtained to identify these 
proteins. Future investigations will use MS to identify these proteins and 
elucidate whether they are proteolytically-cleaved fragments, secreted proteins, 
or cell envelope proteins that have blebbed away from the bacterial surface, as 
has been demonstrated for E. coli (Xia et al., 2008). 
The work presented in this thesis represents the most comprehensive coverage 
of M. haemolytica and M. glucosida outer membrane subproteomes to date. The 
only other previous study of an M. haemolytica outer membrane subproteome 
identified 25 of the confidently predicted OMPs described in the present work in 
a single bovine serotype A1 isolate (Ayalew et al., 2010). In this thesis, a total of 
68 OMPs were identified among several representative M. haemolytica isolates 
and an M. glucosida isolate under a range of different growth conditions. Of 
these 68 OMPs, 63 were confidently predicted by the bioinformatic approach, 
representing 67.8% of the confidently outer membrane subproteome. Despite the 
lack of evidence for roles in host-specificity of the identified OMPs, the work 
presented in this thesis will serve as a primer for further research into the roles 
of OMPs in the pathobiology of M. haemolytica, and has wide implications for 
the design of vaccines to treat pneumonic pasteurellosis. 
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7. APPENDICES 
7.1 Growth media composition 
Brain Heart Infusion broth (BHIB) 
1 litre 
Brain Heart Infusion, dehydrated (Oxoid)  37.0 g 
Distilled water      to 1 litre 
Autoclaved at 121°C for 15 min. 
Brain Heart Infusion agar (BHIA) 
1 litre 
Brain Heart Infusion Agar, dehydrated (Oxoid)  47.2 g 
Distilled water      to 1 litre 
Autoclaved at 121°C for 15 min.  
Luria-Bertani (LB) broth 
1 litre 
LB broth powder (Sigma-Aldrich)    20.0 g 
Distilled water       to 1 litre 
Autoclaved at 121°C for 15 min. 
Luria-Bertani (LB) agar 
1 litre 
LB agar powder (Sigma-Aldrich)    35.0 g 
Distilled water      to 1 litre 
Autoclaved at 121°C for 15 min. 
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7.2 Plasmid DNA 
pOPINF (Berrow et al., 2007) 
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7.3 MemSys screen (Molecular Dimensions, UK) 
Tube # Salt 1 Salt 2 Buffer pH Precipitant 
1 None None 0.1 M Na citrate 5.5 2.5 M ammonium sulphate 
2 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M Na citrate 3.5 30% v/v PEG 400 
3 0.1 M sodium chloride 0.1 M magnesium chloride 
0.1 M Na 
acetate 
4.5 30% v/v PEG 400 
4 0.1 M sodium chloride None 0.1 M Na citrate 5.5 30% v/v PEG 400 
5 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M Na citrate 5.5 30% v/v PEG 400 
6 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M Na citrate 5.5 30% v/v PEG 400 
7 None None 0.1 M MES 6.5 2.5 M ammonium sulphate 
8 None None 0.1 M MES 6.5 30% v/v PEG 400 
9 0.1 M sodium chloride None 0.1 M MES 6.5 30% v/v PEG 400 
10 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M MES 6.5 30% v/v PEG 400 
11 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M MES 6.5 30% v/v PEG 400 
12 None None 0.1 M MOPS 7.0 30% v/v PEG 400 
13 None None 0.1 M Na HEPES 7.5 2.5 M ammonium sulphate 
14 0.1 M sodium chloride None 0.1 M MOPS 7.0 30% v/v PEG 400 
15 None None 0.1 M Na HEPES 7.5 30% v/v PEG 400 
16 0.1 M sodium chloride None 0.1 M Na HEPES 7.5 30% v/v PEG 400 
17 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M Na HEPES 7.5 30% v/v PEG 400 
18 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M Na HEPES 7.5 30% v/v PEG 400 
19 None None 0.1 M Tris 8.5 1.5 M lithium sulphate 
20 0.1 M sodium chloride None 0.1 M Tris 8.5 30% v/v PEG 400 
21 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M Tris 8.5 30% v/v PEG 400 
22 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M Tris 8.5 30% v/v PEG 400 
23 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M CAPSO 9.5 30% v/v PEG 400 
24 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M CAPSO 9.5 30% v/v PEG 400 
25 None None 0.1 M Na citrate 5.5 1.5 M sodium phosphate 
26 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M Na citrate 3.5 12% w/v PEG 4000 
27 0.1 M sodium chloride 0.1 M lithium sulfate 
0.1 M Na 
acetate 
4.5 12% w/v PEG 4000 
28 0.1 M sodium chloride None 0.1 M Na citrate 5.5 12% w/v PEG 4000 
29 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M Na citrate 5.5 12% w/v PEG 4000 
30 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M Na citrate 5.5 12% w/v PEG 4000 
31 None None 0.1 M MES 6.5 1.5 M sodium phosphate 
32 None None 0.1 M MES 6.5 12% w/v PEG 4000 
33 0.1 M sodium chloride None 0.1 M MES 6.5 12% w/v PEG 4000 
34 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M MES 6.5 12% w/v PEG 4000 
35 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M MES 6.5 12% w/v PEG 4000 
36 None None 0.1 M MOPS 7.0 12% w/v PEG 4000 
37 None None 0.1 M Na HEPES 7.5 1.5 M potassium phosphate 
38 0.1 M sodium chloride None 0.1 M MOPS 7.0 12% w/v PEG 4000 
39 None None 0.1 M Na HEPES 7.5 12% w/v PEG 4000 
40 0.1 M sodium chloride None 0.1 M Na HEPES 7.5 12% w/v PEG 4000 
41 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M Na HEPES 7.5 12% w/v PEG 4000 
42 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M Na HEPES 7.5 12% w/v PEG 4000 
43 None None 0.1 M Tris 8.5 1.5 M potassium phosphate 
44 0.1 M sodium chloride None 0.1 M Tris 8.5 12% w/v PEG 4000 
45 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M Tris 8.5 12% w/v PEG 4000 
46 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M Tris 8.5 12% w/v PEG 4000 
47 0.1 M sodium chloride 0.1 M lithium sulfate 0.1 M CAPSO 9.5 12% w/v PEG 4000 
48 0.1 M sodium chloride 0.1 M magnesium chloride 0.1 M CAPSO 9.5 12% w/v PEG 4000 
 
Abbreviations: 
 
CAPSO; 3-(Cyclohexylamino)-2-hydroxyl-1-propanesulfonic Acid Sodium Salt, Na HEPES; N-(2-hydroxyethyl)-piperazine-
N’-2-ethanesulfonic acid sodium salt, MES; 2-(N-morpholino)ethanesulfonic acid, MOPS; 3-(N-Morpholino)-
propanesulfonic acid, PEG; Polyethylene glycol, Tris; 2-Amino-2-(hydroxymethyl)propane-1,3-diol. 
  215
7.4 MemGold screen (Molecular Dimensions, UK) 
 
Tube 
# 
Salt Buffer pH Precipitant 
1 None 0.08 M sodium citrate 5.2 2.2 M ammonium sulfate 
2 None 0.01 M Tris 8.0 1.2 M tri-sodium citrate 
3 None 0.015 M tricine  8.5 24% w/v PEG 4000 
4 
0.36 M sodium chloride/0.1% w/v 
sodium azide 
0.015 M sodium phosphate 7.0 9.9% w/v PEG 4000 
5 0.3 M sodium chloride 0.01 M Tris 8.0 27.5% w/v PEG 4000 
6 None 0.225 M MES/bis-tris 6.6 6.6% w/v PEG 6000 
7 0.1 M ammonium sulfate 0.1 M HEPES 7.5 
12.0% w/v PEG 4000/22% 
v/v glycerol 
8 
0.02 M calcium chloride/0.01 M 
magnesium sulfate/0.02 M 
sodium chloride 
0.02 M MES 6.5 7.7% w/v PEG 1500 
9 None 0.05 M HEPES 7.5 2.5 M ammonium sulfate 
10 None 0.0665 M HEPES 7.5 1.1 M tri-sodium citrate 
11 None 0.15 M potassium phosphate 6.5 3.3 M ammonium sulfate 
12 0.1 M magnesium acetate 0.1 M sodium citrate 5.8 14% w/v PEG 5000 MME 
13 0.1 M sodium chloride  0.02 M sodium citrate 5.6 11% w/v PEG 3350 
14 0.1 M sodium chloride  0.02 M sodium citrate 5.6 5.5% w/v PEG 3350 
15 
0.05 M calcium chloride/0.05 M 
barium chloride 
0.1 M Tris 8.2 32% v/v PEG 400 
16 0.05 M sodium chloride 0.1 M sodium phosphate 6.2 16% w/v PEG 4000 
17 0.1 M magnesium chloride 0.03 M Tris-hydrochloride 8.2 19% w/v PEG 4000 
18 0.2 M sodium chloride 0.025 M HEPES 7.5 13% w/v PEG 4000 
19 None 0.1 M HEPES 7.5 11% w/v PEG 3350 
20 0.1 M sodium chloride  0.02 M KMES 6.7 6.6% w/v PEG 4000 
21 0.1 M potassium chloride 0.02 M Tris 7.0 20% w/v PEG 4000 
22 
0.05 M magnesium chloride/0.1% 
w/v sodium azide 
0.1 M sodium cacodylate 6.7 6.6% w/v PEG 3350 
23 0.2 M potassium chloride 0.1 M sodium citrate 5.5 
37% v/v pentaerythritol 
propoxylate (5/4 PO/OH) 
24 None 0.1 M Tris 8.0 5.5% w/v PEG 4000 
25 0.1 M sodium chloride  0.02 M Tris 7.0 7.7% w/v PEG 4000 
26 0.1 M magnesium chloride 0.1 M Tris 7.5 22% v/v PEG 400 
27 0.04 M sodium chloride 0.04 M Tris 8.0 27% v/v PEG 350 MME 
28 
0.05 M sodium chloride/0.02 M 
magnesium chloride 
0.1 M sodium citrate 6.0 22% v/v PEG 400 
29 None 0.1 M sodium acetate 5.5 8.8% w/v PEG 2000 MME 
30 None 0.4 M ammonium acetate 8.0 13% w/v PEG 2000 MME 
31 None 0.02 M bis Tris 7.0 15% w/v PEG 2000 
32 
0.1 M sodium chloride/0.1 M 
magnesium chloride 
0.02 M Tris 7.5 11% w/v PEG 1500 
33 
0.1 M sodium chloride/0.1 M 
magnesium chloride 
0.1 M HEPES 8.0 11% w/v PEG 1500 
34 
0.2 M sodium acetate/0.2 M 
potassium chloride 
0.1 M HEPES 7.0 22% w/v PEG 3000 
35 0.02 M nickel sulfate 0.01 M HEPES 7.0 33% v/v Jeffamine-M600 
36 0.15 M sodium chloride 0.1 M Tris 8.0 13% w/v PEG 6000 
37 0.2 M calcium chloride 0.1 M HEPES 7.5 53% v/v PEG 400 
38 0.05 M magnesium acetate 0.05 M sodium acetate 5.0 28% v/v PEG 400 
39 None 0.05 M HEPES 7.5 22% v/v PEG 4000 
40 0.2 M calcium chloride 0.1 M Tris hydrochloride 8.0 44% v/v PEG 400 
41 0.05 M magnesium acetate 0.05 M sodium acetate 5.4 24% v/v PEG 400 
42 0.2 M calcium chloride 0.1 M MES 6.5 26% v/v PEG 350 MME 
43 0.1 M potassium chloride 0.1 M Tris 8.5 39% v/v PEG 400 
44 0.05 M magnesium chloride 0.1 M glycine 9.0 22% v/v PEG 400 
45 0.1 M ammonium sulfate 0.1 M glycine 3.8 28% w/v tri-ethylene glycol 
46 0.15 M sodium formate 0.1 M HEPES 7.2 18% w/v PEG 3350 
47 None 0.2 M sodium acetate 6.8 8.8% w/v PEG 6000 
48 0.2 M potassium chloride 0.1 M MES 6.5 18% w/v PEG 6000 
49 0.22 M sodium citrate 0.1 M Tris 8.0 35% v/v PEG 400 
50 None 0.1 M sodium acetate 4.5 17% v/v PEG 400 
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51 None 0.02 M Tris 8.5 
1.0 M lithium sulfate/1.8% 
w/v PEG 8000 
52 None 0.02 M Tris 7.5 22% v/v PEG 550 MME 
53 0.05 M sodium chloride 0.02 M glycine 10.0 33% w/v PEG 1000 
54 0.2 M magnesium chloride 0.1 M Tris 8.5 25% w/v PEG 4000 
55 0.2 M magnesium chloride 0.1 M sodium cacodylate 6.5 31% w/v PEG 2000 
56 None 0.64 M sodium acetate 4.6 18% w/v PEG 3350 
57 
0.1 M sodium chloride/0.1 M 
cadmium chloride 
0.1 M Tris hydrochloride 8.0 33% v/v PEG 400 
58 None 0.1 M Bicine 8.9 31% w/v PEG 2000 
59 
0.05 M sodium sulfate/0.05 M 
lithium sulfate 
0.05 M Tris 8.5 35% v/v PEG 400 
60 0.1 M sodium chloride 0.05 M glycine 9.5 33% v/v PEG 300 
61 0.3 M magnesium nitrate 0.1 M Tris 8.0 23% w/v PEG 2000 
62 0.12 M lithium sulfate 
0.02 M Tris/0.1 M sodium 
citrate 
7.5/5.0 20% v/v PEG 300 
63 0.1 M sodium chloride 0.12 M Tris 9.4 20% v/v PEG 400 
64 0.2 M sodium chloride 0.1 M HEPES 7.0 22% v/v PEG 550 MME 
65 
0.1 M sodium chloride/0.325 M 
sodium acetate 
0.1 M Tris 8.0 21% v/v PEG 400 
66 0.02 M sodium citrate 0.08 M sodium phosphate 6.2 18% w/v PEG 2000 
67 0.02 M potassium nitrate 0.03 M potassium citrate 6.5 7.7% w/v PEG 4000 
68 
0.1 M sodium chloride/0.005 M 
magnesium chloride 
0.1 M Tris 8.5 30% w/v PEG 2000 MME 
69 0.2 M calcium chloride 0.1 M HEPES 7.0 33% v/v PEG 400 
70 0.1 M calcium chloride 0.1 M Tris 6.5 13% w/v PEG 2000 MME 
71 
0.2 M ammonium sulfate/0.02 M 
sodium chloride 
0.02 M sodium acetate 4.0 33% v/v PEG 200 
72 0.07 M sodium chloride 0.05 M sodium citrate 4.5 22% v/v PEG 400 
73 0.2 M ammonium sulfate  0.1 M sodium acetate 4.6 28% v/v PEG 550 MME 
74 None 0.05 M glycine 9.0 55% v/v PEG 400 
75 
0.1 M magnesium chloride/0.1 M 
sodium chloride 
0.1 M Tris 8.5 33% v/v PEG 400 
76 
0.1 M lithium sulfate/0.05 M 
disodium hydrogen phosphate 
0.05 M citric acid None 19% w/v PEG 1000 
77 
0.2 M magnesium chloride/0.1 M 
potassium chloride 
0.025 M sodium citrate 4.0 33% v/v PEG 400 
78 0.05 M zinc acetate 0.05 M MES 6.1 11% w/v PEG 8000 
79 0.3 M magnesium nitrate 0.1 M Tris 8.0 22% w/v PEG 8000 
80 
0.1 M sodium chloride/4% v/v 
ethylene glycol 
0.1 M MES 6.5 33% v/v PEG 400 
81 0.05 M sodium chloride 0.1 M sodium citrate 5.5 26% v/v PEG 400 
82 0.1 M lithium sulfate   0.1 M glycine 9.3 30% v/v PEG 400 
83 
0.15 M potassium citrate/0.05 M 
lithium citrate 
0.1 M sodium phosphate − 22% w/v PEG 6000 
84 0.001 M zinc sulfate 0.05 HEPES 7.8 28% v/v PEG 600 
85 0.1 M sodium chloride 0.1 M sodium phosphate 7.0 33% v/v PEG 300 
86 0.1 M sodium chloride 0.05 M Bicine 9.0 33% v/v PEG 300 
87 
0.05 M zinc acetate/6% v/v 
ethylene glycol 
0.1 M sodium cacodylate 6.0 6.6% w/v PEG 8000 
88 0.2 M lithium sulfate 0.1 M sodium citrate 3.5 28% v/v PEG 400 
89 0.1 M sodium chloride 0.1 M Tris 7.5 11% w/v PEG 4000 
90 0.05 M lithium sulfate 0.1 M tricine 7.4 7% w/v PEG 3000 
91 0.2 M calcium chloride 0.1 M MES 6.5 33% v/v PEG 400 
92 1 M sodium chloride 0.1 M sodium citrate 6.0 28% w/v PEG 4000 
93 None 0.1 M HEPES 7.5 11% w/v PEG 4000 
94 0.002 M zinc sulfate 0.08 M HEPES 7.0 25% v/v Jeffamine ED2001 
95 
0.001 M cadmium chloride/0.03 
M magnesium chloride 
0.1 M MES 6.5 30% v/v PEG 400 
96 None 0.1 M bis-tris-propane 7.0 3.0 M sodium chloride 
 
Abbreviations: 
 
ADA; N-(2-Acetamido)iminodiacetic Acid, Bicine; N,N-Bis(2-hydroxyethyl)glycine, CHES; 2-(N-Cyclohexylamino)ethane 
sulfonic Acid, HEPES; N-(2-hydroxyethyl)-piperazine-N’-2-ethanesulfonic acid, KMES; 2-(N-morpholino)ethanesulfonic 
acid potassium salt, MES; 2-(N-morpholino)ethanesulfonic acid, MME; Monomethylether, PEG; Polyethylene glycol, 
Tricine; N-[Tris(hydroxymethyl)methyl]glycine, Tris; 2-Amino-2-(hydroxymethyl)propane-1,3-diol,Tris HCl; 2-Amino-2-
(hydroxymethyl)propane-1,3-diol, hydrochloride] 
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